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Despite clear recommendations on the minimal amount of physical activity for 
achieving health benefits and reducing risk of chronic disease, the majority of people in 
the Western world remain sedentary. As a ‘lack of time’ has been identified as one of 
the main barriers to becoming and remaining physically active, in the past decade 
research has focused on high-intensity interval training (HIT) as a time-efficient 
alternative to aerobic exercise. Although initial studies convincingly demonstrated equal 
or better health benefits with various HIT protocols compared to much larger volumes 
of aerobic exercise, these HIT protocols tend to be very strenuous and as such are 
unlikely to be adhered to by sedentary populations. Furthermore, most HIT protocols 
are not as time-efficient as sometimes claimed, with the total time per exercise session 
generally exceeding 20-30 minutes. This thesis aimed to characterise the effects of a 
novel reduced-exertion HIT (ReHIT) protocol, requiring a maximum of 2 × 20 s all-out 
sprint efforts in a 10 min training session, upon insulin sensitivity, aerobic capacity, 
glycogen utilisation and associated acute metabolic responses. The ReHIT exercise 
bouts were well tolerated by participants, but were associated with a substantial 
disturbance of physiological homeostasis including muscle glycogen degradation, 
lactate accumulation, excursions in plasma volume, post-exercise oxygen consumption, 
respiratory exchange ratio and heart rate, as well as a skeletal muscle signalling response 
through AMPK, and increases in skeletal muscle GLUT4 and PGC1α mRNA expression 
(Chapter 4 and 5). The combined training studies (n=49) provide some support for 
improvements in key disease biomarkers following ReHIT, with improvements in 
insulin sensitivity observed in men, and increased aerobic capacity observed in men and 
women (Chapter 7). These observations highlight a potential regulatory role for 
glycogen in exercise-induced adaptation. However, the mean improvements in insulin 
sensitivity in men were not consistent between the two training studies (Chapter 2 and 
6), and there was a high level of variability observed between individuals (Chapter 6 and 
7). Therefore, the impact of ReHIT on insulin sensitivity needs to be further explored in 
the context of a randomised controlled trial, and the mechanisms underpinning the large 
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General Introduction and Literature Review 
1.1. Introduction 
Humankind is in the midst of a well-publicised epidemic of chronic disease with 
a consequential elevated risk of premature morbidity and mortality (Bauer et al., 2014). 
The latest statistics from the World Health Organisation suggest that 400 million people 
worldwide were obese in 2008, and this number is expected to have almost doubled by 
2015. At the same time, the worldwide prevalence of type 2 diabetes (T2D) has increased 
from 153 million people in 1980 to 347 million people in 2008 (Danaei et al., 2011). 
Both T2D and obesity substantially increase the risk of cardiovascular diseases (CVD), 
including coronary heart disease and stroke, which remain the major cause of premature 
death in modern societies (Allender et al., 2008b). In addition to the associated 
morbidity, loss of physical function and premature mortality for the patient, the current 
epidemic of chronic disease places great strain upon public health care systems (Allender 
et al., 2008b; Zhang et al., 2009; Zhang et al., 2010). 
The accumulation of excess adiposity, in particular visceral fat, is considered the 
key driver of the development of T2D and CVD (Lebovitz & Banerji, 2005; Pischon et 
al., 2008). The classic hypothesis emphasises that visceral adiposity develops initially, 
and then leads to the induction of local and systemic inflammation, the accumulation of 
ectopic fat in various tissues, and eventually severe insulin resistance, hyperglycaemia 
and T2D (Lebovitz & Banerji, 2005). However, although a lot of focus has been placed 
on the role of obesity, this is just one contributing factor, and there is a growing 
appreciation that more emphasis should be placed upon physical inactivity (Booth et al., 
2002; Chakravarthy & Booth, 2004; Thyfault & Krogh-Madsen, 2011). Indeed, recent 
epidemiological evidence suggests inactivity is a larger contributor to premature death 
compared with obesity (Ekelund et al., 2015), and laboratory experiments have shown 
that physical inactivity plays an important (and possibly primary) role both in the 
accumulation of total/visceral fat and in the development of chronic metabolic and 
vascular disease (Booth et al., 2002; Chakravarthy & Booth, 2004; Thyfault & Krogh-
Madsen, 2011). On the other hand, regular physical activity and/or structured exercise 




training is recognised as an important strategy to prevent obesity, T2D and CVD (Pan et 
al., 1997; Knowler et al., 2002; Szostak & Laurant, 2011; Thompson et al., 2012).  
The knowledge that inactivity contributes to, and regular exercise prevents, the 
development of chronic metabolic disease has led to a concerted worldwide effort to 
promote exercise participation in the general population. Indeed, the first position stand 
and guidelines for exercise participation were published in 1975 and have been updated 
continually since (Blair et al., 2004). In spite of this, current data suggest that the 
majority of individuals do not accumulate appropriate amounts of exercise required to 
improve and maintain metabolic health (Allender et al., 2008a). Of course the reasons 
for this are multifactorial. Whilst psychological factors will undoubtedly be heavily 
involved and part of a large scale solution, it is also clear that the current focus on a high 
volume of moderate intensity exercise fails to take into account key perceived barriers 
to exercise participation, the most common of which appears to be ‘a lack of time’ 
(Reichert et al., 2007; Korkiakangas et al., 2009). As such, over the last 10 years there 
has been a drive from exercise physiologists to develop alternative, more time-efficient 
exercise interventions which remain effective at improving health (Gibala et al., 2012).  
The purpose of this literature review is to: i) explore the role of inactivity in the 
development of chronic disease, with a focus on insulin resistance, T2D and CVD, ii) 
explore the current evidence for the role of exercise in alleviating risk factors for T2D 
and CVD, and iii) to review current progress in developing time-efficient alternatives to 
current exercise recommendations for improving metabolic and cardiovascular health.  
1.2.  Evolutionary Perspectives on Physical Activity and Chronic         
Disease 
The efficiency of human metabolic processes, and by extension long term metabolic 
health status, is determined by the complex interactions between our genes, our 
behaviours and our environment. Even at this point, it is important to take a step back 
and consider that the human genome was naturally selected in a context (50000-10000 
BC; Late-Palaeolithic era) where our ancestor’s existence was dependent on the 
procurement of wild food resources through hunting or foraging (Booth et al., 2002). As 
such, the attainment of adequate nutrition, and indeed other activities of daily living, 
were inextricably linked to a high physical activity energy expenditure, and this would 




likely have been characterised by a mixture of ‘endurance’, ‘strength’ and ‘peak efforts 
alternating with rest’ (Astrand, 1992; Eaton & Eaton, 2003). In line with the ‘survival 
of the fittest’ principle of evolution, it follows that individuals with a high level of 
physical fitness, and a high capacity for performing physical activity, would have thrived 
in such an environment, whilst unfit individuals with a low capacity for performing 
physical activity would have been unable to secure sufficient nutrition, and likely 
perished prior to reaching reproductive age (Booth et al., 2002; Chakravarthy & Booth, 
2004).  
At the same time, we must consider that for prehistoric humans the availability 
of food was likely inconsistent, and hence it would have been common for our ancestors 
to undergo cyclical periods of feast interspersed with periods of food shortage 
(Chakravarthy & Booth, 2004). Neel (1962) speculated that these enforced phases of 
famine and feast, in combination with those of physical activity and rest, would have 
favoured the selection of a ‘thrifty’ genotype that was exceptional both in energy 
utilisation and energy storage. By prioritising the replenishment of intramuscular 
substrates (i.e., glycogen and triglyceride) and the storage of a larger proportion of 
ingested calories in fat depots during periods of feast/low-activity, individuals 
possessing a more ‘thrifty’ genotype would have been better adapted for survival during 
subsequent periods of famine/high-activity (Neel, 1962; Chakravarthy & Booth, 2004). 
Taken together, this hypothesis would suggest that the human genome, and by extension 
human physiology/biochemistry, has become programmed to expect regular physical 
activity (Booth et al., 2002; Chakravarthy & Booth, 2004).  
 This genetic make-up is unlikely to have changed over the last ~40,000 years 
(Eaton & Konner, 1985), whilst in many cultures the past century alone has seen 
dramatic changes to the environment in which these genes were naturally selected. For 
the vast majority of individuals, physical activity is no longer obligatory for many 
activities of daily living and a large portion of the day is spent sedentary (Allender et al., 
2008a). At the same time, access to food is no longer inconsistent; on the contrary we 
have easy access to a large amount of calorie rich but nutritionally poor foods (French 
et al., 2001). Hence, the cycling of feast/low-activity and famine/high-activity is no 
longer a part of our environment. As a result, metabolic genes which were naturally 
selected to expect a high level of physical activity are now maladapted, leading to an 




excess of energy storage in a context where fuel utilization/turnover is vastly reduced 
(Booth et al., 2002; Chakravarthy & Booth, 2004). Over the same time period, there has 
undoubtedly been a substantial increase in the age-specific prevalence of many chronic 
diseases, in particular in obesity, T2D and CVD (Danaei et al., 2011; Wang et al., 2011). 
Whilst the potential genetic propensity for each of these diseases is recognised 
(Marenberg et al., 1994; Poulsen et al., 1999; Zdravkovic et al., 2002; O'Rahilly & 
Farooqi, 2006), the major underlying cause for the rapid increases in prevalence must be 
at least partially related to the changes in physical activity and feeding patterns (Roberts 
& Barnard, 2005). In particular there is an emerging understanding of the fundamental 
role of physical inactivity in the development of each of these diseases (Booth et al., 
2002; Chakravarthy & Booth, 2004; Katzmarzyk & Janssen, 2004; Thyfault & Krogh-
Madsen, 2011).  
The contention that physical inactivity is associated with detrimental effects 
upon human health has long been recognised. For example, over 2000 years ago the 
Greek physician Hippocrates noted: ‘That which is used develops, and that which is not 
used wastes away. . . If there is any deficiency in food or exercise the body will fall 
sick’, whilst in 1769 William Buchan wrote: ‘It seems to be catholic law that no creature, 
without exercise, can enjoy health. Man alone deviates from this original law, and suffers 
accordingly’. Over the last 60 years a substantial body of scientific literature has been 
accrued to support these statements. In 1953, Jerry Morris and colleagues reported on 
data which examined the relationship between occupational physical activity and rates 
of CVD. They showed that sedentary London bus drivers had twice the rate of 
cardiovascular mortality compared with active London bus conductors and suggested 
that physical activity was providing the cardioprotective effects (Morris et al., 1953). 
Following on from this, there are now large well-controlled epidemiological studies 
demonstrating that low levels of physical activity independently associate with a ∼50% 
increased risk of T2D, a ∼40% increased risk of coronary artery disease, a ∼60% 
increased risk of stroke, a ∼30% increase risk of hypertension, a ∼60% increase risk of 
osteoporosis, and a ∼40% increased risk of colon cancer (Katzmarzyk & Janssen, 2004). 
Perhaps even more convincing is the strong inverse relationship between levels of 
cardiorespiratory fitness, the risk of chronic disease, and levels of all-cause mortality 
(Blair et al., 1989; Barlow et al., 1995; Blair et al., 1995; Blair et al., 1996; Lee et al., 
1998; Lee et al., 1999; Myers et al., 2002). The variance in individual levels of 




cardiorespiratory fitness, usually defined as the maximal level of oxygen uptake during 
incremental exercise, is explained by both genetic (~50%) and environmental (~50%) 
factors (Bouchard et al., 1999). Even so, it noteworthy that the only environmental factor 
known, with any relevance, to alter VO2max is physical activity (Church, 2009). Thus, 
the epidemiological data linking VO2max to long term health status also partly indirectly 
implicates the key role of physical inactivity in the development of chronic disease. 
Taken together, there is strong epidemiological evidence that physical inactivity is an 
important risk factor for chronic disease.  
1.3. Physical Inactivity, Insulin Resistance and Chronic Disease 
The biological mechanisms linking physical inactivity to an increased risk of chronic 
metabolic disease are partly linked to the impact of physical inactivity upon insulin 
action and glucose homeostasis (Krogh-Madsen et al., 2010; Thyfault & Krogh-Madsen, 
2011; Mikus et al., 2012). This section will explore the physiological regulation of 
insulin and glucose metabolism in humans, and subsequently examine the effects of 
inactivity and exercise training upon these variables.  
1.3.1. Overview of Metabolic Control in Humans 
In humans, glucose and lipids are quantitatively the most important substrates 
for maintaining cellular energy balance, and their absorption, production, uptake, 
storage and utilisation are intricately controlled. This is largely achieved through the 
complex cross-talk between skeletal muscle, adipose tissue, the liver and the endocrine 
pancreas, but there is also a more broad regulatory input from the central nervous system 
which is influenced by signals from each of these tissues (Wasserman, 2009; Jordan et 
al., 2010). In response to different nutritional and physical activity stimuli, human cells, 
with the notable exception of the brain, are readily able to switch between glucose and 
fatty acid oxidation to meet their ATP demands, which is termed ‘metabolic flexibility’ 
(Kelley & Mandarino, 2000).  
 In the fasted state, when glucose availability is low, non-esterified free-fatty 
acids (NEFA) delivered from adipocytes are preferentially oxidised in tissues such as 
skeletal muscle where the uptake and utilisation of NEFA appears to be largely 
dependent on availability (Frayn et al., 2006). Nevertheless, plasma glucose 




concentrations during times of fasting must still be maintained for use in the brain and 
erythrocytes which rely solely on this sugar, and this is achieved through the 
coordination of hepatic glycogenolysis and gluconeogenesis for subsequent hepatic 
glucose output (Wasserman, 2009). These actions are supported by the low 
insulin/glucagon ratio in the circulation. Insulin is the primary suppressant of adipose 
tissue lipolysis and hepatic glucose production, as well as the primary activator of 
glucose disposal in peripheral tissues, whilst glucagon stimulates endogenous glucose 
production in the liver and helps to promote NEFA release in adipocytes (Abdul-Ghani 
& DeFronzo, 2010). The secretion of other hormonal factors, such as adrenaline, work 
in concert with the low plasma insulin concentrations and high glucagon concentrations 
to activate lipolysis in adipose tissue and hepatic glucose output in the fasted state and 
during exercise (Wasserman, 2009).  
In response to a mixed meal or glucose challenge there is a rise in plasma glucose 
and lipid availability, and the body switches from a predominantly catabolic state to a 
predominantly anabolic state, with a drive for nutrient uptake and storage. There is a 
strong suppression of adipose tissue lipolysis and hepatic glucose output whilst glucose 
uptake in skeletal muscle and lipid uptake in adipose tissue are stimulated. In the 
postprandial state, glucose becomes the primary substrate for oxidation (until blood 
glucose concentrations are normalised), but a proportion of the ingested glucose will 
also be used to replenish both liver and skeletal muscle glycogen stores. These effects 
are largely achieved through the release of insulin into the circulation as well as reduced 
glucagon secretion (Wasserman, 2009).  
1.3.2. Insulin 
Insulin is an endocrine peptide hormone which exerts a myriad of cellular effects 
essential for the maintenance of metabolic homeostasis. Synthesised and released by the 
pancreatic β-cells, insulin is secreted in a biphasic manner in response to increasing 
plasma glucose concentrations, with a rapid first phase occurring within 10 min of 
glucose provocation and subsequently giving way to a more enduring phase over several 
hours (Eliasson et al., 2008). Insulin secretion is much greater following an oral glucose 
load compared with the intravenous injection of glucose (Defronzo, 2009). This effect 
is accounted for by the release of incretin hormones in the small intestine, in particular 




the release of GLP-1 and GIP are known to potentiate insulin secretion (Defronzo, 
2009). GLP-1 is also known to suppress glucagon release from the pancreatic α-cells 
and thus indirectly inhibits hepatic glucose output and helps to reduce glucose entry into 
the circulation in the fed state (Defronzo, 2009).  
The secretion of insulin results in the coordination of several multi-tissue 
metabolic processes which work in concert to restore blood nutrient homeostasis. In 
skeletal muscle insulin stimulates glucose uptake, glucose oxidation and glycogen 
synthesis. In adipocytes, insulin also stimulates glucose uptake but more importantly 
suppresses lipolysis and hence NEFA release as well as promoting lipid uptake and 
triglyceride synthesis. In the liver, insulin is not involved in glucose uptake, but does 
regulate hepatic glycogen synthesis, and is a potent inhibitor of hepatic glycogenolysis 
and gluconeogenesis which plays a key role in blunting the postprandial rise in blood 
glucose concentrations. The suppression of hepatic glucose output occurs at relatively 
low insulin concentrations whereas actions in peripheral tissues require a much higher 
insulin concentration (Prager et al., 1986). Importantly, insulin also acts on endothelial 
cells to stimulate nitric oxide (vasodilator) and endothelin 1 (vasoconstrictor) 
production, alter blood flow dynamics and augment its own delivery to each of these 
tissues (Clark et al., 2003; Muniyappa et al., 2007; Barrett et al., 2011).  
Quantitatively, skeletal muscle is widely accepted to be the major tissue 
responsible for insulin mediated glucose disposal. Under conditions of euglycaemia 
hyperinsulinemia >75% of infused glucose is taken up by the skeletal muscle bed (Baron 
et al., 1988). However, it should be noted that if the glucose is administered orally then 
a substantial proportion will be taken up by other tissues. For example, after an oral 
glucose bolus (1 gram/kg body weight),  29% of the ingested glucose was taken up by 
the liver, 26% by skeletal muscle, 23% by the brain and the other 22% was taken up by 
other unspecified tissues (Kelley et al., 1988). Likewise, following a high carbohydrate 
mixed meal (75 g carbohydrate, 37 g protein, and 17 g fat), skeletal muscle glucose 
uptake accounted for ~50% of the absorbed glucose, with the rest taken up by other 
tissues (Capaldo et al., 1999). Nevertheless, insulin-mediated glucose uptake plays a key 
role in regulation of whole-body metabolic control. Importantly, the beneficial effects 
of exercise upon insulin sensitivity are largely explained by improvements in skeletal 




muscle glucose uptake (Dela et al., 1992; Dela et al., 1995), and therefore insulin’s 
effects in skeletal muscle will be the main focus of this review.  
1.3.3. Insulin action in skeletal muscle 
 In order to bind to the plasma membrane insulin receptor insulin must access the 
interstitial fluid compartment bathing the peripheral target cells, first through delivery 
to the peripheral capillary bed, and then by crossing the endothelial cell barrier. It is now 
recognised that insulin plays a major role in controlling its own delivery, and delivery 
of ingested nutrients, to the interstitial fluid surrounding the cell membrane, and there is 
evidence that these hemodynamic actions of insulin represent an important rate-liming 
step in glucose disposal in muscle and adipose (Clark et al., 2003; Muniyappa et al., 
2007; Barrett et al., 2011). The hemodynamic effects of insulin encompass three distinct 
mechanisms: 1) insulin has been shown to stimulate the dilation of resistance vessels to 
promote an increase in total blood flow to muscle and hence an increase in insulin and 
glucose delivery to muscle; 2) insulin results in recruitment of muscle capillaries to 
simultaneously promote insulin and glucose delivery and, perhaps more importantly, 
broaden the endothelial exchange area and encourage endothelial hormone/substrate 
crossing; and 3) insulin directly augments its transport through the endothelial cell lining 
(i.e., through the endothelial cell itself). These effects are largely regulated through the 
stimulation of nitric oxide production from the endothelium. The haemodynamic effects 
of insulin have recently been covered in several excellent reviews and the reader is 
referred to these for a more detailed discussion (Clark et al., 2003; Muniyappa et al., 
2007; Barrett et al., 2011).  
Following entry into the interstitial fluid insulin stimulates the translocation of 
glucose transporter protein 4 (GLUT4) to the plasma membrane, as well as the activation 
of key intramyocellular enzymes involved in glucose phosphorylation, glucose 
oxidation and glycogen synthesis, all of which work synergistically to promote the 
effective clearance of glucose from the blood/interstitium into skeletal muscle. In the 
fasted state, GLUT4 is stored in intracellular microvesicles within the cytoplasm. 
However, under postprandial conditions (when plasma and interstitial insulin 
concentrations are elevated) the GLUT4 vesicles are moved to the plasma membrane 
and GLUT4 protein fuses with the plasma membrane and allows facilitated transport of 




glucose into the muscle cell. Acceleration of these intracellular events is mediated 
through the binding of insulin to a transmembrane receptor and the subsequent initiation 
of an intracellular phosphorylation/dephosphorylation signalling cascade (Wojtaszewski 
& Richter, 2006). Insulin signalling is an extremely complex process (figure 1.1), 
involving both positive and negative enzyme crosstalk, and ultimately requires 
coordination of several propagating pathways to be fully efficient, especially in the case 
of GLUT4 vesicle trafficking (Wojtaszewski & Richter, 2006).  
The process is initiated when insulin binds to the extracellular α-subunits of the 
insulin receptor which leads to a structural reconfiguration, increased activity of a 
tyrosine kinase within the transmembrane β-subunits, binding of ATP to the 
transmembrane β-subunits, and the subsequent receptor auto-phosphorylation (Saltiel & 
Kahn, 2001). This causes the association and complementary tyrosine residue 
phosphorylation of numerous insulin receptor substrates, the most important of which 
appears to be IRS-1 (Wojtaszewski & Richter, 2006; Abdul-Ghani & DeFronzo, 2010). 
The subsequent docking of the phosphorylated IRS-1 with the p85 regulatory subunit of 
the enzyme phosphatidylinositol 3-kinase (PI3K), leads to the activation of the p110 
catalytic subunit of the same enzyme and initiates its movement to the plasma membrane 
(Wojtaszewski & Richter, 2006). Here PI3K mediates the conversion of 
phosphatidylinositol diphosphate (PIP2) to phosphatidylinositol triphosphate (PIP3) 
within the plasma membrane and the consequential recruitment of phosphoinositol-
dependent protein kinase 1 (PDK-1) to the plasma membrane in association with 
Akt/PKB and atypical protein kinase C (aPKC), all of which then become activated 
(Wojtaszewski & Richter, 2006). In addition, PI3K is thought to activate Rac-1, 
independently of PIP3 production, and the activation of Rac-1 is proposed to directly 
affect GLUT-4 trafficking (Chiu et al., 2011). The activation of Akt/PKB leads to the 
propagation of two pathways important in insulin-mediated glucose disposal. Firstly, 
Akt/PKB is known to phosphorylate glycogen synthase kinase 3 (GSK-3 α/β) which 
subsequently removes the inhibitory action upon glycogen synthase and hence glycogen 
synthesis (Saltiel & Kahn, 2001). Secondly, Akt/PKB is thought to result in the 
activation of AS160 (also known as TBC1D4) (Bogan, 2012). In the fasted state, AS160 
inhibits the activity of Rab proteins; however, upon insulin stimulation the activated 
Akt/PKB phosphorylates AS160, releases the inhibition of Rab proteins which leads to 
the reorganisation of the muscle cytoskeleton which promotes GLUT4 translocation 




(Bogan, 2012). Insulin also stimulates GLUT4 translocation through a signalling 
cascade that is independent of PI3K, since genetic ablation of PI3K does not completely 
prevent skeletal muscle glucose uptake (Kanzaki, 2006). The PI3K independent pathway 
is thought to involve a separate pathway promoted via the phosphorylated insulin 
receptor which involves activation of TC10 which is directly involved in GLUT4 
translocation (Bogan, 2012).  
 
 
Figure 1.1. Insulin signalling related to glucose disposal in skeletal muscle. Solid lines 
represent canonical signalling events, whilst dotted lines represent the final metabolic effect. aPKC 
atypical protein kinase C, Akt/PKB protein kinsase B, GLUT4 glucose transporter 4, IR insulin receptor, 
IRS-1 insulin receptor substrate-1, PDK phosphoinositide-dependent kinase 1, PI3K phosphoinositide 3-
kinase, PIP2 phosphoinositide 4,5-bisphosphate, PIP3 phosphatidylinositol 3,4,5-triphosphate, Rab-GDP 
Rab guanosine disphosphate, Rab-GTP Rab guanoside triphosphate, AS160 Akt substrate of 160 kDa. 



























1.3.4. Insulin Sensitivity and Insulin Resistance 
The effectiveness of insulin action upon insulin sensitive tissues, for example in 
skeletal muscle, can be characterised in terms of insulin sensitivity and insulin 
responsiveness. Insulin sensitivity refers to the concentration of insulin required to elicit 
a half maximal metabolic effect, whilst insulin responsiveness describes the magnitude 
of the effect that is induced by the insulin concentration that is maximally effective 
(Holloszy, 2005). Insulin resistance describes a state whereby ‘normal’ insulin 
concentrations are associated with a reduced physiological action; in other words, there 
is a downward right shift in the insulin action dose response curve meaning there is a 
reduced metabolic response for any given concentration of insulin. The body’s primary 
initial response to tissue insulin resistance is an increase in insulin secretion which is 
required to overcome the tissue resistance and ensure metabolic homeostasis is 























Figure 1.2. The relationship between insulin sensitivity and insulin secretion. Figure taken from 
Roberts et al (2013). If an individual goes from being physically active (point A) to being sedentary (point 
B) there will be a fall in insulin sensitivity and a compensatory rise in insulin secretion to maintain normal 
glucose tolerance. The reverse would be true for an individual going from a sedentary to an active lifestyle. 
A sedentary lifestyle characterised by reduced insulin sensitivity creates a permissive environment 
whereby insulin sensitivity may continue to deteriorate (see text). Progression to prediabetes (impaired 
fasting glucose or impaired glucose tolerance) (point C) and type 2 diabetes (point D) takes many years 
and is characterised by a further reduction in insulin sensitivity, but also a drop in insulin secretion.   
 






There are a number of different methods for the assessment of insulin 
sensitivity/insulin resistance. The gold standard measure is the hyperinsulinemic 
euglycemic clamp (Muniyappa et al., 2008) and this is a popular method for 
demonstrating changes in insulin sensitivity with exercise training. This method uses a 
steady state infusion of exogenous insulin to raise plasma insulin levels, and is combined 
with a continuous infusion of exogenous glucose which is manipulated to keep plasma 
glucose concentrations (measured every 5-10 minutes) constant. Under 
hyperinsulinemic conditions, it is assumed that endogenous glucose output from the 
liver is completely suppressed; thus the rate of glucose infusion required for maintaining 
plasma glucose concentrations at a constant levels can be considered equal to the rate of 
glucose disappearance into all the tissues in the body. In combination with tracers, this 
technique can be used to determine tissue specific insulin sensitivity. Whilst this 
technique is considered the reference standard, it was deemed unsuitable for the series 
of studies described in the present thesis for several reasons:  (i) it is difficult to perform, 
quite invasive and requires well trained and experienced clinical staff; (ii) it is time 
consuming to perform for both participant and researcher; and (iii) it is expensive to 
perform. It could also be argued that this measure is not representative of the 
physiological challenge of meal feeding, which requires the effective coordination of 
multiple tissues, substrates and hormones.  
The oral glucose tolerance test (OGTT) maps the blood glucose and insulin 
response to an orally ingested glucose drink and is commonly utilised in clinical settings 
to detect patients with impaired glucose tolerance and T2D. The OGTT is cost-effective 
and simple to perform: following a 10-12 hour overnight fast, blood samples are drawn 
before and then at various time-points for up to 180 minutes after the oral ingestion of a 
75 g glucose solution and are analysed for glucose and insulin concentrations. The 
OGTT gives a more valid indication of the body’s response to a normal physiological 
challenge that is encountered on a daily basis. The OGTT response is reflective of the 
whole body but calculations have been developed which give an indication of liver (e.g., 
HOMA-IR) and peripheral specific (e.g., Cederholm) insulin sensitivity. These indexes 
have been shown to correlate well with the gold standard clamp measures of insulin 
sensitivity (Piche et al., 2007). However, the between-test reliability of the response to 
an OGTT can be poor (CV 8-15% for repeated tests and is therefore not ideal for 




measuring small or subtle changes in insulin sensitivity (Libman et al., 2008; Jimenez-
Navarro et al., 2010). However, with interventions that are specifically targeting 
relatively large changes in insulin sensitivity, for example exercise training, then the 
OGTT should be able to detect these. The measurement of glycated haemoglobin, which 
reflects long term regulation of blood glucose concentration over the preceding 6 weeks, 
has also been used in research studies.  
The regulation of whole-body insulin action is complex and involves 
coordination of multiple tissues. All of these tissues are able to acutely (i.e. hours to 
days) adjust the level of insulin sensitivity at the cellular level depending largely upon 
intracellular nutrient availability (Schenk et al., 2008). Specifically, in response to 
perturbations in nutrient availability, for example a reduction in skeletal muscle fibre 
glycogen content after prolonged contraction, each cell is able to intrinsically modify 
insulin action and hence nutrient (e.g. glucose) uptake to allow return of intracellular 
nutrient homeostasis (Schenk et al., 2008). To add another level of complexity, these 
acute fluctuations in cellular insulin action will take place (and be modified) in the 
context of chronic extracellular signals determined by interactions between the level of 
obesity, exercise training status, and also genetic variations (Schenk et al., 2008). The 
progressive development of insulin resistance over time, which eventually manifests in 
appearance of metabolic abnormalities (e.g. T2D), is largely determined by changes in 
the chronic factors regulating insulin action (Schenk et al., 2008). However, it is 
important to note that an absence of the intrinsic cellular signals which act to increase 
insulin sensitivity may, over a prolonged period of time, influence the extent to which 
such chronic deterioration of whole body insulin sensitivity occurs (Schenk et al., 2008). 
This is particularly evident when discussing the role of physical inactivity in the 
development of insulin resistance and T2D.  
The development of insulin resistance, in particular in skeletal muscle, is the 
strongest predictor of the future development of T2D (DeFronzo & Tripathy, 2009). The 
metabolic consequences of T2D, including microvascular and macrovasclar damage can 
largely be explained by the characteristic high blood glucose concentrations in this 
disease (Gerich, 2003). However, the development of T2D takes many years and is 
characterised by a slow loss of glycaemic control over time, in other words small 
increases in fasting and postprandial glucose levels. In a meta-analysis including 95,783 




individuals of varying levels of glucose tolerance, there appeared to be an exponential 
relationship between the risk of cardiovascular events and both fasting and postprandial 
glucose concentrations irrelevant of any impaired or diabetic threshold (Coutinho et al., 
1999).  Likewise, studies have shown strong relationships between levels of glycated 
haemoglobin and the risk of cardiovascular disease which is present in both healthy and 
diabetic ranges (Stratton et al., 2000; Khaw et al., 2001). Thus, even in healthy 
individuals controlling postprandial glucose excursions by maintaining or improving 
insulin sensitivity across the lifespan represents an important outcome for preventing 
cardiovascular disease (Lin et al., 2009). Prior to any deterioration in glycaemic control 
the reduction in insulin sensitivity leads to an elevation in insulin secretion and systemic 
hyperinsulinemia. Elevations in systemic postprandial insulin concentrations have also 
been shown to be predictive of future cardiovascular disease in healthy individuals 
(Pyörälä et al., 1998; Pyörälä et al., 2000).   
In 1988, Reaven presented the ‘insulin resistance syndrome’ hypothesis, where 
he outlined potential evidence supporting the primary role of insulin resistance (i.e. 
hyperinsulinemia) in the development of a clustered cardiometabolic disease risk profile 
(Reaven, 1988). The scientific evidence for this hypothesis is strong (DeFronzo, 2010). 
Briefly, it appears as though chronically elevated levels of insulin in the context of an 
energy surplus promotes de novo lipogenesis, elevated VLDL synthesis, the 
accumulation of visceral fat, chronic low grade systemic inflammation, hypertension 
and atherogenesis (DeFronzo, 2010). Thus it appears that insulin resistance represents 
an important risk factor for T2D and cardiovascular disease.  
 
1.3.5. The Role of Inactivity in the Development of Insulin Resistance 
At the metabolic and molecular levels, the causes of skeletal muscle insulin 
resistance are numerous and complex, and include: i) impaired insulin and glucose 
delivery to, and across, the endothelium (Clark, 2008); ii) abnormal secretion and action 
of adipokines, such as leptin and adiponectin (Rabe et al., 2008); iii) impaired insulin-
mediated glycogen synthesis (Petersen et al., 2007); iv) impaired mitochondrial function 
(Petersen et al., 2004); (v) lipid oversupply and elevated intramyocellular fatty acid 
species, such as diacylglycerol (Samuel et al., 2010); vi) chronic systemic inflammation 




(Shoelson et al., 2006); and vii) oxidative stress (Meigs et al., 2007), all of which may 
be intertwined. The driver of these defects is generally considered to be the accumulation 
of visceral adiposity and ectopic fat, however, the role of physical inactivity cannot be 
underestimated, and may in fact be the primary pathological driver (Thyfault & Krogh-
Madsen, 2011). Support from this hypothesis comes from numerous studies which have 
examined changes in insulin sensitivity, metabolic flexibility, lipid trafficking, and 
substrate oxidation in response to enforced periods of inactivity (Bergouignan et al., 
2011; Mikus et al., 2011; Thyfault & Krogh-Madsen, 2011).  
It has repeatedly been shown that a reduction in insulin sensitivity occurs in 
humans following a period of bed rest and can occur in as little as 3 days (Lipman et al., 
1972; Hamburg et al., 2007; Alibegovic et al., 2009; Alibegovic et al., 2010). These 
findings have subsequently been replicated using more applicable models of reduced 
physical activity. For example, Krogh-Madsen and colleagues examined the effect of 
reducing the average daily step count from ~10,000/day to ~1500/day over a period of 
14 days in healthy men who were recreationally active (Krogh-Madsen et al., 2010). 
They demonstrated a 17% reduction in insulin sensitivity (Krogh-Madsen et al., 2010). 
The change in insulin sensitivity appears to be linked specifically to a reduction in 
peripheral glucose disposal (i.e. muscle glucose uptake) in response to a glucose load, 
whilst there does not seem to be any changes in hepatic glucose output (Krogh-Madsen 
et al., 2010). 
An enforced period of inactivity also leads to an increased accumulation of 
visceral fat (Olsen et al., 2008; Krogh-Madsen et al., 2010). Therefore, an important 
question to answer is whether the reduction in insulin sensitivity is a result of the 
inactivity per se or a reflection of positive energy balance. However, a recent study using 
the bed rest model indicates that inactivity causes insulin resistance even when energy 
balance is clamped (Bergouignan et al., 2009). Likewise, Stephens recently showed that 
the deleterious impact of 1 day of sitting upon insulin sensitivity was present both with 
and without an energy surplus across the same time period (Stephens et al., 2011). 
Furthermore, although Olsen and colleagues showed a 7% increase in visceral fat 
following two weeks of step reduction, they also observed a reduction in lean mass and 
a 1.2 kg drop in body mass suggesting that no overall energy surplus was present over 
the two weeks (Olsen et al., 2008; Krogh-Madsen et al., 2010). Lastly, the rapid increase 




in fat pad mass in rodents following forced cessation of voluntary wheel running occurs 
even when energy balance is maintained (Laye et al., 2007). These studies strongly 
suggest that inactivity causes both a reduction in peripheral insulin sensitivity and an 
increase in visceral fat. The effects do not appear to be caused by positive energy 
balance; rather en enforced period of inactivity alters postprandial fate of ingested 
nutrients (by altering insulin sensitivity) and alters energy storage (by increasing fat 
mass) (Thyfault & Krogh-Madsen, 2011). 
The reduction in skeletal muscle insulin sensitivity during a period of inactivity 
appears to take place before any detectable increase in visceral fat mass (Knudsen et al., 
2012). Thus, it has been hypothesised that the initial reduction in insulin sensitivity with 
inactivity may be a mechanism to alter the metabolic fate of ingested nutrients away 
from a fuel replete skeletal muscle cell and towards storage in adipose tissue (Thyfault 
& Krogh-Madsen, 2011). This contention is supported by well controlled laboratory 
experiments showing a re-partitioning of energy in response to changes in skeletal 
muscle insulin sensitivity in humans (Blanc et al., 2000; Petersen et al., 2007; Rabøl et 
al., 2011). Specifically, the greater insulin and glucose spikes induced by muscle insulin 
resistance in response to reduced activity (Krogh-Madsen et al., 2010; Mikus et al., 
2012) may provide a greater opportunity to take up dietary fat into adipose tissue and 
for excess glucose to be diverted toward de novo lipogenesis (Blanc et al., 2000; Petersen 
et al., 2007; Rabøl et al., 2011).  This is supported by recent studies demonstrating that 
exercise prevents both the deterioration in skeletal muscle insulin sensitivity and the 
accumulation in visceral fat mass in response to a two week step reduction and/or 
profound energy surplus (Walhin et al., 2013; Krogh-Madsen et al., 2014). Overall, the 
re-partitioning of ingested nutrients in response to long term inactivity may initiate a 
cycle of events which leads to accumulation of visceral fat, systemic hyperlipidemia, 
elevated systemic glycemia, excess ectopic fat storage, chronic low grade inflammation, 
metabolic inflexibility and atherogenesis (Bergouignan et al., 2011; Mikus et al., 2011; 
Thyfault & Krogh-Madsen, 2011). This hypothesised cycle of events is depicted in 
figure 1.3A and 1.3B, and described in further detail in the figure legends.  
 In summary, recent evidence supports that physical inactivity plays an important 
role in the development of skeletal muscle insulin resistance. This is not to downplay 
the role of other metabolic factors (described above), but rather suggesting that physical 




inactivity is the primary initiating factor and provides a permissive environment by 
which such metabolic dysfunction emerges over time (Booth et al., 2002; Chakravarthy 
& Booth, 2004; Bergouignan et al., 2011; Thyfault & Krogh-Madsen, 2011). When one 
then considers that physical inactivity also results in an accelerated loss of 
cardiorespiratory fitness and lean muscle tissue, two factors which are known to also 
play a role in the development of chronic metabolic disease, then the role of inactivity 
in chronic disease development becomes even more apparent (Krogh-Madsen et al., 
2010). The data described above does not definitively prove that physical inactivity 
causes cardiometabolic disease, however the changes that have been demonstrated are 
moving in a pathological direction and this contention is well supported by 
















Figure 1.3A. Healthy metabolic cycling in the context of high levels of physical activity and/or exercise. Figure adapted from Chakravarthy and Booth (2004). As 
described in text, human evolution took place in the context of cycles of physical activity/famine and inactivity/feast. During periods of feast the short periods of inactivity allowed 
replenishment of muscle glucose and fat stores that would then be utilised during the subsequent period of fasting and physical activity. This ‘thrifty’ genotype was shaped during 
evolution but likely persists today. TG triglyceride, GLUT4 glucose transporter 4, AMPK amp-activated protein kinase 
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Figure 1.3B. Unhealthy metabolic cycling in the context of low levels physical activity and/or exercise. Figure adapted from Chakravarthy and Booth (2004). When 
skeletal muscle stores of glucose and fat are not turned over by regular physical activity and/or exercise, ‘thrifty’ mechanisms continually shunt excess glucose and fat into adipose 
tissues and ectopic fat stores. The continual inactivity and excess fat and glucose intake create a permissive environment which, over 30-40 years, will lead to the manifestation 
of type 2 diabetes and cardiovascular disease. TG triglyceride, GLUT4 glucose transporter 4, AMPK amp-activated protein kinase 
Thrifty Storage
(High storage of excess 
glucose and TG in 
adipose tissue; little 
goes to skeletal muscle)
Famine & Activity
(Essentially Simultaneous) 
(Decrease glycogen and TG stores
Feast
(Intake of glucose and fat)
Unlimited food supply 
without exercise induced 
reduction of glucose and 
TG in skeletal muscle, nor 
exercise induced increase 





shunted to de novo 
lipogenesis; Excess 
FFA shunted towards 
unhealthy storage)
Cycle Stalled
Excess Visceral & 





Further reductions in 
insulin sensitivity





In the context of low 
physical activity




1.4. Exercise and Insulin Sensitivity 
1.4.1. Epidemiological Evidence 
There is good evidence for the positive effect of increasing physical activity in 
the prevention of T2D (Pedersen & Saltin, 2006). For example, numerous correlational 
studies where physical activity has been measured by questionnaire generally report that 
a higher level of physical activity, independent of other risk factors (e.g. body 
composition), is associated with a reduced risk of developing T2D (Helmrich et al., 
1991; Manson et al., 1991; Hu et al., 1999; Laaksonen et al., 2002). Of course, these 
studies do not indicate causation and it is also possible that a high level of physical 
activity is a sign that you are in good health, rather than the physical activity leading to 
good health. However, more convincing evidence comes from several well controlled 
clinical trials which have demonstrated that interventions involving physical activity 
alone (Pan et al., 1997) or in combination with dietary changes  (Pan et al., 1997; 
Tuomilehto et al., 2001; Knowler et al., 2002) are associated with a reduced risk of 
developing T2D in populations with impaired glycaemic regulation and therefore at high 
risk of developing the disease. Pan et al. (1997) included an exercise only intervention 
group and observed that the risk of developing T2D was reduced by 46% with exercise 
over a 6 year period, a risk reduction that was comparable to their intervention which 
combined exercise and dietary changes. It is particularly noteworthy that the 
preventative effects of lifestyle changes (i.e. better diet and more physical activity) are 
greater than those observed with currently recommended pharmacological treatments 
(Knowler et al., 2002). The beneficial impact of exercise training upon the development 
of T2D is thought to be partly related to the maintenance or improvement of whole body 
insulin sensitivity.  
The beneficial effects of physical activity/exercise upon insulin sensitivity are 
largely explained by improvements in glucose uptake into skeletal muscle (Dela et al., 
1992; Dela et al., 1995). In this respect, exercise is thought to exert three distinct 
regulatory roles on skeletal muscle glucose uptake. Firstly, skeletal muscle contractions 
are known to increase glucose uptake independent of insulin (Ploug et al., 1984; Nesher 
et al., 1985; Zorzano et al., 1986; Wallberg-Henriksson et al., 1988; Gao et al., 1994). 
However, in the immediate recovery period the glucose response to an OGTT may 




actually be elevated in healthy subjects uptake due to enhanced intestinal glucose 
extraction in spite of the increased muscle glucose uptake (Knudsen et al., 2014). The 
effect of contraction on muscle glucose uptake is transient, subsiding completely ~2-3 
hours after the cessation of the muscle contractions (Lauritzen et al., 2010). However, it 
appears to be replaced by an acute enhancement of insulin-stimulated recruitment of 
GLUT4 and hence postprandial glucose disposal in the exercised muscle, which can be 
detected for 24-48 hours post-exercise, and may be linked to the replenishment of 
skeletal muscle glycogen stores (Bogardus et al., 1983; Cartee et al., 1989; Gulve et al., 
1990). Lastly, the cumulative effect of many repeated bouts of acute exercise (i.e., 
exercise training) brings about a favourable change in skeletal muscle phenotype and 
body composition which correlates with a more prolonged increase in insulin sensitivity 
that can be detected for several days after the final training bout (Dela et al., 1995). Each 
of these effects will be reviewed in turn.  
1.4.2. Direct Effects of Exercise upon Glucose Uptake 
Glucose uptake into skeletal muscle cells is increased in an intensity dependent 
manner during skeletal muscle contraction through signalling mechanisms that are 
independent of and additive to insulin (Ploug et al., 1984; Nesher et al., 1985; Zorzano 
et al., 1986; Wallberg-Henriksson et al., 1988; Gao et al., 1994). However, similar to 
insulin-stimulated mechanisms, muscle contractions stimulate glucose transport via the 
translocation of GLUT4 protein from cytosolic microvesicles to the plasma membrane 
and t-tubules, allowing glucose uptake through facilitated diffusion (Richter & 
Hargreaves, 2013). Whilst muscle contractions do not activate any components of the 
proximal insulin signalling cascade, it appears that the two pathways converge on 
downstream protein targets (e.g. AS160) which regulate GLUT4 vesicle translocation 
(Richter & Hargreaves, 2013). There is also some evidence that insulin and contractions 
recruit GLUT4 from distinct intracellular pools (Douen et al., 1990; Coderre et al., 1995; 
Lemieux et al., 2000), a finding that would potentially explain the additive impact of 
insulin and contraction on rates of muscle glucose transport (Richter & Hargreaves, 
2013). The effects of muscle contraction upon glucose uptake appears to involve 
molecular signalling events linked to altered cellular energy charge, increased 
sarcoplasmic calcium concentrations, and the production of nitric oxide (Figure 1.5) 
(Richter & Hargreaves, 2013). In addition, activation of Rac-1 and subsequent 




rearrangement of the actin cytoskeleton appears to be important for GLUT4 
translocation and tethering at the plasma membrane (Richter & Hargreaves, 2013). 
 
 
Figure 1.4. Exercise independent signalling for glucose disposal in skeletal muscle. AMP 
adenosine monophosphate, ATP adenosine triphosphate, AMPK amp-activate protein kinase, Ca2+ 
calcium ions, CaMPKII calcium activated mitogen protein kinase II, AS160 Akt substrate of 160 kD, NO 
nitric oxide, Rac1 Ras-related C3 botulinum toxin substrate 1, Rab-GDP Rab guanosine disphosphate, 
Rab-GTP Rab guanoside triphosphate, GLUT4 glucose transporter 4  
 
1.4.3. Effects of Acute Exercise upon Insulin Sensitivity 
An acute bout of exercise increases ATP turnover and results in degradation of 
skeletal muscle glycogen and triglyceride levels, the extent of which is determined 
largely by the relative exercise intensity in combination with the exercise duration 


















exercise a number of cellular processes are accelerated in order to replete muscle 
substrate stores and restore metabolic homeostasis. In fact, the acceleration in cellular 
processes may lead to an increase in muscle glycogen stores over and above pre-exercise 
levels, a phenomenon known as glycogen supercompensation (Bergström & Hultman, 
1966). 
Numerous studies have shown that insulin action is enhanced in the hours 
following an acute bout of aerobic (Richter et al., 1984; Perseghin et al., 1996; Brestoff 
et al., 2009) and resistance (Fenicchia et al., 2004; Koopman et al., 2005; Venables et 
al., 2007) exercise. This effect appears to be localised to the skeletal muscles that were 
activated during the exercise bout (Richter et al., 1984), but can be detected using 
measures of whole-body insulin sensitivity as well (Venables et al., 2007; Brestoff et 
al., 2009). There is some evidence that this response can be detected for up to 48 hours 
post exercise (Perseghin et al., 1996). Importantly, this effect is observed in lean healthy 
men and women (Perseghin et al., 1996; Brestoff et al., 2009), overweight/obese 
individuals (Levinger et al., 2014; Little et al., 2014; Nelson & Horowitz, 2014), and in 
people with insulin resistance (Perseghin et al., 1996; Fenicchia et al., 2004; Bordenave 
et al., 2008; Rynders et al., 2014).  
 The specific mechanisms underpinning the improvements in insulin sensitivity 
during the recovery from a single bout of exercise are not completely understood, but an 
increased translocation of GLUT4 to the plasma membrane is involved (Holloszy, 2005; 
Maarbjerg et al., 2011). However, the enhancement in glucose transport in the hours 
following exercise is not limited only to insulin stimulation, but can be observed with 
other stimuli such as hypoxia (Holloszy, 2005; Maarbjerg et al., 2011). This indicates 
that a late step in the control of GLUT4 translocation that is common to the contraction, 
insulin and hypoxic pathways may be enhanced post exercise (Holloszy, 2005; 
Maarbjerg et al., 2011). Indeed, there appears to be no enhancement of proximal insulin 
signalling events (e.g. PI3K, Akt/PDK) following acute exercise, but recent evidence 
suggests that there may be enhanced signalling via AS160 (Holloszy, 2005; Maarbjerg 
et al., 2011). It has also been hypothesised that as the GLUT4 molecules return to 
intracellular storage sites following the cessation of muscle contraction, they are 
periodically in a ‘high-sensitivity’ area of the cell (e.g., within close proximity the cell 
membrane) and therefore more susceptible to stimulation with lower 




insulin/contraction/hypoxia signalling stimulus (Holloszy, 2005; Maarbjerg et al., 
2011).  
 There is evidence that the improvement in insulin sensitivity is linked to 
replenishment of skeletal muscle glycogen stores. In support of the effect of muscle 
glycogen levels, the magnitude of glycogen depletion correlated with the enhancement 
of insulin sensitivity measured 4 hours post-exercise (Wojtaszewski et al., 1997). 
Likewise, several studies in humans and in rodents suggest that carbohydrate restriction 
following exercise enhances, whilst carbohydrate feeding following exercise 
diminishes, the effect upon insulin sensitivity which tracks with skeletal muscle 
glycogen replenishment (Bogardus et al., 1983; Cartee et al., 1989; Gulve et al., 1990; 
Kawanaka et al., 2000; Holtz et al., 2008; Newsom et al., 2010). The rate of skeletal 
muscle glycogen synthesis is increased following a single bout of aerobic exercise 
(Perseghin et al., 1996; Jensen et al., 2012).  
1.4.4. Effects of Exercise Training Upon Insulin Sensitivity  
Bjontorp and colleagues were the first to demonstrate, in a cross-sectional study, 
that exercise trained men had a lower plasma insulin response to a standardised glucose 
bolus compared with non-exercising controls, indicating improved insulin sensitivity 
with exercise training (Björntorp et al., 1972). Since then, cross-sectional studies 
unequivocally demonstrate that whole-body insulin sensitivity measured with the gold 
standard hyperinsulinemic euglycaemic clamp is elevated in endurance athletes 
compared with matched sedentary individuals (King et al., 1987; Hardin et al., 1995; 
Amati et al., 2009; Nelson & Horowitz, 2014a). This relationship is present regardless 
of age; hence, older endurance athletes have a similar insulin sensitivity level compared 
to matched young athletes and both athletic groups are more insulin sensitive compared 
to the young and older sedentary counterparts (Amati et al., 2009). 
Large longitudinal trials have also shown that previously sedentary individuals 
can substantially improve their insulin sensitivity by undergoing a period of structured 
endurance training. For example, Boulé et al (2005) reported the findings from the 
HERITAGE family study which examined changes in insulin sensitivity following 20 
weeks of progressive aerobic exercise training in 596 individuals classified as sedentary 
according to self-report. They demonstrated that insulin sensitivity improved on average 




by 10% when measured 24 hours following the final training bout. Moreover, an 
increase in insulin sensitivity was evident across a range of subpopulations, including 
both men and women, overweight and lean individuals, and people of white and black 
ethnic origin (Boulé et al., 2005). Improvements in insulin sensitivity with aerobic 
exercise have also been demonstrated in elderly men and women (Evans et al., 2005; 
Davidson et al., 2009) and in populations with impaired glucose tolerance and T2D 
(Hughes et al., 1993). Indeed, there is some evidence that insulin sensitivity improves 
to a greater extent in populations who are insulin resistant (Barwell et al., 2008).  
 The improvements in insulin sensitivity that occur with structured endurance 
training may be related to chronic training adaptations or may simply be a response to 
the last bout of exercise that was performed. For example, in high level endurance 
athletes, abstinence from their training regime for 10 days markedly increased the 
magnitude and the duration of the plasma glucose and insulin response to an orally 
ingested glucose beverage (i.e. returning insulin sensitivity to levels measured in a 
matched group of sedentary subjects) (Heath et al., 1983). In another study, insulin 
sensitivity measured by hyperinsulinemic euglycaemic clamp returned to levels 
comparable with untrained sedentary individuals just 60 hours after training cessation, 
and then remained stable, and comparable to levels in sedentary subjects, during a 
further week of training abstinence (Burstein et al., 1985). Completing a single session 
of endurance training after the 10 days of exercise abstinence almost completely restored 
the insulin and glucose response during an OGTT to “training” levels (Heath et al., 
1983). These studies suggest that the effects of aerobic training upon insulin sensitivity 
are largely explained by the effects of the final exercise bout. However, there are several 
studies which suggest that there may also be a role for training adaptations in the 
improvement in insulin sensitivity. For example, in the study of Perseghin et al (1996), 
whole body glucose uptake was improved 48 hours after a single session of moderate 
intensity endurance exercise but seemed to be further enhanced after 6 weeks of training 
in both insulin resistant offspring of T2D parents and healthy controls (~40% vs. ~25%), 
suggesting there was an accumulated training effect as well as a last bout effect. In 
addition, after a 10 week period of single-legged endurance training the improvements 
in insulin stimulated glucose clearance across the trained leg (measured ~16 hours post 
exercise) could not be mimicked by a single bout of the same exercise in the untrained 
leg (Dela et al., 1992, 1995), however, these improvements may (Dela et al., 1995) or 




may not (Dela et al., 1992) be maintained after 6 days of detraining. Likewise, Segal et 
al. (1991) found no changes in insulin sensitivity following 12 weeks of aerobic training 
in lean, obese and diabetic men when measurements were taken 5 days after the final 
training bout. However, recent data from the STRRIDE randomised controlled trial 
indicated that some the improvements in insulin sensitivity after a 9-month period of 
endurance training were retained after 15 days of training cessation and that the retention 
was dependent on exercise dose (minutes/week) and not on the relative exercise intensity 
(% VO2max) (Bajpeyi et al., 2009). It seems likely that the enduring effect in this study 
was the result of alterations in body mass and body fat distribution (Slentz et al., 2004; 
Bajpeyi et al., 2009). To summarise, an acute bout of endurance exercise can increase 
whole body insulin sensitivity and this may make an important contribution to 
improvements observed with endurance training. However, there appears to be an effect 
of endurance exercise training over and above the effects of the last bout although 
training adaptations may be lost quickly if a further bout of exercise is not performed.  
Another important question pertains to whether relative exercise intensity, 
exercise duration or overall exercise dose (e.g., kcal/week) is most important for the 
adaptations in insulin sensitivity with aerobic exercise training. An early study compared 
the effect of 6-months of low-moderate intensity walking exercise with 6-months of 
moderate-vigorous intensity running on insulin action and glycaemic control (OGTT) in 
a group of 11 healthy older men and women with normal glucose tolerance (Seals et al., 
1984). The 6-month low-moderate intensity walking intervention consisted of 3-4 
weekly sessions exercising for 30 minutes at ~40% of heart rate reserve and was then 
immediately followed by the 6-month moderate-high intensity running intervention 
which consisted of 3-4 weekly sessions exercising for 30-40 minutes at ~75% of heart 
rate reserve. There were no changes in glucose AUC after either exercise intervention. 
However, whilst there were no changes in insulin AUC after the low-moderate intensity 
intervention, after the moderate-high intensity intervention insulin AUC was reduced by 
31% relative to baseline (Seals et al., 1984). Of course, a clear caveat to the results of 
this study is that the low and high intensity exercise interventions were not matched for 
energy expenditure and hence the importance of intensity independent of overall 
exercise dose cannot be determined from these data.  




Several studies have compared energy-matched low and high intensity exercise 
training programs on insulin sensitivity but the results do not give a clear consensus 
(Kang et al., 1996; Houmard et al., 2004; O'Donovan et al., 2005; Coker et al., 2006; 
DiPietro et al., 2006). These studies are summarised in table 1. In a small cohort of 
overweight and previously sedentary older women, 9-months of high intensity treadmill 
running was more effective at improving insulin stimulated muscle glucose uptake 
compared with 9-months of energy matched low-moderate intensity treadmill walking 
(DiPietro et al., 2006). Similar results have been reported in a comparable cohort of 
elderly participants after 3 months of low and high intensity cycling (Coker et al., 2006) 
and after 7 days moderate or high intensity cycling in obese men (Kang et al., 1996). 
However, other studies have reported contradictory findings. For example, energy 
matched moderate intensity cycling was just as effective as vigorous intensity cycling 
for improving fasting indices of insulin sensitivity in untrained middle aged males 
(O’Donovan et al., 2005) and increasing glucose disposal rate during conditions of 
euglycaemia hyperinsulinemia in older subjects (Hughes et al., 1993). Also, low-
moderate intensity exercise may be just as effective as vigorous intensity exercise for 
lowering HbA1c in T2D patients (Hansen et al., 2009) although this finding is contested 
by a meta-analysis which concluded that exercise intensity predicted improvements in 
HbA1c more comprehensively than exercise duration (Boulé et al., 2003). Finally, to 
add another layer of complexity, Houmard et al. (2004) investigated the effects of 3 
different 6-month aerobic training paradigms (low volume/moderate intensity, low 
volume/high intensity and high volume/high intensity) on insulin action in a large cohort 
of matched overweight, sedentary and dyslipidemic subjects. The low volume/moderate 
intensity and the low volume/high intensity interventions were matched on calorific 
expenditure (1200 kcal/week) whilst the low volume/moderate intensity and the high 
volume/high intensity were matched on exercise duration (~170 minutes/week). Post 
training insulin sensitivity testing was performed 24 hours after the final training bout 
so may reflect the combined effect of acute and chronic exercise. There were 
improvements in insulin sensitivity with all three training interventions but significantly 
greater effects were noted with increased exercise duration, irrelevant of the training 
intensity (Houmard et al., 2004). More recent data from the same laboratory suggested 
that the training induced improvements in insulin sensitivity after the interventions with 
longer sessions (~170 minutes/week) are retained for a longer period of time following 
training cessation compared with the intervention involving shorter sessions (Bajpeyi et 




al., 2009). In agreement, a recent study demonstrated that while both exercise dose 
(kcal/week) and exercise intensity (kcal/min) correlated with changes in insulin 
sensitivity after a 16 week varied aerobic training program, the relationship was slightly 
stronger for exercise dose, and exercise dose was a better predictor of changes in insulin 
sensitivity than exercise intensity in multivariate regression analysis (Dube et al., 2011). 
Thus it remains unclear whether exercise intensity, exercise duration or exercise dose is 
the most important variable underpinning the improvements in insulin sensitivity with 
aerobic training.  
 43 
 
Table 1.1. Studies comparing the effects of exercise training intensity on training induced changes in insulin sensitivity 
 




Measure of ISI 
Energy 
Matched 
Exercise Protocols Participants Δ ISI Significance 






72 hours post 
Yes 
Mod: 4 session/week on Treadmill 
~65% VO2max until 300kcal 
expended. 
Elderly F (n = 9) 
Healthy/Sedentary/Untrained 
BMI: 28 ± 4.5 
MGU ↑16% Pre vs. Post: N.S.  
High: 4 sessions/week on Treadmill 
~80% VO2max until 300kcal 
expended. 
Elderly F (n = 9) 
Healthy/Sedentary/Untrained 
BMI: 26.3 ± 3 
 
MGU ↑21% 
Pre vs. Post: P<0.05 






(SI calculated using 
minimal model) 
 
24 hours post 
Yes 
Low Volume/Mod Intensity 
1200 kcal/week at 40-55% VO2max 
~170 minutes/week 
Middle Aged (n = 41; 17F, 24M) 
Sedentary/Untrained/Overweight 
BMI: 30 ± 0.5 
 
SI ↑65% 
Pre vs. Post: P<0.05 
ΔISI vs. Low/High: 
P<0.05 
Low Volume/High Intensity 
1200 kcal/week at 65-80% VO2max 
~115 minutes/week 
Middle Aged (n = 30; 15F, 15M) 
Sedentary/Untrained/Overweight 




Pre vs. Post P<0.05 
No 
High Volume/High Intensity 
2000 kcal/week at 65-80% VO2max 
~170 minutes/week 
Middle Aged (n = 43; 20F, 23M) 
Sedentary/Untrained/Overweight 
BMI: 30 ± 0.5 
 
SI ↑57% 
Pre vs. Post P<0.05 
ΔISI vs. Low/High: 
P<0.05 





Fasting Blood Samples 
 
24 Hours Post 
Yes 
Mod: 3 session/week on Bike 
~60% VO2max until 400 kcal 
expended 
Middle Aged M (n = 10) 
Healthy/Sedentary/Untrained 
BMI: 27.5 ± 6 
SI ↑12% 
HOMA-IR ↓33% 
vs. Control: P<0.05 
vs. High: N.S. 
High: 3 session/week on Bike 
~80% VO2max until 400 kcal 
expended 
Middle Aged M (n = 13) 
Healthy/Sedentary/Untrained 
BMI: 26.2 ± 2.6 
SI ↑10% 
HOMA-IR ↓28% 
vs. Control: P<0.05 
vs. Mod: N.S. 








72 hours post 
Yes 
Mod: 4-5 sessions/week on Bike 
1000 kcal/week at ~50% VO2max 
Elderly (n=7; 4F, 3M) 
Sedentary/Untrained/Overweight 
BMI: 31 ± 1 
MGU ↓7% Pre vs. Post: N.S. 
High: 4-5 sessions/week on Bike 
1000 kcal/week at ~75% VO2max 
Elderly (n=7; 4F, 3M) 
Sedentary/Untrained/Overweight 
BMI: 29 ± 1 
MGU ↑28% Pre vs. Post: P<0.05 
 







12-24 hours post 
Yes 
Mod: 7 days on Bike  
70 minutes at 50% VO2peak 
Obese M (n=6) 
Ins AUC ↔ 
Glu AUC ↔ 
Pre vs. Post: N.S.  
High: 7 days on Bike 
50 minutes at 70% VO2peak 
Same as above 
 (crossover design) 
Ins AUC ↓21% 
Glu AUC ↔ Pre vs. Post : P<0.05 




1.4.5. Resistance Training and Insulin Sensitivity 
Resistance trained subjects have elevated whole body insulin sensitivity 
compared to sedentary subjects and similar whole body insulin sensitivity compared to 
endurance trained athletes when expressed relative to body weight (Yki-Jarvinen & 
Koivisto, 1983). Likewise, the vast majority (Eriksson et al., 1998; Poehlman et al., 
2000; Holten et al., 2004) but not all (Fenicchia et al., 2004) longitudinal training studies 
have demonstrated that insulin action can be improved in previously healthy sedentary 
subjects after a period of resistance training. These effects have been observed in a wide 
ranging number of populations, including healthy older men (Miller et al., 1994; Holten 
et al., 2004), lean young females (Poehlman et al., 2000), individuals with impaired 
glucose tolerance (Eriksson et al., 1998) and in patients with T2D (Ishii et al., 1998). 
Whilst resistance trained subjects are more insulin sensitive compared to 
sedentary subjects when expressed in absolute terms, insulin stimulated glucose disposal 
is similar in resistant trained athletes and matched sedentary controls, and lower in both 
compared with endurance trained athletes, when expressed relative to lean body mass 
(Yki-Jarvinen & Koivisto, 1983; Takala et al., 1999). This suggests that although 
absolute insulin sensitivity is high in resistance trained athletes, this can be explained by 
their increased muscle mass and an increased distribution volume, rather than the muscle 
being intrinsically more insulin sensitive, as appears to be the case with endurance 
athletes. Training studies are equivocal on this topic; on the one hand, some studies have 
shown that improvements in insulin sensitivity with structured resistance training can 
occur independent of changes in muscle mass  (Miller et al., 1994) whilst some studies 
have refuted these findings (Poehlman et al., 2000). Andersen et al. (2003) determined 
insulin sensitivity using the gold standard euglycaemic clamp method and thigh muscle 
mass using gold standard MRI after a period of heavy resistance training and again after 
a period of de training. They observed that glucose disposal per unit of skeletal muscle 
mass decreased by 33% during the transition from the trained state to a detrained state. 
Whilst the effects of the training programme compared to baseline were not determined, 
such observations suggest that resistance training improves the intrinsic sensitivity of 
muscle to insulin. The observation that resistance training is associated with the up 
regulation of key proteins involved in insulin signalling and glucose transport lends 
support to these data (Tabata et al., 1999; Holten et al., 2004). Regardless of whether 




resistance exercise improves the intrinsic sensitivity of muscle to insulin, increasing 
muscle mass will improve insulin action in absolute terms by increasing distribution 
volume, and hence resistance exercise will be effective in improving and maintaining 
glucose homeostasis. 
1.4.6. Exercise Training and Insulin Sensitivity: Potential Mechanisms 
There are several mechanisms thought to contribute to the improvements in 
insulin sensitivity with exercise training. Notwithstanding the beneficial changes in body 
composition which may alleviate inhibitory mechanisms upon the insulin signalling 
cascade and increase the glucose and insulin distribution volume (Poehlman et al., 2000; 
Slentz et al., 2004; Schenk et al., 2008; Bajpeyi et al., 2009), there may also be 
improvements in the delivery of glucose and insulin to the intracellular space, and 
elevated levels and/or activity of proteins involved in intramyocellular glucose transport, 
glucose phosphorylation and glycogen synthesis (Wojtaszewski & Richter, 2006).  
The classic hypothesis centres on GLUT4 protein levels which are increased 
following both aerobic (Houmard et al., 1991; Dela et al., 1993; Hughes et al., 1993; 
Langfort et al., 2003) and resistance training (Holten et al., 2004). Indeed, the 
overexpression of GLUT4 has been shown to increase insulin sensitivity in rats (Hansen 
et al., 1995), whilst muscle specific deletion of GLUT4 in mice results in muscle insulin 
resistance and glucose intolerance (Zisman et al., 2000). In humans, muscle GLUT4 
protein content has been shown to correlate with measures of muscle specific glucose 
disposal (Dela et al., 1993), however, changes in GLUT4 content with training do not 
appear to correlate with changes in insulin sensitivity (Hughes et al., 1993), suggesting 
other intracellular mechanisms may also be involved.  
 Other changes may involve an improvement in the capacity for insulin signalling 
to GLUT4 translocation following exercise training. Studies generally report that the 
expression of proteins involved in the proximal steps of insulin signalling, for example 
IRS1 and PI3K, remain unchanged following exercise training (Yu et al., 2001; Holten 
et al., 2004; Frøsig et al., 2007). There may be in an increased phosphorylation and 
activity of these proteins in the insulin stimulated state following training (Houmard et 
al., 1999; Kirwan et al., 2000; Glynn et al., 2008) although this is not a universal finding 
(Tanner et al., 2002). In contrast, both the expression and activity of distal signalling 




proteins, such as Akt/PKB and AS160, have been shown to increase following exercise 
training (Holten et al., 2004; Frøsig et al., 2007; Vind et al., 2011). These data suggest 
that exercise training may augment the insulin signalling cascade which would be 
expected to result in a more efficient coordination of GLUT4 translocation to the cell 
membrane and an increased capacity for glucose uptake in the exercise training state.  
 Lastly, maintaining a high positive gradient between the interstitial fluid and the 
cytosol is important for maintaining a high rate of glucose uptake into the muscle cell in 
the insulin stimulated state (Wasserman, 2009). There are several exercise induced 
adaptations which may augment this gradient. Firstly, the delivery of glucose (and 
insulin) may be improved by an increase in muscle capillarisation in the trained state 
(Lillioja et al., 1987; Cocks et al., 2013). Indirect evidence for this as a mechanism 
comes from the observation that muscle capillarisation correlated with insulin sensitivity 
in a large cohort of non-diabetic men (Lillioja et al., 1987). There is also some evidence 
that insulin-mediated increases in muscle blood flow in the postprandial state may be 
enhanced in rodents and humans following a period of exercise training (Rattigan et al., 
2001; Mikus et al., 2011). Secondly, there is augmented capacity for insulin-stimulated 
glycogen synthesis in the both the aerobic and resistance trained state, mediated by an 
increase in glycogen synthase expression and activity (Perseghin et al., 1996; Holten et 
al., 2004; Vind et al., 2011). 
1.5. Cardiorespiratory Fitness and Health  
Cardiorespiratory fitness, commonly assessed as the maximal attainable rate of 
oxygen uptake (VO2max) or time to exhaustion during an incremental exercise test to 
volitional exhaustion, has emerged as an important determinant of all-cause morbidity 
and mortality in both men and women (Blair et al., 1989; Barlow et al., 1995; Blair et 
al., 1995; Blair et al., 1996; Lee et al., 1998; Lee et al., 1999; Myers et al., 2002; Gulati 
et al., 2003). This was first shown in 1989 by Blair and colleagues using data collected 
from the Aerobics Centre Longitudinal Study; in a cohort of 10,224 men and 3120 
women, they demonstrated that the risk of all-cause mortality was reduced by ~50% in 
moderately fit compared with low fit individuals (Blair et al., 1989). Since then it has 
been shown that a major portion of the lowed risk of all-cause mortality is due 
specifically to a reduction in the risk of cardiovascular mortality (Lee et al., 1999; Lee 




et al., 2011). Remarkably, the predictive impact of cardiorespiratory fitness holds even 
in populations who already present with other recognised risk factors for cardiovascular 
disease, including overweight/obesity (Barlow et al., 1995; Lee et al., 1999), 
hypertension (Sui et al., 2007), diabetes (Church et al., 2005), and smoking (Lee & Blair, 
2002). The impact of cardiorespiratory fitness on cardiovascular and all-cause mortality 
was recently subject to comprehensive meta-analysis (Kodama et al., 2009). Using data 
from 33 studies and >103,000 participants, Kodama et al. (2009) showed that, compared 
with individuals in the high-fitness group, individuals in the low fitness category had 
70% higher all-cause and 56% higher CVD mortality rates. They also examined the dose 
response relationship and showed that for every 1 MET score achieved during the 
incremental exercise test there was a 13% reduction in CVD mortality (Kodama et al., 
2009). Importantly, a more recent analysis of the Aerobics Centre Longitudinal Study 
has shown that improving cardiovascular fitness in individuals who had previously 
presented with low fitness significantly lowers the risk of all-cause and CVD mortality 
(Lee et al., 2011).  
The specific mechanisms which link cardiorespiratory fitness to a lower risk of 
cardiovascular disease are not well understood. However, a recently developed murine 
model selectively bred for low (LEC) and high exercise capacity (HEC) has provided 
some potential metabolic mechanisms. For example, Wisloff et al. (2005) demonstrated 
that, after 11 generations, exercise capacity was 347% lower in LEC compared with 
HEC, and tracked with the emergence of elevated fasting glucose, fasting insulin, fasting 
lipids, visceral adiposity and blood pressure, as well as endothelial dysfunction.  
 Cardiorespiratory fitness is partly determined by genetic factors (50%) but also 
in large part by environmental factors (50%) (Bouchard et al., 1999). Importantly, the 
only environmental factor known to improve aerobic fitness is physical activity and, in 
particular, structured exercise training (Church, 2009). Numerous large longitudinal 
studies have shown that previously sedentary individuals will, on average, improve their 
aerobic capacity following a period of standardised aerobic training, and the average 
response may be increased with a greater exercise dose or relative exercise intensity 
(Wenger & Bell, 1986; Sisson et al., 2009; Garber et al., 2011). However, regardless of 
the exercise training dose or intensity the magnitude of the response is always highly 
variable between individuals. Improvements in aerobic capacity do not appear to be 




explained by initial fitness levels, age, sex or race, so long as exercise dose/intensity is 
standardised amongst individuals (Skinner et al., 2000). Rather, the variance appears to 
be partly (~50%) the result of heritable factors (Bouchard et al., 1999). Changes in 
aerobic fitness are largely determined by central adaptation in the oxygen transport 
system and therefore oxygen delivery to the peripheral tissues during exercise (Bassett 
& Howley, 2000). In summary, it appears as though cardiorespiratory fitness is an 
important factor for cardiometabolic health and regular exercise plays an important role 
in maintaining/improving aerobic fitness throughout ageing.  
 
1.6. Current Statistics on, and Barriers to Exercise Participation  
  This literature review has shown that physical inactivity is an important risk 
factor for chronic cardiometabolic disease. On the contrary, evidence has been presented 
which shows that the risk of both type 2 diabetes and cardiovascular disease may be 
reduced with regular exercise training and/or increased physical activity. However, it 
might be stating the obvious, but in order to accrue the health benefits of exercise, people 
actually have to do the exercise on a regular basis. Current statistics in the UK suggest 
that exercise remains an underemployed strategy, with just 40% of men and 28% of 
women in the UK achieving the recommended minimum amount of physical activity 
(150 min/week of moderate intensity exercise) when measured by self-report (Allender 
et al., 2008a). However, when physical activity is measured objectively by 
accelerometer the number falls to 6% of men and 4% of women (Allender et al., 2008a). 
  Some of the problem relates to the willingness of health care professionals, as 
well as the average individual, to primarily look towards drug therapies in situations 
where exercise prescription and/or other lifestyle changes are likely to be more effective 
(Church & Blair, 2009). Likewise, many researchers continue to look for the so called 
‘exercise pill’ but such efforts are unsubstantiated and are likely to remain futile (Hawley 
& Holloszy, 2009). It is well accepted by exercise physiologists and physical activity 
practitioners alike that the focus should be to find novel ways of increasing motivation 
for, and long term adherence to, regular physical activity and/or exercise (Hawley & 
Holloszy, 2009). Therefore, the identification of the common barriers that prevent 
adherence and motivation to exercise is essential for alternative exercise paradigms to 
be developed. A recent systematic review of studies examining common barriers to 




exercise identified a ‘lack of time due to work or family commitments’ as the most 
frequently cited, being identified in 9 out of the 13 studies which were reviewed. 
Logically, this would suggest that the current focus on a relatively high volume of 
moderate intensity physical activity on most days of the week is not ideal in terms of 
stimulating exercise participation. Whilst this is by no means the only reason people do 
not perform regular exercise, this particular barrier offers a unique opportunity to 
exercise physiologists as we could theoretically be able to offer a potential solution. It 
has recently been postulated that high-intensity interval training (HIT) may offer a time-
efficient alternative to high volume aerobic exercise training.  
1.7. High-Intensity Interval Training (HIT) 
1.7.1. What is HIT? 
High-intensity interval training (HIT) involves performing brief repeated bouts 
of high-intensity, submaximal, maximal or supramaximal exercise interspersed with 
periods of low intensity or resting recovery. The concept of HIT is not new; this type of 
training paradigm is frequently utilised in athletic populations to stress metabolic 
pathways that are relevant to performance (Gibala et al., 2012). However, more recently 
there has been growing interest in HIT as a potential time-efficient alternative to more 
traditional endurance or resistance exercise for inducing adaptations that are relevant to 
health (Gibala et al., 2012).  
The design of a HIT session is similar to resistance exercise in that both exercise 
modes involve short bursts of high intensity muscular work interspersed with periods of 
rest. However, the nature of the HIT exercise stimulus (i.e., running or cycling), which 
involves high frequency and rhythmic contractions-relaxation cycles, is more like 
traditional cardiorespiratory exercise, albeit at a much higher intensity. Simply by its 
nature, cardiorespiratory exercise performed at intensities above the maximal lactate 
steady state (MLSS) results in the accumulation of metabolites implicated in fatigue and, 
as a result, these power outputs cannot be maintained for a prolonged period of time 
before the onset of fatigue. In order to accumulate a larger volume of exercise at these 
intensities, the muscle must be given periods of recovery in between each bout; in other 
words, the exercise must be performed in intervals. The length of time the high-intensity 




bursts can be performed for is directly related to intensity - an exercise bout performed 
at a power output just above that which elicits MLSS may be maintained for 20-30 
minutes, whilst an ‘all-out’ effort generating power outputs 2-3 fold higher than that 
which elicits V̇O2max (e.g., Wingate sprints), will result in a drop in power output after 
just a few seconds, and may only be maintained for up to ~30 seconds.   
There is a wide scope for variation in protocols with HIT as the frequency, 
intensity and the duration of the high-intensity bursts, as well as the characteristics and 
duration of the recovery periods, may all be manipulated to change the nature of the 
exercise stimulus and thus potentially the adaptations associated with training (Ross & 
Leveritt, 2001; Gibala et al., 2012). As such, there have been a wide range of HIT 
protocols used throughout the literature and, generally speaking, limited standardisation 
of the terminology used to describe the different protocols. HIT protocols can be broadly 
grouped into submaximal, maximal and supramaximal, based on the intensity utilised 
during the high-intensity bouts relative to maximal aerobic power (Figure 1.6). 
However, the majority of protocols utilised to date have used either submaximal or 
supramaximal intensities. Based on this terminology, an example of a submaximal HIT 
protocol would be the 10 × 1 min at ~90% of maximal heart rate with 1 min resting 
recovery, whilst an example of a supramaximal HIT protocol would be the classic 4-6 × 
30 s ‘all-out’ Wingate type sprints (Figure 1.6). Throughout this thesis, the term ‘HIT’ 
will be used to encompass all literature pertaining to high-intensity interval training. In 
some cases, there may be value in providing a description of the complete protocol and, 
where appropriate, this will be used when describing the results of specific studies.  
 














Figure 1.5. Schematic of common HIT protocols vs. current recommendations. Adapted from 
Gibala et al (2014) 
1.7.2. Acute responses to HIT 
Substrate Utilisation and Cardiovascular Responses  
Substrate utilisation during the many varieties of HIT protocol has not been 
determined directly. Our knowledge of fuel metabolism during HIT mainly comes from 
studying the transition from low-moderate-high intensity exercise and from the 
application of single and repeated ‘all out’ sprinting protocols (e.g., Wingate sprints). 
This section will explore the changes in substrate metabolism that occur during the 
transition from submaximal to maximal to supramaximal exercise intensities.   
At rest and in the fasting state, skeletal muscle primarily relies on the oxidation 
of plasma NEFA to meet its free energy requirements but there is also a small 
contribution from blood glucose (van Loon et al., 2001). The physiological importance 
of primarily utilising NEFA delivered from the vast adipose tissue depots in the resting 
post-absorptive state is the sparing of limited carbohydrate stores in the liver and in 
skeletal muscles. With the onset of any exercise, there is a change from primarily 





































and intramuscular triglycerides. Whilst the composition of the fuel mixture being 
oxidised during exercise can be altered by several variables including gender, 
temperature, pre-exercise substrate stores, preceding diet and training status, the 
intensity of the exercise is a dominant influencing factor (Romijn et al., 1993, 2000; van 
Loon et al., 2001). Energy requirements are dictated largely by the absolute exercise 
intensity, whilst the composition of the fuel mix being oxidised is dependent on the 
relative exercise intensity (Romijn et al., 1993, 2000; van Loon et al., 2001).  
As the relative exercise intensity increases, the ratio of carbohydrate to fat 
utilisation increases also (Romijn et al., 1993, 2000; van Loon et al., 2001). 
Nevertheless, in spite of this relative decrease in fat utilisation with increasing exercise 
intensity, the absolute energy demands of the exercise increase and so does the absolute 
rate of fat oxidation during low to moderate exercise intensities (Achten et al., 2002; 
Achten & Jeukendrup, 2003; Achten et al., 2003). In fact, the relationship between 
absolute fat oxidation and exercise intensity is inversely parabolic, with rates of fat 
oxidation reported to reach a zenith (i.e. a maximal rate, sometimes referred to as 
FATmax) at ~55% of VO2max and then falling sharply as the exercise intensity is 
increased further (Achten et al., 2002; Achten & Jeukendrup, 2003; Achten et al., 2003). 
On the contrary, there appears to be a linear relationship between relative exercise 
intensity and absolute and relative utilisation of blood glucose and muscle glycogen, 
with muscle glycogen becoming quantitatively more important at each exercise intensity 
increment (van Loon et al., 2001).  At intensities which elicit maximal oxygen uptake 
there is almost a complete inhibition of lipid contribution to ATP demands (Achten et 
al., 2002; Achten & Jeukendrup, 2003; Achten et al., 2003).  
The metabolic pathways involved in fuel utilisation during exercise can be 
broadly grouped into ‘aerobic’ (i.e., oxidative phosphorylation – requiring oxygen) and 
‘anaerobic’ (substrate level phosphorylation – not requiring oxygen). Oxidative 
phosphorylation is largely considered ‘metabolically clean’, whilst substrate level 
phosphorylation, either through depletion or generation of metabolites, is implicated in 
fatigue during high intensity exercise. Nevertheless, although exercise is often 
categorised as being ‘anaerobic’ or ‘aerobic’, there will always be some blending of 
oxidative and substrate level phosphorylation contributing to ATP resynthesis during 
exercise. Indeed, there is some lactate appearance into the systemic circulation from 




skeletal muscle at low ‘aerobic’ exercise intensities (Richardson et al., 1998), whilst 
during a supramaximal sprint (considered ‘anaerobic’) some ATP resynthesis from 
oxidative phosphorylation is evident even during the initial seconds and increases in 
importance as the sprint progresses (Parolin et al., 1999). The relative blend of the two 
pathways is largely dependent on the relative exercise intensity, with the relative 
proportional contribution of substrate level phosphorylation increasing with increasing 
exercise intensity, and probably partly reflecting the hierarchical recruitment of type IIa 
and IIx muscle fibres during incremental exercise (Mcphedran et al., 1965; Gordon et 
al., 2004). However, at lower exercise intensities the generation of fatigue-causing 
metabolites through substrate level phosphorylation is well matched with the activity of 
pathways designed to remove those metabolites. Such a trend continues until the 
maximal lactate steady state is reached, after which the balance between 
production/removal is disrupted, and metabolites will continue to accumulate until 
fatigue is initiated. So, at exercise intensities which elicit maximal oxygen uptake, fat 
oxidation is almost completely inhibited, and glycolysis and carbohydrate oxidation are 
maximally activated. However, there is also a heavy contribution from substrate level 
phosphorylation which acts as an ATP buffer, and a significant proportion of pyruvate 
will be converted to lactate in order to both maintain NAD+/NADH redox balance and 
the level of flux through glycolysis. As a result, exercise at VO2max can only be 
maintained for a few minutes before fatigue ensues (Bangsbo et al., 1990). 
Exercise at supramaximal intensities presents a unique challenge to skeletal 
muscle. As processes which increase oxygen delivery and oxygen uptake require several 
minutes to be maximally active (Bangsbo et al., 1990), the relative contribution of 
substrate level phosphorylation is greater in the initial seconds of a sprint. Substrate 
utilisation during isolated supramaximal sprint exercise is extremely complex, involving 
the rapid depletion of phosphocreatine (PCr) stores, reductions in intramyocellular ATP 
and glycogen concentrations, a rapid accumulation of lactate, but also an increasing 
emphasis on oxidative metabolism as the duration of the sprint increases (Gaitanos et 
al., 1993; Bogdanis et al., 1996; Esbjornsson-Liljedahl et al., 1999; Parolin et al., 1999; 
Esbjornsson-Liljedahl et al., 2002). The hydrolysis of phosphocreatine (PCr) provides 
the majority of the energy for ATP resynthesis during the initial stages of the sprint when 
peak power outputs are achieved, but as PCr stores are rapidly depleted other fuels 
become more important and power output progressively falls (Parolin et al., 1999). 




Glycolysis is maximally activated ~6 seconds into a sprint (maybe even sooner) and is 
maintained for a further 10 seconds, but is then strongly attenuated, returning to baseline 
levels by the end of a 30-s bout (Parolin et al., 1999). Stored muscle glycogen provides 
almost all of the glycolytic substrate with little or no contribution from extracellular 
glucose; concordantly, a single Wingate sprint has consistently been shown to reduce 
total skeletal muscle glycogen concentrations by ~20-30% (Esbjornsson-Liljedahl et al., 
1999; Parolin et al., 1999; Esbjornsson-Liljedahl et al., 2002). As the resulting increase 
in pyruvate levels far exceeds its level of oxidation there is a large excursion in both 
muscle and blood lactate concentrations (Parolin et al., 1999); the associated reduction 
in muscle pH likely inhibits glycolytic enzyme activity, interferes with the calcium 
dependent contractile mechanism, and may contribute to a decrease in central motor 
drive, making ‘all-out’ sprinting extremely fatiguing (Billaut and Bishop, 2009). 
Pyruvate dehydrogenase (PDH) is maximally active by 15 s meaning pyruvate oxidation 
is more closely matched to rate of pyruvate production, correlating with a shift towards 
aerobic energy production and a reduction in the rate of lactate accumulation as the sprint 
progresses (Parolin et al., 1999).  
Energy provision during repeated sprinting is substantially altered. The total 
work done and mean power output are reduced during subsequent bouts (Gaitanos et al., 
1993; Parolin et al., 1999). There appears to be no activation of glycogen phosphorylase 
during repeated bouts; hence the contribution of glycogenolysis to energy provision is 
negligible and there is no further reduction in intramyocellular glycogen stores (Parolin 
et al., 1999). Phosphocreatine is regenerated rapidly following cessation of exercise and 
hence remains an important source of ATP synthesis in the initial seconds of repeated 
bouts of sprinting, as long as the recovery period is sufficient (~4 min) (Parolin et al., 
1999). Oxidative metabolism provides the majority of subsequent energy requirements 
following the degradation of PCr stores with a very small contribution of anaerobic 
glycolysis (Parolin et al., 1999). The inhibition of glycogenolysis in the third bout 
compared with the first is presumably to prevent excessive glycogen breakdown as a 
plentiful supply of substrate remains from the first bout (Parolin et al., 1999). Similar 
increases in pyruvate dehydrogenase activity are noted in the third bout meaning the 
primary fate of pyruvate is oxidative metabolism and hence the rate of lactate 
accumulation is negligible during the third bout (Parolin et al., 1999). 
 







Figure 1.6. Changes in substrate utilisation during a repeated Wingate sprint protocol. The 
contribution of PCr hydrolysis, glycolysis and oxidative phosphorylation to ATP re-synthesis during the 
first (A), and third (B) ‘all-out’ 30-s bout of maximal cycling. Figure from Parolin et al (1999). 
 
The substantial energy demands placed upon skeletal muscle during sprint 
exercise have a dramatic knock-on effect upon the cardiovascular system. Not only is 
there a large aerobic component to each sprint, but the utilisation of phosphocreatine and 
glycogen in the initial seconds of the sprint also creates a substantial oxygen deficit. 
Thus, oxygen demands during the latter part of the sprint and early on in the recovery 
are high and, in fact, VO2 approaches maximal values following each sprint effort 
(Hazell et al., 2014; Townsend et al., 2014). In order to aid oxygen delivery and removal 
of metabolic products (e.g. lactate, CO2), ventilation increases dramatically and blood 
flow to active muscles can increase by ~100 fold during maximal dyanamic exercise 
(Hawley et al., 2014). There is a rapid increase in heart rate which will also approach 
maximal levels during an ‘all-out’ sprint largely as a result of the large spike in 
adrenaline with sprint exercise (Boutcher, 2011). Nevertheless, there will also be 
localised reductions in oxygen tension within the activated skeletal muscles, particularly 
during the early onset of the sprint (Bhambhani, 2004). In addition, the increase in heart 
rate, cardiac output and peripheral hyperaemia is associated with an increase in mean 
arterial blood pressure and endothelial shear stress (Hawley et al., 2014).  
Substrate utilisation in the hours following HIT has not been well characterised 
given that its measurement is hindered by the limitations of indirect calorimetry during, 




and following, high intensity exercise which places great strain on muscle and blood 
buffering mechanisms (Hazell et al., 2012). However, it does appear as though HIT 
results in a more prolonged elevation in post-exercise oxygen consumption (EPOC) 
compared with moderate intensity aerobic exercise. Indeed, there are now several studies 
reporting that HIT results in similar elevations in 24 hour oxygen uptake compared with 
moderate aerobic exercise, despite large estimated differences in energy expenditure 
during the exercise bout itself (Hazell et al., 2012; Skelly et al., 2014). In addition, 
similar to submaximal aerobic exercise, studies that have measured substrate utilisation 
several hours following HIT suggest there is a shift towards a greater reliance on lipid 
substrates during recovery (Chan & Burns, 2013; Whyte et al., 2013; Williams et al., 
2013).  
Hormonal Responses 
Single or repeated sprints result in alterations in the systemic hormonal milieu. 
Perhaps most importantly, plasma concentrations of adrenaline and noradrenaline are 
increased dramatically following both single and repeated Wingate sprints, an effect that 
may (Gratas-Delamarche et al., 1994), or may not  (Vincent et al., 2004), be attenuated 
in women. The rise in concentrations is short-lived and returns to baseline levels very 
quickly following cessation of exercise (Zouhal et al., 2008; Williams et al., 2013). The 
physiological significance of the increase in catecholamines is likely related to the stress 
response during the exercise bout itself, for example, acting to increase heart rate, 
cardiac output and oxygen delivery to the peripheral tissues. There is also a 10-fold 
increase in systemic levels of growth hormone (Nevill et al., 1996) and a 15% increase 
in cortisol (Esbjörnsson et al., 2009) following sprint exercise. 
Molecular Responses in Skeletal Muscle 
HIT presents an acute ‘energy crisis’ in the contracting skeletal muscle cell, 
resulting in excursions in intracellular calcium (Ortenblad et al., 2000), rapid 
degradation of phosphocreatine and glycogen (Gaitanos et al., 1993; Parolin et al., 
1999), alterations in the ATP/ADP/AMP ratio (Karatzaferi et al., 2001a), disruption of 
the cellular redox balance (Cuevas et al., 2005; Kang et al., 2009), and a significant 
accumulation of metabolites and electrolytes (Gaitanos et al., 1993; Parolin et al., 1999). 
Such intracellular changes are associated with the activation of several signalling 




cascades which regulate the acute metabolic response and switch on processes which 
aid recovery and adaptation. HIT results in adaptive improvements in carbohydrate/fat 
metabolism and increased oxidative capacity (see below), and HIT also stimulates 
signalling pathways which are linked to mitochondrial biogenesis and transcription of 
genes involved in carbohydrate and lipid handling. For example, HIT has been 
associated with increased signalling through AMP activated protein kinase (AMPK), 
p38 mitogen activated protein kinase (p38 MAPK) and p53 (Gibala et al., 2009; Little 
et al., 2011b; Bartlett et al., 2012; Fuentes et al., 2012; Fuentes et al., 2013; Cochran et 
al., 2014). The current understanding of the signalling response to HIT in relation to 
muscle adaptation is summarised in Figure 1.8.  
Firstly, both single and repeated ‘all-out’ sprint protocols are associated with 
increased phosphorylation of AMPK in both men and women (Gibala et al., 2009; 
Fuentes et al., 2012; Fuentes et al., 2013). In addition, matched work submaximal high 
intensity interval and continuous moderate intensity running exercise is associated with 
a similar increase in AMPK activation (Bartlett et al., 2012). Such a response is probably 
largely determined by an increased AMP/ADP: ATP ratio, but may also be regulated by 
the level of glycogen degradation with high intensity exercise (Moore et al., 1991; 
Corton et al., 1994; McBride et al., 2009; McBride & Hardie, 2009). AMPK has been 
linked with transcription of genes relating to mitochondrial biogenesis and carbohydrate 
metabolism in skeletal muscle (Holmes et al., 1999; Jørgensen et al., 2006; Winder et 
al., 2006; Pogozelski et al., 2009).  
p38 MAPK is activated by signals of intracellular stress, including elevations in 
intracellular calcium (Wright et al., 2007), oxidative stress (Gomez-Cabrera et al., 
2005), glycogen availability (Chan et al., 2004) and osmotic tension (Sheikh-Hamad & 
Gustin, 2004). The activation of p38 MAPK has been shown following repeated sprint 
exercise (Gibala et al., 2009; Bartlett et al., 2012) but does not appear to occur with a 
single sprint effort (Fuentes et al., 2012; Fuentes et al., 2013). The role of p38 in 
regulating mitochondrial biogenesis is emphasised by recent data which demonstrated 
that cellular ablation of the gamma subunit attenuated mRNA expression of PGC-1α and 
mitochondrial biogenesis following aerobic exercise training (Pogozelski et al., 2009).  
There is also some evidence that p53, which has arisen as a key regulator of 
mitochondrial adaptation with exercise training (Bartlett et al., 2014; Saleem et al., 




2014), is activated with HIT. To the authors’ knowledge, only one study has examined 
the response of p53 to HIT (Bartlett et al., 2012). Bartlett et al (2012) demonstrated a 
2.5 fold increase in p53ser15 phosphorylation 3 hours following a bout of high intensity 
interval running (6 × 3 min at 90% VO2max). The increase in activation of p53 was 
similar compared with an acute 50 min bout of continuous running at 70% of VO2max. 
It would be interesting to examine the response of p53 to lower volume supramaximal 
HIT protocols.  
 Signalling through AMPK, p38 MAPK and p53 is proposed to up-regulate 
mitochondrial adaptation by signalling through PGC-1α (peroxisome-proliferator 
activated receptor γ coactivator), which has been termed ‘the master regulator’ of 
mitochondrial biogenesis (Puigserver & Spiegelman, 2003). The proposed role of PGC-
1α in mitochondrial adaptation mainly comes from rodent studies which have 
demonstrated that overexpression of this enzyme is associated with an elevated activity 
of oxidative enzymes and an improvement in exercise tolerance (Calvo et al., 2008). 
PGC-1α has also been shown to promote the transcription of GLUT4 mRNA and in 
some situations may be involved in the regulation of insulin sensitivity (Summermatter 
et al., 2013). In response to an acute bout of HIT, the total content of PGC-1α does not 
appear to increase (Little et al., 2011b; Bartlett et al., 2012). However, there is evidence 
of translocation of PGC-1α from the cytosol to the nucleus following HIT (Little et al., 
2011b). This may be of key importance for interaction with transcription factors and 
regulation of gene expression. In addition, increases in the transcription of PGC-1α 
mRNA have repeatedly been shown following acute bouts of HIT (Gibala et al., 2009; 
Little et al., 2011b). Likewise, the levels of PGC-1α protein have repeatedly been shown 
to increase following 2-6 weeks of HIT (Burgomaster et al., 2005; Gibala et al., 2006; 
Little et al., 2010b; Hood et al., 2011). 





Figure 1.7. Putative signalling cascades regulating adaptation following HIT. Solid lines represent 
a pathway which there is strong evidence for, whilst dotted lines represent proposed signalling pathways. 
AMP adenosine monophosphate, ATP adenosine triphosphate, AMPK amp-activate protein kinase, Ca2+ 
calcium ions, GLUT4 glucose transporter 4, ROS reactive oxygen species, p38 MAPK p38 mitogen 
activated protein kinase, PGC-1α peroxisome-proliferator activated receptor γ coactivator, Tfacs 
transcription factors 
1.7.3. Chronic Adaptations following HIT 
Effects on Aerobic Capacity 
As previously reviewed in this thesis, evidence suggests that VO2max represents 
one of the strongest predictors of adverse health and all-cause mortality. There are now 
a number of studies which have investigated a variety of different HIT protocols on 
aerobic capacity, and these studies have recently been summarised by three meta-






















 The magnitude of improvement in absolute VO2max with 2-6 weeks of HIT is 
in the region of ~10%, and appears to be comparable to changes observed following 
traditional continuous aerobic training at 60-70% of VO2max (Burgomaster et al., 2008; 
Rakobowchuk et al., 2008; Cocks et al., 2013). This response does not appear to be 
different between men and women (Astorino et al., 2011) and similar effects are 
observed in overweight and obese individuals (Whyte et al., 2010; Trilk et al., 2011). 
Interestingly, several studies report that VO2max may be improved with a remarkably 
small volume of supramaximal HIT. For example, Ma et al. (2013) have shown that 4 
sessions/week of a HIT protocol, requiring eight 20 s cycling efforts at ~170% VO2max 
with 10 s recoveries, resulted in a 19% increase in VO2max in a group of young healthy 
men. Likewise, Hazell et al (2010) reported that just two weeks of supramaximal HIT, 
utilising 4-6 × 10 sec ‘all-out’ sprints, resulted in a 9% improvement in VO2max. This 
response was similar compared with a group of participants performing 4-6 × 30 sec 
‘all-out’ sprints over the same time period (Hazell et al., 2010), which suggests that 
some mechanisms intrinsic to the intensity of the exercise bout is important for 
adaptations in maximal oxygen uptake.  
Improvements in V̇O2max have also been observed in a variety of clinical 
populations using submaximal/maximal HIT interventions; for example, in patients with 
metabolic syndrome (Tjønna et al., 2008), cardiovascular disease (Rognmo et al., 2004), 
and, quite remarkably, in patients recovering from heart failure as well (Wisløff et al., 
2007; Moholdt et al., 2011). Despite the relatively high training intensities, HIT is 
reported to be well tolerated in these patient groups, and importantly from a patient 
recuperation perspective, the majority of studies report that submaximal/maximal HIT 
is the superior stimulus for improving V̇O2max when compared to volume matched 
continuous moderate intensity cardiorespiratory exercise (Rognmo et al., 2004; Wisløff 
et al., 2007; Tjønna et al., 2008; Ciolac et al., 2010). Question marks over the safety of 
HIT interventions in these populations may be assuaged by recent data reporting no 
elevated risk of cardiovascular events during HIT compared with traditional high 
volume continuous exercise (Rognmo et al., 2012) although further studies on the safety 
of HIT in clinical populations are warranted.  
 
 




Effects on Aerobic Performance and Oxidative Capacity 
In their seminal research papers, Gibala and colleagues demonstrated that just 
six sessions of supramaximal HIT, requiring a maximum of 3.5 min of high-intensity 
exercise each session, over a period of two weeks was sufficient to double the time to 
exhaustion during an exercise bout at 80% of pre-training VO2peak, and improve 
performance during a time-trial matched on total work, both of which rely heavily on 
oxidative metabolism (Burgomaster et al., 2005; Burgomaster et al., 2006). This 
improvement in aerobic performance were subsequently confirmed in independent 
laboratories (Babraj et al., 2009), and shown to be of similar magnitude to the 
improvements observed with traditional high-volume continuous exercise training, even 
though total exercise volume was ~90% lower, and total time commitment was ~75% 
lower, with the HIT intervention (Gibala et al., 2006).  
 The improvements in performance in tasks relying primarily on aerobic 
metabolism with HIT can likely be ascribed to local adaptations in oxidative enzymes 
and substrate storage within the skeletal muscle. The maximal activity of citrate synthase 
is increased with HIT, as is the maximal activity of cytochrome c oxidase (COX), the 
expression of COX II and COX IV protein subunits, and the expression of pyruvate 
dehydrogenase (Burgomaster et al., 2005; Burgomaster et al., 2006; Gibala et al., 2006; 
Burgomaster et al., 2008). In addition, the maximal activity of β-HAD, which is the rate-
limiting enzyme in the oxidation of fatty acids, is up-regulated with HIT (Burgomaster 
et al., 2008), and so is the expression of perilipin 2 and perilipin 5 which are thought to 
be important in regulating lipolysis of IMTG during exercise (Shepherd et al., 2013). 
Lastly, resting stores of IMTG and glycogen are both increased with HIT (Burgomaster 
et al., 2005; Shepherd et al., 2013). Overall, such adaptations afford better metabolic 
control in exercising skeletal muscle, such that lipid utilisation is increased, and 
glycogen utilisation, phosphocreatine utilisation and lactate accumulation are reduced 
during matched intensity exercise (Burgomaster et al., 2006; Burgomaster et al., 2008; 
Perry et al., 2008), and greater voluntary power outputs can be maintained during 
matched work time-trials (Burgomaster et al., 2006; Burgomaster et al., 2008). Taken 
together, it appears as though HIT represents a time-efficient stimulus for inducing a 
range of adaptations classically seen following high-volume continuous aerobic exercise 
training.  




Effects on Insulin Sensitivity 
The metabolic and morphological adaptations associated with HIT appear to 
coincide with improvements in insulin action and glycaemic control (summarised in 
table 1). Whilst a couple of studies had tentatively suggested improvements in fasting 
insulin and glucose following submaximal HIT interventions (Tjønna et al., 2008; Trapp 
et al., 2008), the first comprehensive data came from Babraj et al. (2009), who reported 
a substantial reduction in both the duration and magnitude of the plasma glucose and 
insulin response to an orally ingested glucose solution (i.e., OGTT) following two weeks 
of supramaximal HIT, indirectly indicating improved whole-body insulin sensitivity for 
at least three days following the final training bout. This finding was subsequently 
replicated in a similar cohort of recreationally active men and women using the gold 
standard euglycemic hyperinsulinemic clamp technique, suggesting that the observed 
improvements in whole body insulin sensitivity following SIT are probably attributable 
to enhanced peripheral glucose handling, most likely in skeletal muscle (Richards et al., 
2010). More recent work has shown that the improvements in insulin sensitivity 
following 6 weeks of supramaximal HIT appear to be of a similar magnitude to those 
observed following 6 weeks of continuous moderate intensity training, at least in young 
sedentary male subjects (Cocks et al., 2013).   
Follow up investigations have begun to characterise the impact of different 
models of HIT on insulin action in populations either at an elevated risk of developing 
insulin resistance, such as overweight and obese men and women (Whyte et al., 2010; 
Gillen et al., 2013), or in populations already presenting with severe insulin resistance 
such as patients with T2D (Little et al., 2011a). Whyte et al 2010) demonstrated an 
improvement in insulin sensitivity in overweight men at 1 day, but not 3 days, following 
a two week supramaximal HIT intervention. A subsequent study by the same group 
found no change in insulin sensitivity measured 14-16 hours following a single bout of 
HIT in a matched cohort, suggesting that the improvements observed following the 2 
week training intervention were the result of chronic adaptations (Whyte et al., 2013), 
albeit more transient than observed in lean individuals (Babraj et al., 2009; Richards et 
al., 2010; Cocks et al., 2013). In a cohort of overweight women, Gillen et al (2013) 
utilised a 6 week maximal HIT protocol (10 × 1 min at ~90% HRmax) and could detect 
no mean change in insulin sensitivity, although they did note a small reduction in glucose 




AUC during an OGTT. Little et al. (2011a) examined the effect of the same HIT protocol 
on glycaemic control, as measured by 24-h continuous glucose monitoring, in 8 patients 
presenting with T2D. Follow up measurements taken 48-h following the final training 
revealed a ~13% reduction in mean 24-h blood glucose concentrations, as well as a 29% 
reduction in the aggregate glucose AUC to the standardised breakfast, lunch and evening 
meals.  Taken together, it appears as though HIT results in improvements in insulin 
sensitivity in a variety of different populations (table 1.2).  
The mechanisms underpinning the improvements in insulin action with HIT 
remain speculative, but could be explained either by improvements in postprandial 
insulin and glucose delivery resulting from muscle angiogenesis and enhanced NO-
mediated increases in postprandial muscle blood flow (Cocks et al., 2013), by an 
improved intramyocellular glucose transport capacity (Burgomaster et al., 2007; Hood 
et al., 2011; Little et al., 2011a; Gillen et al., 2013) and increased drive for muscle 
glycogen storage (Burgomaster et al., 2005; Gibala et al., 2006), or most likely some 
combination of these. Firstly, insulin-mediated increases in macro- and microvascular 
flow signalled through NO is a vital step in peripheral glucose uptake and is attenuated 
in people with insulin resistance (Barrett et al., 2011). Cocks et al. 2013) recently 
reported a 27% increase in muscle capillary density as well as a 36% increase in muscle 
eNOS content following HIT, which coincided with a 26% increase in insulin 
sensitivity. Whether or not HIT results in augmented postprandial increases in blood 
flow and transendothelial transport remains to be determined. From an intracellular 
perspective HIT results in a robust increase in intramuscular GLUT4 protein content 
(Burgomaster et al., 2007; Hood et al., 2011; Little et al., 2011a; Gillen et al., 2013) and 
elevations in muscle glycogen inferring a greater drive for glycogen synthesis 
(Burgomaster et al., 2005; Gibala et al., 2006) both of which might play an important 
regulatory role in increasing insulin sensitivity. Following on from this, it is also 
plausible that the reduction in abdominal fat (Gillen et al., 2013), enhanced oxidative 
capacity (Burgomaster et al., 2005; Gibala et al., 2006) and greater intramuscular lipid 
stores (Shepherd et al., 2013) following HIT result in better overall lipid handling in 
skeletal muscle, less accumulation of fatty-acid intermediates, and hence an 
augmentation of the insulin signalling cascade. Indeed, Gillen et al (2013) reported a 
significant relationship between the reduction in abdominal fat and the reduction in 
insulin area under the curve following 6-weeks of HIT in a cohort of 16 overweight 




women. However, a reduction in intramyocellular intermediate lipid species and an 
improved postprandial insulin signalling response remains to be shown following HIT. 
When considering skeletal muscle adaptations to HIT it must also be borne in the mind 
that the extreme exercise intensities recruit a larger muscle mass, and both type 1 and 
type 2 muscle fibres, which is then susceptible to adaptation.  
The effect of a single bout of HIT on insulin sensitivity has also been explored 
and the majority of studies in healthy lean or overweight populations report that there is 
no effect when measure 14-72 hours post-exercise (Brestoff et al., 2009; Richards et al., 
2010; Whyte et al., 2013). However, Ortega et al. (2014) recently reported a substantial 
increase in insulin sensitivity (measured via intravenous glucose tolerance testing 
(IVGTT)) which lasted for at least 48 hours post-exercise. Likewise, Little et al (2014) 
recently reported a reduction in mean 24 h glucose concentrations and 24 h postprandial 
glucose AUC following a single bout of maximal HIT (10 × 1 min >90% HRmax) in a 
small cohort of overweight men. The reasons for these discrepancies is unclear but may 
be related to the different method of assessing insulin sensitivity (IVGTT and CGM vs. 
OGTTs). Further studies examining the acute effect of HIT on insulin sensitivity in 
healthy populations are required, ideally using the gold standard clamp technique. Only 
one study has examined the acute effects of HIT in clinical populations. In 7 men with 
T2D, Gillen et al (2012) reported that a single bout of HIT (10 × 1 min >90% HRmax) 
reduced postprandial glucose excursions and time spent in hyperglycaemia over a 24 h 












Table 1.2. Studies examining changes in insulin sensitivity following HIT  
 
Reference Subjects Protocol Duration 
(wks)  
Si 
Method ∆Glucose  ∆Insulin  ∆Si 
Tjonna et al (2008) 
4♂7♀ sed 
metsyn 
4 x 4 min 90% 
HRmax running 




47 min at 70% 
VO2max 
16  Fasting n.s n.s n.s 
Trapp et al (2008) 11♀ lean sed 
8 s all-out/12 s 
recovery × 60 reps 








Babraj et al. (2009) 16♂ lean untr 
4-7 × 30 s 
all-out cycling 
2  
3 d post 
(OGTT) 
-12% AUC -37% AUC +23% 
Richards et al. (2010) 5♂ 7♀ lean untr 
4-7 × 30 s 
all-out cycling 
2  
3 d post 
(Clamp) 
- - +26% 
Whyte et al. (2010) 10♂ ovr sed 
4-7 × 30 s  
all-out cycling 
2  
1 d post 
(OGTT) 
n.s -15% AUC +23% 
    
3 d post 
(OGTT) 
n.s n.s n.s 
Nybo et al. (2010) 8♂ untr  
5 x 2 min >95% 
HRmax running 
12  Fasting -0.5 mmol/L - - 
    
OGTT – 2h 
glucose 
-1 mmol/L - - 
Little et al (2011a) 8♂ sed T2D 




24 h glu 
-1mmol/L - - 
    
CGM 24 h 
glu AUC 
-14% - - 
Hood et al (2010) 4♂ 3♀ sed 
10 x 1 min 80-95% 
HRreserve 





Skerlyk et al (2013) 8♂ ovr sed 
8-12 × 10 s  
all out cycling 
2 Fasting n.s n.s n.s 
Gillen et al. (2013) 16♀ ovr sed 
10 × 1 min 90% 
HRmax cycling 
6 
3 d post 
(OGTT) 
-6% AUC n.s n.s 
Cocks et al. (2014) 8♂ lean untr 
4-7 × 30 s 
all-out cycling 
6  
3 d post 
(OGTT) 
-17% AUC -34 AUC% +48% 
 8♂ lean untr 
60 min 65% VO2max 
cycling 
6  
 3 d post 
(OGTT) 
-12% AUC -19 AUC% +27% 
♂ men, ♀ women, SED sedentary, METSYN metabolic syndrome patients, UNTR untrained, OVR 
overweight, N.S. not significant, AUC area under the plasma curve, HRmax heart rate max, OGTT oral 
glucose tolerance test, CGM continuous glucose monitor, GLU glucose, SI insulin sensitivity 
 
 
Effects on Blood Lipid Profile and Postprandial Lipaemia  
 
 The impact of a period of HIT on the systemic lipid profile has not been explored 
to the same extent as the effect upon insulin sensitivity. Babraj et al. (2009) showed a 
trend for a reduction in fasting plasma NEFA following 2 weeks of supramaximal HIT 
in a cohort of young healthy men. However, Whyte et al (2010) could find no alterations 




in fasting NEFA, triglycerides, HDL cholesterol or total cholesterol following 2 weeks 
of supramaximal HIT in a group of 10 overweight males, despite an improvement in 
insulin sensitivity. The effect of a single bout of HIT upon postprandial lipid responses 
have been better characterised and, in general, appear to show a small but meaningful 
reduction in the blood lipid response to a high fat meal (Freese et al., 2011; Gabriel et 
al., 2012; Bellou et al., 2013; Gabriel et al., 2013), although this is not a universal 
finding (Tan et al., 2013). For example, Gabriel et al (2012) demonstrated a reduction 
in the triacylglycerol response to a high fat breakfast and lunch meal 18 hours following 
a bout of supramaximal HIT in young men. Likewise, Bellou et al (2013) reported an 
elevation in plasma triglyceride clearance between 14-20 hours following a single bout 
of supramaximal HIT in lean young men. 
 
Effects on Blood Pressure and Endothelial Function 
 
Several studies have examined changes in other indices of cardiovascular health 
including blood pressure and endothelial function. With respect to blood pressure, 
relatively few studies have examined changes following HIT interventions and, given 
the large variability and poor reproducibility of blood pressure measurements, are 
limited by small sample sizes (Rakobowchuk et al., 2008; Tjønna et al., 2008; Whyte et 
al., 2010; Tjønna et al., 2013). Nevertheless, Whyte et al (2010) demonstrated a small 
reduction in both systolic and diastolic blood pressure following 2 weeks of 
supramaximal HIT in a group of overweight men. Likewise, submaximal/maximal HIT 
interventions are associated with reductions in both systolic (~6-10 mm Hg) and 
diastolic (~6 mm Hg) pressure in both overweight men (Tjønna et al., 2013), and in 
patients with metabolic syndrome (Tjønna et al., 2008). Remarkably, Tjonna et al (2013) 
reported similar reductions following protocols using 1 × 4 min and 4 × 4 min intervals 
at ~90% maximum heart rate, highlighting the potency of a small volume of intense 
exercise upon cardiovascular health. However, it should be noted that Rakobowchuk et 
al (2008) found no reduction in a group of lean young men who had a similar baseline 
blood pressure following 6 weeks of supramaximal HIT. Perhaps the reductions in blood 
pressure following HIT are limited to individuals who are overweight and/or already 
presenting with elevations in blood pressure.  




With regards to other vascular adaptations, Rakobowchuk et al (2008) have 
shown that the distensibility and flow-mediated dilation of the popliteal artery is 
improved following supramaximal HIT, suggestive of improvements in endothelial 
structure and function. These improvements were observed following 6 weeks of 
training which involved 6-7 × 30 s ‘all-out’ sprints performed 3×/week in young healthy 
males, and were similar to improvements observed following 6 weeks of continuous 
moderate intensity training, despite a 90% lower training volume with HIT. More 
recently, Cocks et al (2014) have shown, using a comparable HIT protocol and 
experimental design, that improvements in peripheral microvascular densitity and 
endothelial eNOS content are also observed. In support of this finding, several studies 
have observed improvements in peripheral oxygen uptake kinetics which indirectly 
suggests augmented microvascular perfusion (Bailey et al., 2009; McKay et al., 2009).  
Effects on Body Composition 
 
With respect to creating a meaningful energy deficit and hence promoting 
reductions in body fat content, it was previously thought to be optimal to focus on 
continuous steady state exercise for several hours per week. However, there is concern 
over the efficacy of such interventions under free-living conditions as there may be a 
compensatory stimulation of appetite and hence energy intake, negating any increase in 
total energy expenditure created with the exercise (Turner et al., 2010). At the other end 
of the spectrum, several studies over the last 5 years have reported positive changes in 
direct and indirect measures of body composition with different models of HIT (Whyte 
et al., 2010; Heydari et al., 2012; Gillen et al., 2013), and one study has demonstrated 
greater reductions in total and central abdominal fat mass when compared with 
prolonged moderate intensity continuous training (Trapp et al., 2008). Boutcher et al. 
(2011) has previously reviewed the potential mechanisms underlying these observed 
effects, and suggested this may be related to recently demonstrated prolonged elevations 
in post-exercise energy expenditure (Hazell et al., 2012; Skelly et al., 2014) or 
suppressions upon appetite and daily energy intake (Sim et al., 2013).  
1.7.4. Summary of HIT Research  
 This literature review demonstrates that HIT is an effective exercise intervention 
for altering various physiological factors in a direction that would be expected to reduce 




the risk of developing chronic cardiometabolic disease. Indeed, in many studies HIT has 
been shown to similarly effective to traditional high volume aerobic exercise 
interventions (Gibala et al., 2006; Rakobowchuk et al., 2008; Cocks et al., 2013; 
Shepherd et al., 2013). Moreover, the beneficial effects of HIT have been demonstrated 
in various populations including recreationally active and sedentary young to middle 
aged males and females, overweight and obese men and women, cohorts presenting with 
T2D and metabolic syndrome, and in patients recovering from cardiovascular events 
(Gibala et al., 2012). As such, the effectiveness of current models of HIT for improving 
metabolic and cardiovascular health is not in question.  
 However, HIT has been proposed to be a time efficient alternative to current 
exercise recommendations. Whilst this is technically correct given that the actual 
exercise time is reduced, the inclusion of recovery intervals means that the total time 
commitment of the main HIT protocols which have been used to date is not dramatically 
reduced (Figure 1.6). Moreover, many of the HIT protocols that have been utilised are 
associated with high levels of fatigue and can be associated with feelings of nausea. Thus 
they require a high level of participant motivation. Given that motivation to perform 
exercise is low in the majority of individuals, and ‘lack of time’ and ‘feelings of 
discomfort/fatigue’ are major barriers toward exercise participation, it is evident that the 
current design of HIT protocols is not appropriate for recommendation to the general 
population. Thus there is scope for research to examine whether or not it is possible to 
reduce the number of sprints and/or the duration of the sprints whilst still maintaining 
the positive effects. By reducing the sprint number and duration it should also be 
possible to reduce the total time commitment of the exercise bout and also the feelings 
of fatigue. In this context it is noteworthy that signalling pathways associated with 
training adaptations in oxidative capacity and carbohydrate/lipid metabolism are 
activated following a single 30 second ‘all-out’ sprint (Fuentes et al., 2012; Fuentes et 
al., 2013). Likewise, several recent HIT training studies have offered hints that 
shorter/easier protocols may still be effective at improving health markers so long as the 
intensity remains high enough (Hazell et al., 2010; Ma et al., 2013; Tjønna et al., 2013). 
However, this topic requires further exploration.  




1.7.5. Overview of Experimental Work 
The initial aim of this thesis was to design a HIT exercise intervention that was 
both time-efficient and not associated with high levels of fatigue and characterise its 
effects upon human health and metabolism. Chapter 2 outlines the theory which 
underpins the design of the HIT intervention, and then provides an initial 
characterisation of its effects upon insulin sensitivity and aerobic capacity. Having 
observed promising effects in Chapter 2, subsequent studies were undertaken to explore 
acute effects on insulin sensitivity (Chapter 3), and whole-body and skeletal muscle 
metabolism (Chapters 4 and 5). A further training study was then undertaken to explore 
the effects on key metabolic health parameters (Chapter 6).  
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Towards the minimal amount of exercise for improving 
metabolic health: beneficial effects of reduced-exertion high-
intensity interval training (ReHIT) 
2.1. Introduction  
Several recent studies have suggested that high-intensity interval training (HIT), 
a training model involving a series of 30-s ‘all-out’ cycling sprints (i.e. Wingate sprints) 
with 4 min of rest/recovery between each bout, may provide a time-efficient strategy for 
inducing adaptations that are similar to traditional cardiorespiratory training 
(Burgomaster et al., 2005; Gibala et al., 2006; Burgomaster et al., 2007; Burgomaster et 
al., 2008; Rakobowchuk et al., 2008; Trilk et al., 2011; Cocks et al., 2013; Shepherd et 
al., 2013). Furthermore, Babraj et al. (2009) recently demonstrated the beneficial impact 
of HIT on insulin sensitivity, a finding that has since been confirmed by several other 
independent groups (Richards et al., 2010; Whyte et al., 2010; Little et al., 2011; Cocks 
et al., 2013). However, whilst these observations are interesting from a human 
physiological perspective, their translation into physical activity recommendations for 
the general population is uncertain for two reasons; firstly, the relatively high exertion 
associated with ‘classic’ HIT sessions requires strong motivation and may be perceived 
as too strenuous for many sedentary individuals (Hawley & Gibala, 2009); secondly, 
although a typical HIT session requires only 2-3 minutes of actual sprint exercise, when 
considered as a feasible exercise session including a warm-up, recovery intervals and 
cool-down, the total time commitment is more than 20 minutes, reducing the time-
efficiency (Garber et al., 2011). Thus, there is scope for further research to determine 
whether the current HIT protocol can be modified to reduce levels of exertion and time-
commitment while maintaining the associated health benefits. 
Over the past decade it has become clear that skeletal muscle glycogen 
concentrations play a key role in regulating the skeletal muscle’s response to insulin, 
and it has been suggested that high levels of glycogen depletion observed during 
repeated 30-second Wingate sprints may play an important role in mediating the 




improvements in insulin sensitivity following HIT (Babraj et al., 2009; Whyte et al., 
2010). From an acute perspective, it has been demonstrated that glycogen levels 
modulate the effect of insulin on skeletal muscle GLUT4 content and glucose transport 
(Derave et al., 2000). Moreover, muscle glycogen availability influences the activity of 
glycogen synthase and the potency of proximal insulin signalling (Jensen et al., 2006). 
Consequently, several studies have demonstrated an inverse relationship between 
skeletal muscle glycogen content and skeletal muscle insulin sensitivity (Derave et al., 
2000; Kawanaka et al., 2000; Laurent et al., 2000; Jensen et al., 2006; Litherland et al., 
2007). The logical assumption here is that the glycogen depleted muscle cell up-
regulates the glucose transport system to efficiently replenish glycogen stores when 
dietary carbohydrate becomes available, and this response appears to largely explain the 
improvements in insulin sensitivity that can be detected during the recovery from a 
single bout of endurance exercise (Bogardus et al., 1983; Cartee et al., 1989; Gulve et 
al., 1990). Whether or not repeatedly degrading and replenishing skeletal muscle 
glycogen (i.e., increasing glycogen turnover) partly underpins the more prolonged 
adaptive increase in insulin sensitivity that occurs with exercise training is less clear, 
but given that glycogen synthesis is a major fate for the glucose taken up into the muscle 
cell, and the major role of muscle glycogen is to support high intensity muscle 
contractions, it is entirely conceivable that glycogen would exert a major regulatory role 
in the adaptive response for muscle carbohydrate metabolism with exercise. The 
discovery that the β1-subunit of the AMP-activated protein kinase (AMPK) complex 
contains a glycogen-binding domain (Hudson et al., 2003; Polekhina et al., 2003) 
provides a plausible mechanism for this hypothesis: muscle glycogen depletion through 
exercise leads to release of glycogen-bound AMPK, the increased AMP/ATP ratio with 
exercise elevates AMPKα2 activity, initiates the translocation of AMPKα2 to the 
nucleus, and increases GLUT4 mRNA (Holmes et al., 1999; Jørgensenet al., 2006; 
Steinberg et al., 2006). Alternatively, it may be that release of other proteins associated 
with glycogen may initiate signalling mechanisms influencing insulin sensitivity 
(Graham et al., 2010). Regardless of the potential mechanisms however, if muscle 
glycogen regulates insulin sensitivity then exercise protocols aiming to reduce glycogen 
levels should be effective.  
It has consistently been shown that a single 30-second Wingate sprint can reduce 
muscle glycogen stores in the vastus lateralis by 20-30% (Esbjornsson-Liljedahl et al., 




1999; Parolin et al., 1999; Esbjornsson-Liljedahl et al., 2002; Gibala et al., 2009). What 
is intriguing however, is that glycogenolysis is only activated during the first 15 seconds 
of the sprint and is then strongly attenuated during the final 15 seconds (Parolin et al., 
1999). Moreover, activation of glycogenolysis is inhibited in subsequent repeated sprints 
(Parolin et al., 1999). This suggests that the traditional HIT protocol (4-6×30 seconds) 
may be unnecessarily strenuous as similar glycogen depletion may be achieved using 1-
2 sprints of shorter duration (15-20 seconds). In turn, this would make the training 
sessions more time-efficient, less strenuous and more applicable to the largely sedentary 
general population. Therefore, in the current study we investigated the impact of a 
reduced-exertion HIT (ReHIT) intervention on insulin sensitivity in previously 
sedentary humans. We hypothesised that despite reducing sprint time and number, 



















Twenty-nine sedentary but healthy young men (n=13) and women (n=16) were 
recruited to take part in the study and allocated to a training group or a control group. 
Subjects allocated to the training group completed the full experimental protocol whilst 
subjects in the control group completed the pre- and post-training assessments without 
an exercise intervention. Baseline characteristics for each subject group are shown in 
Table 1. No significant differences existed between the ReHIT and control groups at 
baseline (Tables 3.1-3.3). All participants were classified as sedentary according to the 
criteria of the International Physical Activity Questionnaire (IPAQ) (Craig et al., 2003) 
and fit to take part in strenuous exercise according to the conditions of the physical 
activity readiness questionnaire (PAR-Q) (Thomas et al., 1992). Further exclusion 
criteria included clinically significant hypertension (>140/90 mm Hg) and a personal 
history of metabolic or cardiovascular disease. All subjects were fully informed of the 
experimental protocol and any associated risks, both verbally and in writing, before 
providing written informed consent to participate. In addition, the potentially 
confounding effect of changing dietary or physical activity patterns was fully explained 
to all participants and they were asked to maintain their normal lifestyle patterns 
throughout the study period. The experimental protocol was approved by the Heriot-
Watt University School of Life Sciences Ethics Committee and was conducted in 
accordance with the Declaration of Helsinki.  
 
2.2.2. Experimental Design 
All participants underwent pre- and post-intervention testing for insulin 
sensitivity and aerobic capacity. Insulin sensitivity was assessed using an oral glucose 
tolerance test (OGTT) and aerobic capacity was assessed using a conventional V̇O2max 
cycling test. The baseline OGTTs were performed two weeks before training 
commenced and post training OGTTs were conducted 3 days after the final training 
bout, at the same time of day as the pre-intervention OGTTs.  This meant that there were 
exactly 8 weeks between the pre- and post-training OGTTs which ensured that female 




subjects were in the same stage of their menstrual cycle. The V̇O2max tests took place 
1-2 days after the OGTTs.  
 
Table 2.1. Participant Characteristics  
 Training  Control 
 Male (n=7) Female (n=8)  Male (n=6) Female (n=8) 
Age (y) 26±7 24±7  19±1 21±3 
Height (m) 1.74±0.05 1.62±0.05  1.78±0.07 1.65±0.08 
Weight (kg) 73.7±15.9 59.6±7.5  80.1±16.1 60.8±15.1 
BMI (m/kg2) 24.4±4.9 22.7±3.1  25.2±3.9 22.2±4 
VO2max 
(ml/kg/min)  
36.3±5.8 32.5±4.4  38.0±6.7 32.9±6.0 
Data is shown as mean ± SD 
2.2.3. Oral Glucose Tolerance Test (OGTT) 
Prior to OGTTs subjects performed no moderate or vigorous intensity physical 
activities for three days, and refrained from drinking alcohol for one day. Furthermore, 
subjects completed a 3-day food diary before each OGTT which was analysed for total 
energy and macronutrient content using commercially available dietary analysis 
software (Dietplan6, Forestfield Software, UK). There were no significant differences 
in total energy, carbohydrate, fat or protein content over the 3 days before the pre- and 
post-intervention OGTTs in any of the subject groups (table 2.2).   
On the day of the OGTT subjects reported to the laboratory between 7:30 and 
9:30 am following an overnight fast from 10 pm the previous evening. A fasting blood 
sample was obtained from a forearm antecubital vein by venepuncture using the 
vacutainer system. 75 g of anhydrous glucose (Fisher Scientific, Loughborough, UK) 
dissolved in 100 ml of water was then orally administered and further blood samples 
were taken at 60 and 120 min after glucose ingestion. Blood samples were collected into 
pre-cooled plastic tubes containing EDTA, immediately placed on ice, and then 
centrifuged for 10 min at 1600 g to separate the plasma, which was stored at -20°C prior 
to the determination of plasma glucose and insulin concentrations. Plasma glucose 
concentration was determined by the glucose oxidase reaction using an automated 




analyser (YSI Stat 2300, Yellow Spring Instruments, Yellow Spring, OH). Plasma 
insulin concentration was measured using a commercially available ELISA according to 
the manufacturer’s instructions (Invitrogen, UK). All glucose and insulin assays were 
carried out in duplicate; the coefficient of variation (CV) for repeated measures of 
insulin and glucose was 2.6% and <1%, respectively. Area under the curve (AUC) for 
plasma glucose and insulin was calculated using the trapezoid model. Peripheral insulin 
sensitivity was determined using the Cederholm index (Cederholm & Wibell, 1990) 
which is calculated using the formula: 
 
𝟕𝟓𝟎𝟎𝟎 +  (𝑮𝟎 − 𝑮𝟏𝟐𝟎) ×  𝟏. 𝟏𝟓 ×  𝟏𝟖𝟎 ×  𝟎. 𝟏𝟗 ×  𝑩𝑾
𝟏𝟐𝟎 ×  𝑮𝒎𝒆𝒂𝒏 ×  𝒍𝒐𝒈 (𝑰𝒎𝒆𝒂𝒏)
 
 
Where BW is body weight, G0 and G120 are plasma glucose concentration at 0 and 120 
min (mmol·l-1), and Imean and Gmean are the mean insulin (mU·l
-1) and glucose (mmol·l-
1) concentrations during the OGTT. The Cederholm Index has previously been shown 
to correlate well with the gold standard insulin clamp method (Piche et al., 2007).  
 
Table 2.2.  Nutritional intake over the 3 days prior to the OGTTs 
 Male Female 
 
REHIT (n=7) Control (n=6) REHIT (n=8) Control (n=8) 
 
Pre Post Pre Post Pre Post Pre Post 
Carbohydrate (g/day) 217±38 240±90 309±75 284±66 196±44 193±48 210±46 189±40 
Fat (g/day) 60±20 64±30 106±25 98±27 69±8 58±16 60±20 58±16 
Protein (g/day) 82±22 88±33 87±7 79±16 79±28 61±18 72±20 53±13 
Alcohol (g/day) 5±8 0±0 12±24 20±21 18±25 12±19 4±6 6±13 
Energy (Kcal/day) 1818±244 1948±649 2702±614 2555±471 1904±328 1668±409 1745±354 1575±362 
Data is shown as mean ± SD calculated from nutritional scores averaged over the 3 days  
2.2.4. V̇O2max Test 
Maximal oxygen uptake capacity (V̇O2max) was determined using a graded 
cycling test to volitional exhaustion on a mechanically braked cycle ergometer 




(Ergomedic 874e, Monark, Vansbro, Sweden). Subjects cycled at 60 W for one minute 
after which the resistance was increased by 30 W∙min-1 until the pedal cadence could no 
longer be maintained at 60 rpm. Participants respired through a rubber mouthpiece 
which was connected to an online gas analysis system (Sensor-Medics, Bilthoven, the 
Netherlands). Respiratory volume, flow and levels of expired O2 and CO2 were 
measured and used to determine V̇O2 via indirect calorimetry (Frayn, 1983). The breath-
by-breath data was inspected visually using scatterplots in Microsoft Excel and any 
outlying (i.e., unphysiological) data points were removed. 15-breath rolling averages for 
V̇O2 were subsequently calculated and V̇O2max was taken as the highest 15-breath value 
achieved during the test. In all tests two or more of the following criteria were met: a 
plateau in V̇O2 despite increasing intensity, RER > 1.15, heart rate within 10 beats of 
age-predicted maximum, and/or volitional exhaustion. 
2.2.5. Training Protocol 
Participants allocated to the training group completed three exercise sessions per 
week for 6 weeks, completing 18 sessions overall. All exercise sessions lasted 10 min 
in total, including a warm up and cool down, which meant a total training time of 30 min 
per week. Each training session consisted of low intensity cycling (60 Watts) and one 
(1st session) or two (all other sessions) all-out cycling sprints. Just before each sprint, 
resistance was removed, subjects increased the pedal cadence to their maximal speed, a 
braking force equivalent to 7.5% of body weight was then applied to the ergometer, and 
participants sprinted against the braking force for a designated time period. The duration 
of the sprints increased from 10 seconds in week 1, to 15 seconds in weeks 2 and 3, and 
20 seconds in the final 3 weeks. A full schematic of the training protocol is shown in 
Figure 3.1. Training sessions were fully supervised and verbal encouragement was given 
during each sprint. A rating of perceived exertion (RPE) was collected using the 15-
point Borg scale (Borg, 1970) at the end of the first session, and subsequently at the end 
of each training week, immediately following the completion of the 10-minute training 
session. When giving their RPE scores, participants were asked to consider the whole 
10-minute training session.  




2.2.6. Statistical Analysis 
All data are presented as mean ± SD unless otherwise stated. Data were analysed 
using the commercially available SPSS statistics package (PASW Statistics, version 
17.0). Three-way mixed-model ANOVAs (sex [male, female] × group [ReHIT, control] 
× time [pre, post]) were performed to test the effects of the ReHIT intervention on body 
mass, V̇O2max, glucose AUC, insulin AUC and insulin sensitivity. For variables with 
significant sex × time interactions, males and females were analysed separately using 2-
way mixed model ANOVAs (group × time). ANOVA were performed regardless of any 
minor deviances from a normal distribution (Maxwell & Delaney, 2004), and with 
Greenhouse-Geisser corrections applied for contrasts where ɛ<0.75 and the Huynh-Feldt 
corrections applied for less severe asphercity (Atkinson, 2002).  Comparisons in RPE 
data between men and women were made using an independent sample t-test. 





Figure 2.1. Schematic of the ReHIT training protocol. Grey boxes represent ‘all-out’ sprints against 
a fixed resistance of 7.5% of body mass 





2.3.1. Exercise adherence and characteristics  
Ten out of fifteen training group participants completed all 18 training sessions 
(100% adherence), with a mean adherence to the ReHIT training programme of 97% for 
all subjects combined. 
RPE data over the course of the ReHIT training program is shown in Figure 3.2. 
On the whole, despite the incorporation of brief but intense sprints, the training sessions 
were well tolerated by all of the participants. Mean RPE values peaked at the end of 
session 12 (week 4; 2×20 s), corresponding to ‘somewhat hard’ and between ‘somewhat 
hard’ and ‘hard’ in men and women respectively. None of the participants gave an RPE 
score higher than 15. When mean RPE values over the whole training program were 
calculated, female participants found the training program significantly harder than male 
participants (13.6±0.5 vs. 12.5±0.7, P<0.05). 
The heart rate response (averaged across participants) during training sessions 4, 
10 and 18 are shown in figure 2.3. The ReHIT sprints were associated with rapid 
excursions in heart rate, reaching in excess of 90% of maximum heart rate during each 









Figure 2.2. Ratings of perceived exertion during the ReHIT training sessions. Data is shown as 
mean ± SD.  














Figure 2.3. Heart rate responses during the ReHIT training sessions. Data shown represents the 
mean response for all participants during that training session. Black boxes denote timings of the all-out 
sprints. Dotted line represents the mean maximum heart rate.  
2.3.2. V̇O2max and Body Mass 
There were no changes in weight or BMI following the ReHIT training 
programme in any of the groups (Table 2.3). For V̇O2max there were significant main 
effects of sex (P<0.001) and time (P<0.01), and a significant interaction effect for group 
× time (P<0.01): following ReHIT V̇O2max was increased by on average 15% in men 
and by 12% in women with no significant sex difference in this effect (Table 2.2). These 











Table 2.3. Effects of ReHIT on BMI, V̇O2max, and glucose and insulin AUC 
 Male Female 
 REHIT (n=7) Control (n=6) REHIT (n=8) Control (n=8) 
 Pre Post Pre Post Pre Post Pre Post 
BMI 
    (kg/m2) 
24.4±4.9 24.0±4.6 25.2±3.9 25.3±4.0 22.7±3.1 22.8±3.7 22.3±4 22.3±3.9 
V̇O2max 
    (ml/kg/min) 
36.3±5.8 41.6±3.9* 38.0±6.7 38.0±5.6 32.5±4.4 36.4±3.6* 32.9±6.0 31.6±6.0 
Glucose AUC                                                     
(   (mmol/min/l) 
789±171 695±141 762±101 801±134 671±190 712±215^ 748±305 850±263^ 
Insulin AUC  
    (mU/min/l) 
11713±4840 7147±3048 8728±4688 9944±5118 7399±3939 8599±4888 6734±4035 7970±4177 
Note: Male training group V̇O2peak data is shown for n=5 and female training V̇O2peak is shown for n=6 
due to technical problems during the pre-training tests. 
Data shown are mean ± SD 
*: P<0.01 for the group × time interaction effect 
^: P<0.05 for the main effect of time in women 
 
2.3.3. Glucose and Insulin Responses to the OGTT 
Effects of the ReHIT intervention on glucose and insulin responses to an oral 
glucose load are shown in Figure 2.2, with glucose and insulin AUCs shown in Table 
2.2. As we observed a significant interaction effect for sex × time for glucose AUC 
(P<0.05), results for male and female subjects were analysed separately using a two-way 
mixed-model ANOVA (group × time). No significant effects were observed for men. A 
significant main effect for time for women (P<0.05) indicated that post-intervention 
values for glucose AUC were increased, but there was no significant difference between 
the female ReHIT and control groups. No significant changes in insulin AUC were 
observed (Table 2.2). 
A significant interaction effect for sex × time was also observed for insulin 
sensitivity (P<0.01), so male and female subjects were analysed separately. Following 
ReHIT, insulin sensitivity significantly improved by 28% in male subjects (P<0.05), but 
not in female subjects (Figure 2.3). 
 
 






Figure 2.4. The impact of ReHIT on plasma glucose and insulin responses to OGTTs. Plasma 
Glucose (A and B), Plasma Insulin (C and D), Men (A and C), Women (B and D); Solid lines ReHIT 






Figure 2.4. The impact of ReHIT on insulin sensitivity in men (A) and women (B). Data is 
presented at mean ± SEM for clarity. * denotes P<0.05 for group × time interaction effect.  
 





The present data demonstrate that a 6-week novel exercise intervention, 
consisting of very brief sessions with relatively low ratings of perceived exertion, is 
associated with improved insulin sensitivity in sedentary young men, and improved 
aerobic capacity in men and women. These beneficial effects were observed 
independently of significant changes in body mass and since post-training measurements 
were taken 3 days after the final exercise bout, are likely to represent chronic training 
adaptations. Importantly, the improvements were observed despite the low time 
commitment (totalling 30 minutes per week) and low required effort: RPE peaked at an 
average of 14 (‘somewhat hard’) in week 4 which is comparable with RPE scores 
reported with prolonged cycling at 50-75% V̇O2max (Borg, 1982). These data extend 
the previous literature demonstrating the beneficial effects of HIT (Burgomaster et al., 
2007; Rakobowchuk et al., 2008; Babraj et al., 2009; Richards et al., 2010; Trilk et al., 
2011; Whyte et al., 2010; Cocks et al., 2013; Shepherd et al., 2013), by showing that the 
sprint number and duration can be substantially reduced whilst still maintaining the 
associated positive effects.   
Based on our current knowledge, when considering the health effects of exercise 
solely from a physiological perspective, it is fair to state that more (within reason) is 
better (Garber et al., 2011). In other words, in order to optimise the metabolic, 
cardiovascular and psychological benefits that exercise can offer, people should be 
encouraged to perform a large volume (at least 30 minutes per day) of both moderate 
and vigorous intensity cardiorespiratory exercise on most days of the week, as well as 
sessions focused on strength and flexibility 2-3 times per week (Garber et al., 2011). 
The associated health benefits with exercise are expected to increase with larger volumes 
of exercise and at higher intensities (Houmard et al., 2004; Swain, 2005; DiPietro et al., 
2006; Church et al., 2007; Bajpeyi et al., 2009; Sisson et al., 2009). However, although 
such guidelines may be effective in those people who adhere to them, they remain 
largely ineffective at a population level (Allender et al., 2008a), partly because they fail 
to sufficiently consider key barriers which prevent people from performing regular 
exercise, such as ‘lack of time’ (Reichert et al., 2007; Korkiakangas et al., 2009). For 
exercise prescriptions to provide a positive effect for society there must be a balance 
between providing adequate health benefits and helping to generate motivation to 




perform exercise by overcoming key barriers. One possible alternative strategy could be 
to define the minimum volume of exercise required to improve health indices with the 
aim of increasing exercise adherence. At the time of analysis, the training programme 
utilised in the current study represented the smallest volume of exercise (when 
considered per session) that has been shown to induce positive effects on health.  
Insulin sensitivity was improved by 28% in men following ReHIT, a finding 
which is strengthened by the inclusion of a ‘lifestyle maintenance’ control group in 
which we measured no significant change over the same time period. The magnitude of 
improvement in insulin sensitivity with ReHIT is comparable with responses observed 
following 2-6 weeks of classic HIT in young sedentary or recreationally active men and 
women (Babraj et al., 2009; Richards et al., 2010; Cocks et al., 2013; Shepherd et al., 
2013), as well as in obese men (Whyte et al., 2010). We designed our intervention based 
on the hypothesis that glycogen degradation would be similar to that observed with the 
classic HIT protocol, since glycogenolysis is attenuated during latter sprints (Parolin et 
al., 1999). Our observation that insulin sensitivity still improved to a similar extent 
supports the idea that repeated glycogen turnover might be a key determinant of 
improved insulin sensitivity following HIT, at least in young lean sedentary male 
subjects. However, as we did not determine glycogen degradation during the ReHIT 
training sessions this remains speculative and further studies are required to elucidate 
the mechanisms by which ReHIT improves insulin sensitivity.  
The improvements in insulin sensitivity after ReHIT appear to be sex-specific as 
mean insulin sensitivity was not improved in the female subjects after the training 
programme. This is in contrast to a previous study which did not observe any sex 
differences in the improvements in insulin sensitivity in 12 recreationally active subjects 
after 2 weeks of classic HIT (Richards et al., 2010), but in agreement with more recent 
studies which could detect no change in insulin sensitivity in sedentary overweight 
women following a 6 week modified HIT protocol (Gillen et al., 2013; Gillen et al., 
2014). No other study has investigated the effects of HIT on insulin sensitivity in 
women. Following a traditional aerobic exercise intervention in a large cohort, insulin 
sensitivity improved to a greater degree in men when compared with women but (similar 
to our study) the female participants had a higher baseline level of insulin sensitivity 
which may have impacted on the subsequent training response (Boulé et al., 2005). The 




sex differences in the change in insulin sensitivity in response to our ReHIT intervention 
may in part be caused by the low statistical power of our study, with only 8 female 
subjects performing the ReHIT intervention. However, it can be speculated that 
differences in metabolic perturbations during the brief high-intensity cycle sprints may 
contribute to the observed sex difference, as women have been shown to break down up 
to 50% less glycogen during a single Wingate sprint (Esbjornsson-Liljedahl et al., 1999; 
Esbjornsson-Liljedahl et al., 2002). New data from Gillen et al who showed a lesser 
increase in skeletal muscle GLUT4 protein content in women compared with men 
following 6 weeks of HIT would fit with this hypothesis (Gillen et al., 2014). From this 
perspective, it would be interesting to determine whether the extent of muscle glycogen 
breakdown during a ReHIT training bout correlates with changes in GLUT4 protein 
content, insulin-stimulated canonical signalling protein content and activation, glycogen 
synthase activity, and insulin sensitivity following the training programme. 
Alternatively, it could be that our small sample included several non-responders. 
Previous studies have comprehensively demonstrated that following a period of exercise 
training part of the population will not adapt for specific parameters (non-responders), 
and for insulin sensitivity this has been shown to be the case for up to 40% of the 
population (Bouchard & Rankinen, 2001; Boulé et al., 2005; Vollaard et al., 2009). 
Therefore, further studies with larger sample sizes will be needed to confirm or refute 
our initial observations. Furthermore, the post-intervention OGTT was scheduled three 
days following the final exercise session, and we cannot rule out that insulin sensitivity 
was improved in female subjects at an earlier time-point. Finally, although we did not 
measure power output during the sprints, we observed that some of the female volunteers 
struggled with the transition from 60 W to the all-out sprints, and were unable to 
substantially increase their pedal frequency, and thus their power output during the 
sprints. This may have increased the aerobic contribution to energy supply and reduced 
glycogen depletion. For sedentary women substituting the 60 W cycling with unloaded 
pedalling may make the sprints more effective.  
Maximal oxygen uptake capacity increased by 15% and 12% in men and women 
respectively after the ReHIT intervention, a physiologically important observation since 
a high aerobic capacity is associated with a lower risk of cardiometabolic disease (Wei 
et al., 1999; Church et al., 2005). Interestingly, since women improved their aerobic 
capacity but not their insulin sensitivity, it appears that there is dissociation between 




changes in aerobic capacity and changes in insulin sensitivity. Our results are in 
agreement with previous HIT studies that have observed increases in VO2max ranging 
from 5 to 13% irrespective of sex or initial body mass index (Hazell et al., 2010; 
Astorino et al., 2011; Trilk et al., 2011), although it must be noted that improved aerobic 
capacity is not a universal finding with HIT (Burgomaster et al., 2005). Studies utilising 
reduced volume HIT protocols are inconsistent. Hazel et al utilised 4-6 × 10 s ‘all-out’ 
sprints over 2 weeks and demonstrated a ~10% increase in VO2max in recreationally 
active subjects (Hazell et al., 2010), whilst Gillen et al utilised 3 × 20 s all out sprints 
over 6 weeks and showed a similar increase in overweight men and women (Gillen et 
al., 2014). On the other hand, Skleryk et al utilised 8-12 x 10 s ‘all-out’ sprints over 2 
weeks and could detect no change in aerobic capacity in 10 overweight/obese men 
(Skleryk et al., 2013). Each of these studies used relatively small sample sizes and as a 
result the impact of ReHIT on VO2max requires confirmation with a larger cohort.  
Average RPE values reported on immediate completion of the ReHIT training 
sessions were comparable with RPE values obtained during prolonged moderate 
intensity cardiorespiratory exercise at 50-75% V̇O2max (Borg, 1982). However, there 
are limitations to the use of the RPE scale in the current study, as the RPE scale is 
designed for use during (or immediately following) continuous exercise at a constant 
intensity and may not be a valid measure of exertion during interval based exercises, 
especially when values are given retrospective of the most intense exercise, as was the 
case in this study. RPE values obtained in this manner may underestimate exertion 
during the sprints; indeed, other studies where RPE has been obtained following a 20-
second all-out sprint have reported higher values of ~16-18 (Baker et al., 2001; Gearhart 
et al., 2005). However, we were interested in gaining an exertion measure to characterise 
our entire training intervention and our subjects were asked to consider the whole 10 
min exercise session when giving their ratings. Whether the effort required to perform 
ReHIT sessions would deter individuals from performing this type of intervention is a 
question to be answered in future studies.  
In conclusion, in this study we have shown that a very brief and feasible exercise 
intervention is associated with improvements in metabolic health and aerobic capacity. 
Our findings suggest that this ReHIT protocol may offer a genuinely time-efficient 




alternative to HIT and conventional cardiorespiratory exercise training for improving 
risk factors of T2D.  
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The impact of an acute bout of ReHIT and continuous vigorous intensity 
cardiorespiratory exercise on insulin sensitivity 
3.1. Introduction 
In the first study of this thesis (Chapter 2), we demonstrated that a modified HIT 
protocol, consisting of 10 min of low intensity cycling interspersed with two 20-s ‘all-
out’ sprints (ReHIT), was effective in improving insulin sensitivity in sedentary men, 
and aerobic capacity in sedentary men and women. Importantly, these benefits were 
observed despite the very low time commitment and low ratings of perceived exertion. 
This makes ReHIT a more promising intervention for improving health in sedentary 
populations compared to other HIT protocols, and this protocol is worthy of further 
study.   
The majority of HIT intervention studies demonstrating improvements in insulin 
sensitivity have performed their measurements between 48-72 hours after the final 
training bout and hence the changes are likely attributable to chronic training adaptations 
(Babraj et al., 2009; Richards et al., 2010; Cocks et al., 2013). This is supported by 
recent acute studies demonstrating no change in insulin sensitivity 14-16 hours (Brestoff 
et al., 2009; Whyte et al., 2013) and 72 hours (Richards et al., 2010) following a single 
bout of HIT. Our assessment of insulin sensitivity following the 6 week ReHIT 
intervention was also performed 3 days following the cessation of training (Chapter 2) 
and it seems unlikely that there would be any residual impact of the final exercise bout. 
However, this contention needs to be confirmed experimentally. Therefore, the aim of 
this study was to determine the impact of a single bout of ReHIT on insulin sensitivity 
measured the following day in comparison to a no-exercise control condition. We 
hypothesised that there would be no increase in insulin sensitivity with ReHIT. As a 
hypothesised positive control, we also included a condition involving an acute prolonged 
bout of moderate-vigorous intensity cardiorespiratory exercise, which has previously 
been shown to improve insulin sensitivity at a similar time point (Brestoff et al., 2009).  






Fourteen healthy young men (n=8) and women (n=6) gave their written informed 
consent to take part in this study which received ethical approval from the Heriot-Watt 
University School of Life Sciences Ethics Committee (Table 3.1). All participants were 
classified as sedentary according to the conditions of the International Physical Activity 
Questionnaire (Craig et al., 2003) and were eligible to take part on the basis that they 
were fit to perform strenuous exercise according to the conditions of the Physical 
Activity Readiness Questionnaire (Thomas et al., 1992), free from metabolic disease, 
cardiovascular disease, acute viral infection and clinically relevant hypertension (i.e., 
>140/90 mmHg). All participants were weight stable in the preceding 3 months and were 
asked to maintain their normal diet and patterns of physical activity throughout the study 
period. 
3.2.2. Baseline Testing and Familiarisation 
Prior to the main experimental trials participants visited the laboratory on four 
separate occasions. During the initial visit peak oxygen uptake capacity (V̇O2max) was 
determined during a continuous incremental cycling test to their limit of tolerance on an 
electronically braked cycle ergometer (Lode, Excalibur Sport, the Netherlands). Resting 
oxygen consumption was first determined over a 5-min period and then a 25 W∙min-1 
continuous ramp (starting from 0 W) was initiated with participants cycling at a self-
selected cadence until the cadence could no longer be maintained above 50 rpm. Breath-
by-breath analysis of respiratory volume, flow, and O2 and CO2 concentrations 
(SensorMedics, Bilthoven, the Netherlands) allowed determination of pulmonary gas 
exchange via indirect calorimetry (Frayn, 1983). A 15-breath rolling average for V̇O2 
was calculated and V̇O2max was taken as the highest 15-breath value achieved during 
the test. During each test, at least two of the following criteria were met: a plateau in 
V̇O2 despite increasing intensity, RER > 1.15, heart rate within 10 beats of age-predicted 
maximum, and/or volitional exhaustion.  
Following the incremental cycling test the participants performed three 
familiarisation sessions (two for ReHIT and one for AER). The AER familiarisation 




session was mainly used to check the intensity predicted to elicit 75% V̇O2max 
(calculated using linear regression from the V̇O2 responses during the incremental 
cycling test). Participants cycled for 15 min at the prescribed intensity and V̇O2 was 
measured continuously throughout (SensorMedics, Bilthoven, the Netherlands). If 
necessary, adjustments were made to the intensity used during the main trials. The 
ReHIT sessions were used to familiarise participants with the procedures and the effort 
required during Wingate-type sprints. Ten-second sprints were used in the first 
familiarisation and twenty-second sprints in the second. 
 
Table 3.1. Participant Characteristics  
Variable  Males (n=8) Females (n=6) Combined (n=14) 
Age (y) 22 ± 5 24 ± 5 23 ± 5 
Height (m) 1.78 ± 0.08 1.62 ± 0.04 1.71 ± 0.11 
Weight (kg) 72.1 ± 12 60.0 ± 16.8 67.3 ± 14.9 
BMI (kg/m
2
) 22.6 ± 4.2 22.9 ± 5.6 22.7 ± 4.7 
V̇O2max (L/min) 2.95 ± 0.68 1.90 ± 0.34 2.50 ± 0.76 
V̇O2max (ml/kg/min) 41.4 ± 9.1 32.0 ± 3.4 37.4 ± 8.6 
Maximal Workload (W) 254 ± 45 176 ± 14 220 ± 53 
Data presented as mean ± SD 
3.2.3. Main Experimental Trials 
Participants completed three main experimental trials (ReHIT, AER and REST) 
in a randomised cross-over design, with each trial taking place over a 2-day period. 
During each trial participants underwent an oral glucose tolerance test (OGTT) on the 
morning after performing either: (1) a single bout of vigorous intensity aerobic exercise 
(AER); (2) a single bout of reduced-exertion high intensity interval training (ReHIT); or 
(3) a no-exercise control condition (REST). Each trial was separated by at least 1 week 
and prior to each trial participants were asked to avoid any strenuous or tiring physical 
activities for 48 hours and avoid consuming any alcohol of caffeine for 24 hours.  
 On the evening prior to each OGTT, participants attended the laboratory between 
4:30 pm and 7:00 pm to perform the exercise session. 30 min after completion of the 
exercise bout, participants were given a standardised evening meal consisting of a 




microwaveable ready meal, a yogurt, a cereal bar and orange juice (Table 3.1). For each 
participant, the time of attendance was standardised and staggered so that the time of 
completion of the exercise bouts and consumption of the post-exercise evening meal 
was consistent between each experimental condition. Having fasted overnight (since the 
post-exercise meal), participants returned to the laboratory the following morning 
between 7:00 am and 9:30 am, rested quietly for 15 minutes, and then the OGTT was 
performed. 
 
                     Table 3.2. Characteristics of the standardised evening meals 
Dietary Variable Mean ± SD 
Energy (Kcal) 773 ± 118 
Total Carbohydrate (g) 107 ± 17 
Sugars (g) 48 ± 8 
Total Fat (g) 21 ± 7 
Saturated Fat (g) 8 ± 4 
Protein (g) 35 ± 10 
Fibre (g) 8 ± 3 
                         Data presented as mean ± SD 
 
3.2.4. Exercise Protocols 
All exercise protocols were performed on an electronically braked cycle 
ergometer (Lode, Excalibur Sport, the Netherlands). The aerobic exercise protocol was 
identical to that used by Brestoff et al. (2009) and involved 45 min at an intensity 
predicted to elicit ~75% of V̇O2peak. Cadence was self-selected and the exercise was 
completed in intervals of 15 min with 2 min of resting recovery between each interval. 
V̇O2 was collected during the final 5 min of the first bout (SensorMedics, Bilthoven, the 
Netherlands), heart rate was measured throughout (Polar Electro, Vansbro, Sweden), 
and an RPE was collected during the final minute of each 15-min interval using the 15-
point scale (Borg, 1970). The ReHIT condition involved 10 min of low-intensity cycling 
(unloaded pedalling) and two ‘all-out’ sprints. Just before each sprint, participants 
increased their pedal cadence to their maximal speed, a braking torque was applied to 
the ergometer, and participants sprinted maximally against the braking torque for 20 s. 
The braking torque (Nm) was calculated by multiplying the participants body mass (Kg) 




with a torque factor of 0.70 Nm∙Kg-1 for males and 0.60 Nm∙Kg-1 for females. Heart rate 
and power output were measured throughout each sprint. RPE scores were collected at 
the end of each sprint and on completion of the 10 min protocol; for RPE scores obtained 
at the end of each sprint participants were asked to consider their exertion at that exact 
moment in time, whilst for RPE scores collected at the end of the full protocol, 







Figure 3.1. Overview of the experimental design. Aerobic exercise (AER) and reduced-exertion high 
intensity interval training (REHIT) protocols.V̇O2peak, peak oxygen uptake capacity; OGTT, Oral 
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3.2.5. Oral Glucose Tolerance Test and Plasma Analysis 
The OGTTs were started on average 14.5 hours (range: 13.5-16.0 hours) 
following completion of the exercise bouts and the timings were consistent between 
conditions. A baseline blood sample was obtained from a forearm antecubital vein by 
venepuncture using the vacutainer system. 75 g of anhydrous glucose (Fisher Scientific, 
Loughborough, UK) dissolved in 100 ml of water was then orally ingested and further 
blood samples were collected at 60 and 120 minutes after the glucose ingestion. Blood 
samples were collected into pre-cooled plastic tubes containing EDTA and immediately 
placed on crushed ice. At the end of the OGTT, samples were centrifuged for 10 minutes 
at 2000 g and 4°C to separate the plasma, which was stored at -20°C prior to the 
determination of glucose and insulin concentrations. Plasma glucose concentration was 
determined in duplicate using the glucose oxidase method on an automated analyser with 
a CV of <1% (YSI Stat 2300, Yellow Spring Instruments, Yellow Spring, OH). Plasma 
insulin concentrations were measured in duplicate using a commercially available 
ELISA according to the manufacturer’s instructions (Invitrogen, UK). The CV for 
repeated measures of insulin was 4%.  
3.2.6. Calculations and Statistics 
All statistical analysis was performed using the commercially available Statistics 
Package for Social Sciences (SPSS) software. To simplify analysis and interpretation of 
an otherwise complex data set, the OGTT responses for each condition were converted 
into simple summary statistics (i.e., within subject fasting, total AUC and insulin 
sensitivity scores). The total areas under the glucose and insulin curves were calculated 
using the trapezoid rule, whilst the Cederholm Index of insulin sensitivity was calculated 
as previously described in Chapter 2. For all OGTT derived variables, two-way repeated 
measures ANOVA revealed no gender × group interactions so all data was pooled, and 
comparisons were made using 1-factor repeated measures ANOVA with post hoc Ryan 
Holm Bonferroni corrected t-tests if appropriate. Significance was accepted at P<0.05 









3.3.1. Exercise Characteristics 
All participants successfully completed all exercise bouts. During the AER 
exercise session participants cycled at 116 ± 44 W; this elicited 76 ± 4 % of V̇O2max, 
and 86 ± 7 %, 90 ± 6 % and 91 ± 6 % of maximal heart rate during bouts 1, 2 and 3 
respectively. Participants gave RPE scores of 14 ± 1 during bout 1, 15 ± 1 during bout 
2 and 16 ± 2 during bout 3. The power output characteristics of the ReHIT exercise bout 
are shown in table 3.3; the ReHIT session was well tolerated by all participants and was 




Table 3.3. Characteristics of the ReHIT exercise bout 
  Sprint 1 Sprint 2 
Duration (s)  20 20 
Torque (nM)  44.5 ± 11.4 44.5 ± 11.4 
Peak Power (W)  829 ± 264 808 ± 257* 
Average Power (W)  442 ± 145 392 ± 126* 
Minimum Power (W)  289 ± 105 253 ± 93* 
Fatigue Index (%)  64 ± 10 67 ± 11 
Peak Heart Rate (% max)  93 ± 4  94 ± 3 
RPE (Borg Scale)  15 ± 2 17 ± 2* 
Data is presented as mean ± SD; * P≤0.05 sprint 1 vs. sprint 2 
 
 
 3.3.2. Glucose and Insulin Responses to the OGTTs 
The plasma glucose and insulin responses to the 75 g OGTT are shown in figure 
3.2, whilst the insulin sensitivity (Cederholm Index) data is presented in figure 3.3. 
There were no significant differences in fasting glucose concentrations, fasting insulin 
concentrations, total plasma glucose AUC, total plasma insulin AUC or insulin 
sensitivity (Cederholm Index) between any of the three conditions.  
 






Figure 3.2. Plasma glucose (A+B) and insulin (C+D) responses to acute exercise. For clarity, the 
responses over time to the OGTT are presented as mean ± SEM, whilst the AUC data is presented as mean 






Figure 3.3. Insulin sensitivity responses to acute exercise. Data is presented as mean ± SD. ReHIT 
reduced-exertion HIT, AER aerobic exercise, REST no exercise control.  





 In this study we investigated the effects of a single bout of ReHIT, compared 
with a bout of vigorous intensity endurance exercise, on insulin sensitivity measured 14-
16 hours following the cessation of exercise. We could not detect any effect of either 
exercise bout on either fasting glucose, fasting insulin or in a dynamic index of whole-
body insulin sensitivity. The lack of improvement in insulin sensitivity following a 
single bout of ReHIT strengthens our contention that the increase in insulin sensitivity 
we detected 3 days following the 6-week ReHIT intervention in male subjects (Chapter 
2) could be ascribed to chronic training adaptations.  
 In line with our hypothesis, there was no acute impact of ReHIT on insulin 
sensitivity measured 14-16 hours post-exercise. This is in agreement with the majority 
of previous studies which have measured insulin sensitivity by OGTT at a similar time-
point after more strenuous Wingate based HIT protocols in both recreationally active 
subjects (Brestoff et al., 2009; Richards et al., 2010) and in overweight/obese men 
(Whyte et al., 2013). Similarly, HIT did not appear to attenuate the systemic glucose or 
insulin response to a high-fat mixed meal challenge administered 14 hours post-exercise, 
although the overall lipemic response was reduced (Freese et al., 2011; Gabriel et al., 
2012). However, a recent HIT study has demonstrated improvements in estimates of 
insulin sensitivity measured using an intravenous glucose tolerance test which remained 
for 48 hours into the recovery period (Ortega et al., 2014). Thus the acute impact of HIT 
remains unresolved. Nevertheless, the current data have important implications for the 
prescription of HIT/ReHIT as a preventative intervention in the general population. If 
reductions in postprandial systemic insulin and glucose concentrations are the primary 
targeted endpoint then single bouts will not be effective; rather HIT/ReHIT needs to be 
repeated regularly over several weeks in order for adaptations to be accrued. The 
situation may differ for specific populations: the only study in men presenting with T2D 
has demonstrated that an acute bout of HIT (10 x 60 s at 90% Wmax) performed in the 
morning reduced peak postprandial glucose excursions, the overall postprandial 
glycaemic response, and the proportion of time spent in hyperglycaemia over the 
following 24-h (Gillen et al., 2012). Whether this holds true for ReHIT, or in other 
populations such as those with prediabetes, will need to be answered in future 
investigations.  




In disparity to our hypothesis, we could detect no increase in insulin sensitivity 
measured 14-16 hours following an acute bout of vigorous intensity aerobic exercise (45 
minutes at ~75% V̇O2peak). This is in contrast to recent data from Brestoff et al. (2009) 
who, using a comparable cohort of participants, identical exercise bout and a similar 
post-exercise time point, demonstrated a ~25% reduction in insulin AUC during an 
OGTT. However, when considered as a whole the literature is somewhat inconsistent, 
with many studies in healthy lean individuals reporting no measurable changes at similar 
time-points following acute aerobic exercise of varying intensities and durations 
(Bogardus et al., 1983; Devlin & Horton, 1985; Baynard et al., 2005; Venables et al., 
2007; Hasson et al., 2010; Short et al., 2012), whilst others have shown improvements 
for as long as 48 hours post-exercise (Mikines et al., 1988; Young et al., 1989; Perseghin 
et al., 1996; Short et al., 2013). This makes the interpretation of the literature difficult; 
however, the lack of change in our study may be explained by a combination of two 
factors. Firstly, the timing and composition of post-exercise feeding appears to have a 
strong influence on the response. For example, several studies show that restriction of 
carbohydrate intake appears to prolong any increase in insulin sensitivity post-exercise 
both in rodents (Cartee et al., 1989; Gulve et al., 1990; Kawanaka et al., 2000) and in 
healthy lean humans (Bogardus et al., 1983; Holtz et al., 2008; Newsom et al., 2010). 
This makes sense from an evolutionary perspective, as any acceleration in metabolism 
following exercise is presumably an attempt to restore intramuscular substrate stores as 
quickly as possible so that further exercise may be performed (Chakravarthy & Booth, 
2004). Secondly, there is evidence that individuals with lower baseline levels of insulin 
sensitivity (e.g. overweight/obese, type 2 diabetics) tend to exhibit a more prolonged 
increase in post-exercise insulin sensitivity which can be detected even after several 
meals have been consumed (Burstein et al., 1985; Devlin & Horton, 1985; Gill et al., 
2004; Nelson & Horowitz, 2014). This is perhaps reflective of the decrement in insulin 
action resulting in delayed restoration of intramuscular substrate stores after exercise, 
thereby necessitating a more prolonged increase in insulin sensitivity. In any case, given 
that our cohort of participants already had a relatively high baseline level of insulin 
sensitivity, and we fed them a meal containing ~100 g of carbohydrate approximately 
30 minutes post-exercise which would be expected to stimulate rapid glycogen 
resynthesis (Ivy et al., 1988a; Ivy et al., 1988b), it is perhaps not all that surprising that 
we observed no change in insulin sensitivity following the aerobic exercise bout in the 
current study. 




There are several limitations to the current analysis which provide opportunity 
for further study. Firstly, financial restrictions only permitted the inclusion of three time-
points during the OGTT for our calculation of insulin sensitivity. Whilst this protocol 
was sensitive enough to detect the relatively large changes in insulin sensitivity observed 
following the ReHIT training intervention, it must be acknowledged that we may have 
missed more subtle changes in the current analysis. It would therefore be useful to repeat 
the current study using the more sensitive gold standard euglycemic clamp 
methodology. Secondly, we only included a 14-16 hour post-exercise time point in this 
study and cannot therefore rule out that ReHIT impacts on insulin sensitivity in the more 
immediate post-exercise period (i.e., in response to the first feeding). Lastly, in order to 
be able to make firm comparisons between the current acute study and the previous 
training intervention (chapter 3) we recruited a similar cohort of participants who, 
although sedentary, were young, lean and otherwise healthy, with a high level of baseline 
insulin sensitivity. It is therefore necessary to investigate the acute impact of ReHIT in 
populations with insulin resistance, particularly in light of the recent finding that other 
models of HIT substantially improve glycaemic control in middle aged men presenting 
with T2D (Gillen et al., 2012).  
In summary, these data demonstrate no effect of an acute bout of ReHIT on 
insulin sensitivity, suggesting that the utility of HIT/ReHIT for improving insulin 
sensitivity may be limited to a training response.  
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Acute metabolic and appetite responses following ReHIT and continuous 
moderate-intensity aerobic exercise 
4.1. Introduction 
Previously in this thesis it was demonstrated that a modified version of the ‘all-
out’ HIT protocols (reduced-exertion HIT; ReHIT), consisting of 10 min of low-
intensity cycling interspersed with two 20-s ‘all-out’ sprints, was effective in improving 
insulin sensitivity in sedentary men, and aerobic capacity in sedentary men and women 
(Chapter 2). Importantly, these benefits were observed despite the very low time 
commitment (a total of 30 min per week) and relatively low ratings of perceived exertion 
(peaking at an average of 13, i.e. ‘somewhat hard’). As the ReHIT protocol is both highly 
time-efficient (total training time of 30 min per week) and manageable (mean RPE ~13 
or ‘somewhat hard’) it may provide a suitable alternative or adjunct to current physical 
activity recommendations. However, further larger studies will be needed to confirm 
these initial positive observations (Metcalfe et al., 2012; Gillen et al., 2014). 
At the same time it also needs to be established why such a small volume of high-
intensity exercise (total 40-60 s per session) appears to be so effective for promoting 
beneficial skeletal muscle and whole-body adaptations. Previous studies investigating 
more time-consuming and more strenuous HIT protocols have demonstrated a molecular 
response which includes a 20-30% drop in muscle glycogen concentrations, substantial 
lactate accumulation, an altered ATP:ADP ratio, and increases in AMPK activity, p38 
MAPK activity, and a 6-fold increase in mRNA expression of PGC1a (Esbjornsson-
Liljedahl et al. 1999; Gibala et al. 2009; Parolin et al. 1999). What’s more, the acute 
disturbance in muscle metabolism is associated with a substantial disruption of whole-
body/systemic homeostasis, including a prolonged increase in post-exercise oxygen 
consumption (EPOC), and alterations in the appetite regulating hormones, acylated 
ghrelin and peptide YY, in a direction which would be expected to suppress appetite 
(Hazell et al. 2012; Williams et al. 2013; Deighton et al. 2013a). Such changes may 
explain why studies have observed beneficial alterations in body composition following 
several weeks of HIT (Whyte et al. 2010; Gillen et al. 2013; Heydari et al. 2012; Trapp 




et al. 2008). However, to date little is known about whether these acute responses to 
‘classic’ HIT are retained with shorter, more manageable protocols such as REHIT. This 
represents an important area of research since it may provide information about the 
initial stimuli responsible for the activation of signalling pathways and chronic 
phenotypic adaptations. The aim of the present study was to characterise the acute 
metabolic and appetite responses to ReHIT compared with traditional aerobic exercise 
recommendations (30 min at 50% V̇O2max; AER). We hypothesised that ReHIT would 
result in a more pronounced disturbance in metabolic homeostasis and a greater 





















 Eight healthy young men (mean ± SD age: 21±2 y; height: 1.79±0.07 m; weight: 
80.7±16.4 kg; BMI: 25±4 kg·m-2; V̇O2max: 39±10 ml·kg-1·min-1) gave written informed 
consent to take part in this study, which received approval from the Research Ethics 
Approval Committee for Health (REACH) at the University of Bath. Participants were 
recruited on the basis that they were able to take part in strenuous exercise according to 
the Physical Activity Readiness Questionnaire (Thomas et al., 1992), were sedentary or 
moderately active according to the International Physical Activity Questionnaire (Craig 
et al., 2003), and were free from metabolic disease, cardiovascular disease, acute viral 
infection, and clinically relevant hypertension (i.e. blood pressure ≥ 140/90 mmHg 
and/or resting heart rate ≥ 100 bpm). All participants were weight-stable during the 6 
months prior to the study and were not dieting. They were requested to maintain their 
normal diet and patterns of physical activity throughout the study period. 
4.2.2. Baseline Testing and Familiarisation 
Prior to the main experimental trials participants visited the laboratory on four 
separate occasions. During the initial visit participants underwent a continuous 
incremental cycling test to determine maximal oxygen uptake capacity (V̇O2max). 
Briefly, the test started at a work rate of 60 W and increased in increments of 30 W every 
3 min until volitional exhaustion. Expired air was collected into Douglas bags during 
the final min of the first four incremental stages and then during the final min before 
volitional exhaustion. Heart rate and ratings of perceived exertion (Borg, 1970) were 
obtained at 1-min intervals throughout the test and at the point of exhaustion. In all tests 
two or more of the following criteria were met: heart rate within 10 beats of age-
predicted maximum, RER ≥ 1.10, RPE ≥ 19, and/or volitional exhaustion.  
Following the incremental cycling test the participants performed three 
familiarisation sessions (two for ReHIT and one for AER), each lasting approximately 
15 min. The AER familiarisation session was mainly used to check the intensity 
predicted to elicit 50% V̇O2max (calculated using linear regression from the V̇O2 
responses during the incremental cycling test). Participants cycled for 10 min at the 




prescribed intensity and an expired air sample was collected during the final min. If 
necessary, adjustments were made to the intensity used during the main trials. The 
ReHIT sessions were used to familiarise participants with the procedures and required 
effort required during Wingate-type sprints. Ten-second sprints were used in the first 
familiarisation and twenty-second sprints in the second.  
4.2.3. Main Experimental Trials 
Participants completed three main experimental trials (ReHIT, AER and REST) 
in a randomised cross-over design. Prior to each experimental trial, participants were 
asked to refrain from strenuous physical activity for 48 hours and refrain from alcohol 
or caffeine for 24 hours. In addition, prior to the first trial a 24-hour food record was 
completed and participants were asked to replicate this diet prior to subsequent trials. To 
ensure adequate hydration participants drank ~1 pint of water upon waking on the 
morning of each experimental trial.  
Participants reported to the laboratory between 8:30 and 9:30 am having fasted 
overnight from 10 pm the previous evening. Participants rested quietly for 15 min prior 
to collection of a 5-min baseline expired air sample, venous blood sample, and subjective 
feelings of appetite and physical tiredness (through visual analogue scales). These 
measurements were repeated at 0, 15, 30 and 90 min post-exercise or 30 min of rest. 
During the post-exercise period participants rested quietly, either reading, watching TV 
or working at a computer. Water was allowed ad libitum throughout each trial.  
4.2.4. Exercise Protocols 
All exercise bouts were performed on a mechanically-braked cycle ergometer 
(Monark 894E, Varberg, Sweden). In the AER condition, participants cycled 
continuously for 30 min at an intensity predicted to elicit 50% of V̇O2max. Heart rate, 
RPE and an expired air sample were collected during the final min of exercise. The 
ReHIT condition involved 20 min of rest followed by a 10-min sprint interval exercise 
protocol. This involved 10 min of low intensity cycling (60 Watts) and two ‘all-out’ 
sprints. Just before each sprint, participants increased the pedal cadence to their maximal 
speed, a braking force equivalent to 7.5% of bodyweight was then applied to the 
ergometer, and the participants sprinted against the braking force for 20 s. Power output 




was measured continuously throughout each sprint. During the REST trial participants 
rested quietly for 30 min.  
4.2.5. Collection and Analysis of Expired Air 
Participants respired through a rubber mouthpiece connected to a two-way Hans 
Rudolph valve and expired air was collected into pre-evacuated Douglas bags. During 
each gas collection, samples of ambient (i.e. inspired) CO2 and O2 concentrations were 
measured within close proximity to the participant (Servomex miniMP 5200) rather than 
just assuming standard atmospheric concentrations, as has recently been recommended 
(Betts & Thompson, 2012). This is in order to account for small changes that could occur 
throughout the day in an enclosed laboratory environment. 
Expired concentrations of O2 and CO2 were measured using paramagnetic and 
infrared analysers respectively (Servomex miniMP 5200). Douglas bags were then 
completely evacuated using a dry gas meter (Harvard Apparatus, Kent, UK) and the total 
volume and temperature (Model C, Edale Intruments, Cambridge, UK) were recorded 
for calculation of V̇O2, V̇CO2, and RER. All values were corrected to reflect standard 
temperature and pressures. In order to estimate EPOC, V̇O2 from the REST trial was 
subtracted from both of the exercise trials, excess V̇O2 from each 5-min measurement 
period was totalled, and then total area under the oxygen curve was calculated.  
4.2.6. Subjective Appetite and Tiredness Ratings 
Perceptions of hunger and prospective food consumption were assessed using 
validated 100 mm visual analogue scales, with standard descriptors anchored at each 
end (Flint et al., 2000). Perceptions of physical tiredness were assessed using 100-mm 
visual analogue scales ranging from “not at all physically tired” to “as physically tired 
as I have ever felt”.  
 
4.2.7. Blood Collection and Analysis  
Venous blood samples were collected through a cannula (BD Venflon Pro, BD, 
Helsingborg, Sweden). Haematocrit and haemoglobin concentrations were determined 




from 1-ml aliquots of EDTA-treated whole blood at each time point. Haematocrit was 
determined manually using a micro-centrifuge and Hawksley reader with a CV of 2.4% 
(Hawksley & Sons Ltd, Sussex, UK). Haemoglobin concentration was analysed in 
duplicate on an automatic analyser with a CV of 1.2% (Sysmex R-3000, Sysmex Ltd, 
UK). Changes in plasma volume from baseline during each trial were then calculated 
using published equations (Dill & Costill, 1974). Hormone responses were corrected for 
changes in plasma volume. For plasma glucose, the uncorrected and corrected responses 
have been presented.  
For glucose, NEFA, lactate and total PYY analysis, whole blood was dispensed 
into a 4-ml EDTA tube, immediately spun at 3466 g and 4°C for 10 min to separate the 
plasma, before being stored at -80°C until subsequent analysis. Plasma concentrations 
of glucose and non-esterified fatty acids (NEFA) were analysed on an automatic analyser 
using commercially available kits with a CV of <1% for both measures (Randox 
Daytona, Country Antrim, UK). Plasma concentrations of lactate were also analysed in 
duplicate on an automatic analyser with a CV of <1% (YSI Stat 3000, Yellow Springs 
Instruments, Yellow Spring, OH). Plasma total PYY concentrations were analysed in 
duplicate using commercially available ELISA with a CV of ~5% (Millipore, 
Hertfordshire, UK). 
For analysis of acylated ghrelin, 2 ml of whole blood was first dispensed into a 
4-ml EDTA tube containing 20 µl of p-hydroxymercuribenzoic acid (PHMB). Samples 
were then spun at 3466 g for 10 min at 4°C, and 500 µl of the supernatant transferred 
into a separate plain tube containing 50 µl of 1 M hydrochloric acid in order to preserve 
acylated ghrelin (Hosoda et al., 2004). Samples were then centrifuged again at 3466 g 
for 10 min at 4°C and the supernatant transferred into a separate tube and frozen at -
80°C until subsequent analysis in duplicate using commercially available ELISA with a 
CV of ~6% for repeated measures (Bertin Pharma, Montigny le Bretonneux, France).  
4.2.8. Statistics 
All data were analysed using the commercially available Statistics Package for 
Social Sciences (SPSS) software. Area-under-the-curve (AUC) calculations were 
performed using the trapezoid rule. Two way repeated measures ANOVAs (condition 
[ReHIT, AER, REST] × time [Pre, 0, 15, 30, 90]) were used to analyse the response of 




all measured variables over time. ANOVA were performed regardless of any minor 
deviances from a normal distribution (Maxwell & Delaney, 2004), and with 
Greenhouse-Geisser corrections applied for contrasts where ɛ<0.75 and the Huynh-Feldt 
corrections applied for less severe asphercity (Atkinson, 2002).  Post hoc comparisons 
were made using paired sample t-tests corrected using the Ryan-Holm Bonferonni 
stepwise adjustment. Hormone AUCs were compared using 1-factor repeated measures 
ANOVA with post hoc paired sample t-tests. Significance was accepted at P<0.05 and, 





















4.3.1. Exercise Characteristics 
During the AER exercise bout participants cycled at 86 ± 5 W, which elicited 53 
± 5 % of V̇O2max, a respiratory exchange ratio (RER) of 0.96 ± 0.03, and 70 ± 4% of 
maximum heart rate. Peak power, average power and minimum power for the ReHIT 
session were 9.2 ± 1.2, 7.3 ± 1.1 and 5.5 ± 1.1 W·kg-1 for the first sprint, and 8.2 ± 1.4, 
6.5 ± 1.1 and 4.5 ± 1.4 W·kg-1 for the second sprint. Perceptions of physical tiredness 
increased immediately following both exercise bouts (both P<0.01 vs. REST) and tended 
to increase more following ReHIT compared with AER (P=0.06; Figure 5.1). Elevated 
physical tiredness ratings remained at 15 min post-exercise (both P<0.05 vs. REST) but 
there were no longer any differences between ReHIT and AER at either of this time-












Figure 4.1. Changes in perceptions of physical tiredness. Data is presented as mean ± SEM for 
clarity. * denotes P<0.05 for ReHIT vs. REST; # denotes P=0.06 for ReHIT vs. AER; † denotes P<0.05 
for AER vs. REST. Black square, ReHIT; White rectangle, aerobic exercise.  
 
 




4.3.2. Oxygen Uptake and Respiratory Exchange Ratio 
V̇O2 was elevated immediately after both exercise bouts relative to REST (both 
P<0.01) and to a greater extent following ReHIT compared with AER (P<0.01; Table 
4.1). V̇O2 had returned to baseline levels 15 min after AER but remained elevated for at 
least 30 min following ReHIT (all P<0.05), resulting in a higher EPOC following ReHIT 
compared with AER (5.1 ± 0.9 vs. 1.0 ± 0.8 L; P<0.01). 
RER was increased following both exercise bouts compared with REST (both 
P<0.01) but the magnitude of the increase was greater following ReHIT compared with 
AER (P<0.01; Table 4.1). Whilst RER had returned to resting values at 15 min following 
AER, there was a decline in RER below baseline values which reached significance at 
30 min (P<0.01) and appeared to persist for 90 min post-exercise (P<0.05 vs. AER and 
baseline, P=0.18 vs. REST).  
 
Table 4.1. Changes in oxygen uptake and respiratory exchange ratio  
Data is presented as mean ± SD. * denotes P<0.05 for ReHIT vs. REST; † denotes P<0.05 for AER vs. 
REST; # denotes P<0.05 for ReHIT vs. AER. 
 
4.3.3. Plasma Volume 
Both exercise bouts resulted in a reduction in plasma volume relative to REST 
(both P<0.0001) but ReHIT resulted in a greater reduction compared with AER (P<0.01; 
Figure 5.2). Whilst plasma volume had normalised at 15 min post-exercise in AER, it 
remained reduced in ReHIT at this time-point (P<0.001 vs. REST and AER). 
 
Post-Exercise Time (Min) 
 Pre 0-5 15-20 30-35 90-95 
V̇O2  
(L/min) 
REST 0.31±0.07    0.29±0.05 0.29±0.05 0.28±0.05 0.30±0.06 
AER 0.31±0.06  0.46±0.10† 0.31±0.05 0.30±0.05 0.30±0.05 
ReHIT 0.30±0.04    0.62±0.10*#    0.38±0.06*#    0.34±0.05*#  0.31±0.04 
RER  
(V̇CO2/V̇O2)  
REST 0.84±0.04 0.82±0.04 0.81±0.05 0.82±0.02 0.81±0.04 
AER 0.86±0.06  1.04±0.06† 0.82±0.09 0.81±0.07 0.83±0.05 
ReHIT 0.82±0.06    1.29±0.08*#    0.76±0.05*#    0.68±0.04*#   0.75±0.06# 












Figure 4.2. Changes in plasma volume. Data is presented as mean ± SEM for clarity. * denotes P<0.05 
for ReHIT vs. REST; # denotes P=0.06 for ReHIT vs. AER; † denotes P<0.05 for AER vs. REST. Black 
square, ReHIT; White rectangle, aerobic exercise.  
4.3.4. Glucose, Lactate and NEFA  
Both exercise bouts resulted in an increase in plasma lactate concentration 
relative to REST which persisted for at least 30 min following AER (all P<0.01) and at 
least 90 min following ReHIT (all P<0.01; Table 4.2). The increase in plasma lactate 
concentration was greater following ReHIT compared with AER and concentrations 
remained higher at all measured time-points (all P<0.05; Table 4.2).  
For plasma NEFA there was a main effect of time (P<0.01) but no main effect 
of condition and no condition × time interaction effect; i.e. plasma NEFA concentrations 
increased over time and this effect was not changed by either exercise bout (Table 4.2).  
When uncorrected plasma glucose concentrations were compared, there was an 
increase in plasma glucose following ReHIT which persisted for at least 15 min post-
exercise (all P<0.05; Figure 4.3A), whilst concentrations remained constant throughout 
the REST and AER trials. However, when plasma glucose concentrations were corrected 
for changes in plasma volume there was no change in glucose levels following ReHIT 
with a small reduction immediately post-exercise in AER compared with REST 
(P<0.05), after which concentrations remained similar between trials throughout the rest 
of the recovery period (Figure 4.3B).  
 




Table 4.2. Changes in plasma lactate and NEFA concentrations  
 Time (Min) 
Pre 0 15 30 90 
Plasma Lactate  
(mmol/l) 
REST 1.45±0.56 1.03±0.31 1.01±0.33 1.00±0.38 1.00±0.35 
AER 1.88±1.11  3.54±1.81†  1.88±0.75†   1.41±0.45† 1.12±0.36 
ReHIT 1.51±0.99  15.37±3.53*#  12.51±2.81*#    7.73±2.08*#    1.88±0.52*# 
Plasma NEFA  
(mmol/l) 
REST 0.46±0.25 0.45±0.19 0.47±0.21 0.54±0.23 0.66±0.20 
AER 0.43±0.24 0.46±0.31 0.60±0.40 0.46±0.28 0.57±0.33 
ReHIT 0.46±0.13 0.34±0.12 0.39±0.17 0.36±0.14 0.58±0.18 
Data is presented as mean ± SD. * denotes P<0.05 for ReHIT vs. REST; # denotes P=0.06 for ReHIT vs. 
AER; † denotes P<0.05 for AER vs. REST.  
 
 
Figure 4.3. Uncorrected (A) and corrected (B) plasma glucose responses Data is presented as mean 
± SEM for clarity. * denotes P<0.05 for ReHIT vs. REST; # denotes P=0.06 for ReHIT vs. AER; † denotes 
P<0.05 for AER vs. REST. Black square, ReHIT; White rectangle, aerobic exercise.  
 
.3.5. Acylated Ghrelin and Peptide YY 
Plasma acylated ghrelin decreased immediately after both exercise bouts when 
compared with REST (both P<0.05). Whilst concentrations were similar in AER and 
REST from 15 minutes post-exercise, they continued to decline in the ReHIT trial, and 
were lower at the 15- and 30-min time-points compared with both REST and AER (all 
P<0.01; Figure 4.4A). There were no significant differences between trials at the 90-min 
time-point. Post-exercise total AUC for acylated ghrelin was lower in ReHIT (4612 ± 




3281 pg∙ml-1∙90 min) compared with REST (8845 ± 4690 pg∙ml-1∙90 min; P<0.01) and 
AER (8904 ± 5532 pg∙ml-1∙90 min; P<0.01).  
Plasma total PYY concentrations decreased over time (P<0.05) and this effect 
was not altered by either exercise bout (Figure 4.4B). There were no significant 
differences in post-exercise total AUC for PYY between any of the groups (ReHIT: 5984 





Figure 4.4. Changes in plasma acylated ghrelin (A) and PYY (B) concentrations. Data is 
presented as mean ± SEM for clarity. * denotes P<0.05 for ReHIT vs. REST; # denotes P=0.06 for ReHIT 
vs. AER; † denotes P<0.05 for AER vs. REST. Black square, ReHIT; White rectangle, aerobic exercise. 
Concentrations of both hormones have been corrected for changes in plasma volume.  
 
4.3.6. Subjective Appetite  
For perceptions of hunger there was a main effect of time (P<0.05) but no main 
effect of condition or condition × time interaction, i.e. perceptions of hunger increased 
over time and this effect was not altered by either exercise bout (Table 4.3). For PFC 
there was no main effect of condition, but there was a main effect of time (P<0.05) and 
a tendency for lower ratings following ReHIT (P=0.08 for the time × condition 
interaction; Table 4.3).  
 




Table 4.3. Changes in subjective perceptions of appetite (n=8)  
  Time (Min) 
 Pre 0 15 30 90 
Hunger$ 
(0-100 mm) 
REST 36±30 41±31 45±34 49±30 55±29 
AER 33±28 45±28 46±27 46±27    53±24 
ReHIT    30±24    37±24    38±25    37±26    42±23 
PFC$ 
(0-100 mm) 
REST 43±28 46±30 50±29 55±29    59±26 
AER 37±27    54±25    53±25    54±24    59±21 
ReHIT    36±22    42±22    38±23    39±26    45±23 






































We have previously demonstrated that an exercise training intervention requiring 
a maximum of 40 s of high-intensity exercise within a 10-min training session (ReHIT) 
can be effective in improving insulin sensitivity and maximal aerobic capacity over a 6-
week period (Chapter 2). In the present study we examined the acute metabolic and 
appetite response to ReHIT. We demonstrate that circulating concentrations of acylated 
ghrelin are reduced by >50% following ReHIT, indicating that ReHIT may be associated 
with a reduction in appetite. Furthermore, our data show that a single bout of ReHIT 
induces a markedly greater disturbance of homeostasis compared with 30 min of cycling 
at an intensity of 53±2% of V̇O2max. Although ratings of physical tiredness directly 
after cessation of exercise were moderately higher for ReHIT compared to AER, this 
difference had disappeared within 15 min after exercise, confirming our previous 
observations that ReHIT is not overly strenuous (Chapter 2). The substantial disturbance 
of physiological homeostasis (presumably ultimately responsible for chronic training 
adaptations), extreme time-efficiency, and low associated perceived exertion and fatigue 
suggest that ReHIT has potential as a feasible alternative, or adjunct to, current physical 
activity recommendations for the general population.  
4.4.1. Appetite and EPOC following REHIT 
The current study demonstrates that circulating levels of the appetite-stimulating 
hormone acylated ghrelin are significantly reduced following ReHIT, which with a total 
duration of 10 min makes it the lowest volume of exercise to be associated with such an 
effect to date. However, the decrease in acylated ghrelin was no longer significant 90 
min after cessation of exercise. Similarly, EPOC was significantly greater following 
ReHIT compared to aerobic exercise, but for a limited duration only. These findings are 
of importance as several previous HIT studies have observed reductions in fat mass 
following training with some evidence for superior reductions compared with traditional 
aerobic training (Trapp et al., 2008; Whyte et al., 2010; Heydari et al., 2012; Gillen et 
al., 2013). Since the direct exercise energy expenditure is much lower with HIT 
compared with prolonged steady state aerobic exercise, the (potentially superior) 
reductions in fat mass following HIT have been hypothesised to be a result of either a 
more prolonged EPOC and/or suppression in appetite resulting in reduced energy intake 




(Boutcher, 2011). Hazell et al. (2012) provided some initial support for a prolonged 
EPOC following HIT by demonstrating that 24-h total oxygen consumption was similar 
(~100 L above rest) following a bout of HIT (4 x 30-s Wingates) compared with 30 min 
of continuous aerobic exercise at ~70% V̇O2max, due to a small but more prolonged 
elevation in metabolic rate following HIT. However, in follow up investigations which 
have either utilised identical ‘all-out’ HIT protocols (Chan & Burns, 2013; Williams et 
al., 2013) or a modified less intense HIT protocol (10 x 1 min at ~90% HRpeak; (Kelly et 
al., 2013)), the elevation in oxygen uptake has been modest and any effect lost ~45 min 
into the recovery period. In the present study we show that ReHIT is associated with a 
5-fold greater EPOC compared with moderate intensity aerobic exercise, but the 
duration and magnitude of EPOC is similar to that observed in these latter HIT studies 
(Chan & Burns, 2013; Kelly et al., 2013; Williams et al., 2013). On balance, the current 
state of evidence suggests that EPOC would only make a small contribution to any 
reduction in fat mass with HIT.  
It has also been suggested that HIT may result in suppression of appetite during 
recovery and hence lead to a reduction in energy intake across a training intervention 
(Boutcher, 2011). From a physiological perspective, appetite is thought to be controlled 
by the hypothalamus, which receives information on short and long term nutrient 
availability via the complex interaction between several gastrointestinal organs, adipose 
tissue, and the circulating episodic and tonic hormonal milieu (Wynne et al., 2005; 
Stensel, 2010). The gut hormones acylated ghrelin (orexigenic effects) and PYY 
(anorexigenic effects) have emerged as important episodic regulators of hunger, feeding 
latency and caloric intake (for review see Wynne et al. (2005)) and may therefore play 
a role in mediating any changes in appetite with exercise. Following ReHIT systemic 
concentrations of acylated ghrelin were reduced by >50% in the immediate post exercise 
period, with little or no change observed following a bout of continuous cycling at a 
moderate intensity. This is consistent with other HIT studies (Deighton et al., 2013a; 
Sim et al., 2013) and fits with previous research which highlights the key effect of 
relative exercise intensity on modulating the response of acylated ghrelin to aerobic 
exercise, with suppression occurring at higher (≥70% V̇O2max) but not lower (≤50% 
V̇O2max) exercise intensities (Broom et al., 2007; Broom et al., 2009; Ueda et al., 2009; 
King et al., 2010; Wasse et al., 2013). The current study suggests that the total duration 
of ‘all-out’ sprint exercise is of less importance than intensity in suppressing acylated 




ghrelin levels. Conversely, circulating levels of total PYY appear to be unaffected by 
ReHIT. The effect of other HIT protocols on total PYY is currently inconsistent with 
one study demonstrating an increase in the immediate post-exercise period (Deighton et 
al., 2013a) and another showing no detectable changes (Sim et al., 2013). It is worth 
pointing out however that in the study by Deighton et al. (2013a), PYY values were not 
corrected for plasma volume changes, and considering the large drop in plasma volume 
following ReHIT in the current study the increase in PYY levels may partly have been 
caused by hemoconcentration. A limitation of the current study is that we only measured 
total PYY concentrations whereas it appears that the PYY3-36 isoform is the most potent 
regulator of satiety (Karra et al., 2009).  
Whereas there was a strong attenuation of acylated ghrelin following ReHIT, 
there was no significant suppression of ratings of appetite (although it is noteworthy that 
ratings of prospective food consumption tended to be lower in the REHIT trial). To date, 
there is limited data on the effects of HIT on indices of appetite and findings are 
equivocal (Deighton et al., 2013a; Sim et al., 2013; Williams et al., 2013). Whilst 
Deighton et al. (2013a) demonstrated a clear ‘anorexic’ effect of HIT on appetite-
regulating hormones as well as subjective appetite ratings immediately post exercise, 
this did not translate into a reduction in caloric intake during laboratory controlled ad 
libitum lunch and dinner buffet meals. On the other hand, in a group of overweight men, 
there was a less robust effect of HIT on gut hormone responses and no effect on 
subjective appetite ratings, yet ad libitum energy intake during a laboratory-controlled 
breakfast meal and over the following day (as assessed using self-report food diaries) 
were both substantially reduced (Sim et al., 2013). Although the physiological relevance 
of short-term suppression of circulating levels of acylated ghrelin with HIT remains 
unclear, we can confirm this effect and demonstrate that it can be achieved with a 
substantially smaller amount of exercise than previously reported. Future research 
should look to further characterise the effect of ReHIT on appetite and examine changes 
in body composition following a training intervention. 
  




4.4.2. Metabolic Responses Following ReHIT 
In the present study we observed a substantial disturbance of metabolic 
homeostasis following ReHIT. Whereas the ATP requirements of moderate intensity 
aerobic exercise can largely be met through oxidative pathways, predominantly via a 
constant supply of NEFA and glucose from the circulation (Romijn et al., 1993; Romijn 
et al., 2000; van Loon et al., 2001), the brief ‘all-out’ sprints in the ReHIT protocol 
present an acute ‘energy crisis’ to the muscle cell. The supramaximal exercise intensity 
leads to rapid depletion of intracellular stores of phosphocreatine, the instantaneous 
activation of glycogen phosphorylase, and degradation of glycogen stores by 20-30% 
within the first of repeated sprints (Esbjornsson-Liljedahl et al., 1999; Parolin et al., 
1999; Esbjornsson-Liljedahl et al., 2002; Gibala et al., 2009). This extremely rapid 
mobilisation of muscle glycogen is a unique characteristic of ‘all-out’ Wingate-type 
sprints and likely explains a number of the differences between ReHIT and AER 
observed in the present study. The considerable amount of glucose-6-phosphate released 
in the early stages of the initial ReHIT sprint poses a challenge to the intramyocellular 
milieu. Although the glycolytic conversion of glucose-6-phosphate results in a rapid 
accumulation of pyruvate, only a small fraction of this is immediately oxidised, and most 
is instead converted to lactate in order to maintain flux through glycolysis (Parolin et al., 
1999), as evidenced by the large spike in plasma lactate concentrations observed in our 
study. The strong reliance on glycolysis for ATP resynthesis will also result in a 
reduction in both intramyocellular and blood pH levels. Consistent with previous 
observations following more strenuous and time-consuming HIT protocols (Hazell et 
al., 2012; Chan & Burns, 2013), we observed a sharp increase in RER immediately after 
ReHIT which then rebounded and remained lower throughout the ReHIT recovery 
period compared with AER and REST. This pattern of change in RER is characteristic 
of the immediate bicarbonate-mediated buffering of  the metabolic acidosis induced by 
high-intensity exercise, followed by the retention of CO2 to replenish the depleted blood 
bicarbonate stores during recovery (Laforgia et al., 1997). Given that the majority of 
glycogenolysis, and hence metabolic acidosis, occurs during the first sprint of a repeated 
sprint protocol (Parolin et al., 1999) it is not surprising that a protocol involving a 
smaller number of shorter sprints poses a similar challenge to buffering mechanisms 
compared with more strenuous HIT protocols, and hence still have this effect on RER 
(Hazell et al., 2012; Chan & Burns, 2013). This regular overloading (and recovery) of 




muscle and blood buffering mechanisms may explain the adaptations in buffering 
capacity observed following six weeks of HIT (Gibala et al., 2006).  
Another consequence of the rapid glycogenolysis occurring during the ReHIT 
sprints is that the accumulation of metabolic derivatives will result in a hypertonic 
intramyocellular environment leading to an influx of water (Raja et al., 2006), which 
may explain the considerable drop in plasma volume observed following ReHIT. 
Potentially this subsequently places the cell in a transient state of osmotic stress 
(Haussinger, 1996). Intriguingly, in various cell types osmotic swelling has previously 
been shown to independently activate various signalling cascades, including the MAP-
kinases, which are known to be involved in cellular remodelling (Haussinger, 1996; Liu 
& Cao, 2009). It is interesting to speculate as to whether this type of osmotic stress could 
be a mechanism of skeletal muscle adaptation with HIT. From a practical research 
perspective, a consequence of the change in plasma volume following ReHIT (which is 
presumably similar following other supramaximal HIT protocols), is that various plasma 
protein levels may have to be corrected for plasma volume changes if measured during 
the initial post-exercise recovery period. Similarly, it seems reasonable to suggest that 
hemoconcentration due to the rapid drop in plasma volume explains previously observed 
increases in plasma glucose concentrations with sprint exercise (Vincent et al., 2004; 
Esbjornsson et al., 2009; Stokes et al., 2013), rather than an increase in glucose rate of 
appearance.  
In conclusion, the present findings demonstrate that ReHIT suppresses 
circulating acylated ghrelin levels and induces a more pronounced disturbance in whole-
body metabolic homeostasis when compared with continuous moderate intensity 
exercise. Future studies should determine whether the suppression of acylated ghrelin 
following acute bouts of ReHIT may reduce calorific intake across a chronic training 
intervention and thus reduce body fat content.  
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The impact of ReHIT on glycogen degradation, AMPK and p38 MAPK 
signalling, and mRNA expression of GLUT4 and PGC-1α in human 
skeletal muscle 
5.1 Introduction 
 High-intensity interval training (HIT) has recently emerged as a potent exercise 
strategy for inducing adaptations similar to traditional cardiorespiratory training (Gibala 
et al., 2006; Burgomaster et al., 2008). As an example, marked increases in skeletal 
muscle proteins related to oxidative metabolism and glucose transport have been 
demonstrated following HIT (Burgomaster et al., 2005; Burgomaster et al., 2007), and 
such adaptations at least partially explain the parallel improvements in skeletal muscle 
and whole-body insulin sensitivity observed (Babraj et al., 2009; Richards et al., 2010). 
At the cellular level, such adaptations are thought to result from the cumulative transient 
increases in gene transcription that follow each acute exercise bout, with the metabolic 
perturbations induced by contraction activating various signalling kinases which, in turn, 
target downstream transcriptional coactivators and regulators (Perry et al., 2010). Two 
important signalling kinases implicated in the adaptive response for skeletal muscle 
insulin sensitivity with exercise are AMP-activated protein kinase (AMPK) and p38 
mitogen-activated protein kinase (p38 MAPK). Both have been shown to be activated 
following aerobic exercise (Little et al., 2010; Bartlett et al., 2012) and HIT (Gibala et 
al., 2009; Little et al., 2011b; Bartlett et al., 2012; Fuentes et al., 2012; Fuentes et al., 
2013), and are known to target downstream transcriptional regulators of genes related to 
skeletal muscle glucose transport (e.g., GLUT4) and mitochondrial biogenesis (e.g., 
PGC 1α) (Holmes et al., 1999; Jørgensen et al., 2006; Winder et al., 2006; Pogozelski 
et al., 2009).  
Whilst skeletal muscle glycogen has long been appreciated as an important acute 
regulator of skeletal muscle metabolism, accumulating evidence also supports its role as 
a signalling molecule potentiating exercise-induced adaptation (Philp et al., 2012). 
Several important signalling kinases, for instance AMPK, contain glycogen binding 
domains (Hudson et al., 2003; Polekhina et al., 2003), suggesting that their activity is 




regulated, at least in part, by glycogen availability (Akerstrom et al., 2006; Steinberg et 
al., 2006; McBride et al., 2009; McBride & Hardie, 2009). It has also been speculated 
that rapid glycogen degradation may be indirectly linked to activation of other stress 
signalling kinases, for example p38, through changes in intramyocellular osmotic 
pressure (Philp et al., 2012). Concordantly, performing acute exercise in a low-glycogen 
state augments signalling through AMPK and p38 (Wojtaszewski et al., 2003; Chan et 
al., 2004), enhances transcription of various metabolic genes including GLUT4 
(Pilegaard et al., 2002; Steinberg et al., 2006), and stimulates a superior adaptive 
metabolic response, for example in oxidative capacity, over the course of an exercise 
training intervention (Morton et al., 2009; Hulston et al., 2010). Of course, the benefits 
of exercising in a low glycogen state on skeletal muscle are limited mainly to athletic 
and highly trained individuals. However, in skeletal muscle which usually experiences 
very little glycogen turnover (i.e., repeated degradation and resynthesis of glycogen), 
such as in sedentary persons, it is plausible that even modest reductions in glycogen 
concentrations may be sufficient to stimulate an adaptive response. Our current working 
hypothesis is that glycogen turnover with exercise (e.g. HIT) underpins several key 
adaptive metabolic responses with training in sedentary individuals, in particular the 
adaptations in skeletal muscle carbohydrate metabolism which beneficially impact upon 
whole-body insulin sensitivity.  
Glycogen use increases with increasing exercise intensity, becoming the major 
substrate at intensities >55% Wmax (van Loon et al., 2001). Glycogen would therefore 
be expected to contribute largely to energy provision during a classic HIT protocol. 
Indeed, several authors have cited glycogen depletion as a potential mechanism 
underpinning improvements in insulin sensitivity with HIT (Babraj et al., 2009; Whyte 
et al., 2010). However, during a repeated sprint protocol glycogenolysis only appears to 
be robustly activated during the first ~15 s of the first sprint (Parolin et al., 1999). 
Therefore, whilst a single 30-s sprint reduces glycogen stores by approximately 20-30% 
(Parolin et al., 1999; Gibala et al., 2009), it is likely that similar degradation may be 
achieved with shorter sprints (e.g., 20-s). Moreover, performing repeated sprints will not 
result in further glycogen degradation (Parolin et al., 1999; Gibala et al., 2009). In 
chapter 3 of this thesis we demonstrated improvements in insulin sensitivity following 
a HIT intervention requiring a maximum of 2 x 20-s ‘all-out’ sprint efforts (reduced-
exertion HIT; ReHIT). Our observation that insulin sensitivity improved to a similar 




extent as with more strenuous protocols (Babraj et al., 2009; Richards et al., 2010; Cocks 
et al., 2013; Shepherd et al., 2013) provides support for the hypothesis that repeated 
glycogen turnover is a key determinant of improved insulin sensitivity following HIT. 
However, the contention that ReHIT induces similar glycogen depletion compared to 
supramaximal HIT protocols involving 4-6 × 30 s ‘all-out’ sprints (~20-30% from 
resting) is yet to be confirmed experimentally. Thus, the primary aim of the current study 
was to determine glycogen utilisation in the vastus lateralis muscle during a single bout 
of ReHIT. In addition, we measured changes in the activation of signalling molecules 
thought to be influenced by glycogen availability (AMPK and p38), and alterations in 
gene expression related to carbohydrate metabolism (GLUT4) and mitochondrial 
biogenesis (PGC1α). We hypothesised that ReHIT would be associated with reductions 
in glycogen, increased phosphorylation of AMPK and p38 MAPK, and increased 



















Twelve healthy active men (n=6) and women (n=6) agreed to take part in this 
study after being advised of the full experimental procedures and potential risks. The 
study protocol was given ethical approval from the NHS South West Research Ethics 
Committee (Frenchay REC Reference: 12/SW/0258) and all subjects provided written 
informed consent. We were unable to obtain usable muscle biopsies in one male subject, 
so they were excluded from the analysis and the final sample size was n=11. Baseline 
characteristics are presented in table 1. Exclusion criteria for this study were: anyone 
aged <18 or >40, anyone with contraindications to strenuous exercise as determined by 
a standard PARQ, anyone with clinically relevant hypertension (≥140/90 or resting heart 
rate ≥100 bpm) or pre-existing disease, anyone with a known bleeding disorder or on 
the anticoagulant Warfarin, and anyone with a tendency to keloid scarring. The study 
was conducted in accordance with the Declaration of Helsinki.  
Table 5.1. Participant Characteristics  
Variable  Males (n=5) Females (n=6) Combined (n=11) 
Age (y) 26 ± 7 26 ± 7 26 ± 7 
Height (m) 1.81 ± 0.06 1.64 ± 0.06 1.71 ± 0.11 
Weight (kg) 74.7 ± 6.7 62.3 ± 9.2 67.9 ± 10.1 
BMI (kg/m
2
) 22.9 ± 2.5 23.2 ± 2.7 23.1 ± 2.5 
V̇O2max (L/min) 4.3 ± 0.8 2.8 ± 0.5 3.5 ± 1.0 
V̇O2max (ml/kg/min) 57.9 ± 12.6 45.7 ± 5.2 51.2 ± 10.9 
Data is presented as mean ± SD 
5.2.2. Baseline Testing and Familiarisation 
 Prior to the main experimental trial participants visited the lab on three separate 
occasions. During the initial visit peak oxygen uptake capacity was determined during a 
continuous incremental ramp test to limit of tolerance on an electronically braked cycle 
ergometer (30 W∙min-1 ramp; Lode, Excalibur Sport, the Netherlands) with V̇O2 
measured continuously using an online metabolic cart (ParvoMedics TrueOne 2400, 
Utah, USA). On separate days each participant performed two ReHIT sessions on a 
mechanically braked cycle ergometer (Monark 894e, Vansbro, Sweden) in order to 




become familiarised with the procedures and required effort during Wingate-type 
sprints. Ten-second sprints were used in the first familiarisation and twenty-second 
sprints in the second.  
5.2.3. Main Experimental Trial 
 At least 1 week following the final familiarisation, and having refrained from 
strenuous/prolonged physical activity for 2 days, and alcohol and caffeine for 1 day, 
participants attended the lab at 8 am following an overnight fast. After resting quietly 
for 15 min, two small incisions (~5 mm) were made in the vastus lateralis of one leg 
under local anaesthetic (1% lidocaine) for collection of muscle biopsy samples using the 
Bergstrom needle technique adapted for suction (Tarnopolsky et al., 2011). One of these 
incisions was used for collection of the baseline muscle sample and immediately closed 
with steristrips, whilst the second was initially covered with sterile gauze and used for 
collection of the sample immediately post-exercise. Further muscle biopsy samples were 
collected at 30 min and 180 min post-exercise through separate incisions and on the 
opposite leg to the first two samples. The starting leg (i.e. dominant or non-dominant) 
for collection of the muscle samples was counterbalanced, and the first biopsy on each 
leg was always taken at a more distal point to the second (~3 cm between incisions). 
Following each muscle biopsy procedure, the muscle sample was immediately snap-
frozen and stored in liquid nitrogen until subsequent analysis. Throughout the recovery 
period participants remained fasted (i.e. water only) and sat quietly in the lab and read, 
watched TV or worked at a computer.  
5.2.4. ReHIT Exercise Bout 
 The ReHIT exercise bout involved 10 min of low intensity cycling (60 Watts) 
and two ‘all-out’ sprints against a braking resistance of 7.5% body mass (Monark 894e, 
Vansbro, Sweden). Just before each sprint, participants increased their pedal cadence to 
their maximal speed, a braking torque was applied to the ergometer, and participants 
sprinted maximally against the braking torque for twenty seconds. 
 




5.2.5. Skeletal Muscle Analysis 
Glycogen Analysis 
 Approximately 20-mg of frozen wet tissue was freeze-dried, powdered, and 
dissected free of visible blood and connective tissue. Samples were then suspended in 
dH2O (0.5-mg/100µl) and homogenised on ice; first manually using a dounce 
homogeniser (30-40 passes) and then by sonication (4 x 10 s bursts at 10 microns with 
50 seconds in between bursts). Homogenates were then heated at 95°C for 5 min, 
centrifuged at 13000 rpm for 5 min, before the glycogen content of the resulting 
supernatant was determined in duplicate using an enzymatic assay adapted for 
fluorimetry according to the manufacturer’s instructions (Abcam Glycogen Assay Kit 
(ab65620), Cambridge, UK). Glycogen concentrations were determined as glucosyl 
units (mmol/kg dry weight) and background glucose concentrations were determined 
and subtracted from the final glycogen readings. The intra-assay coefficient of variation 
was ~3%.  
Western Blotting 
Approximately ~30 mg of frozen wet tissue was freeze dried, powdered and 
dissected free of visible blood and connective tissue, and added to ice cold lysis buffer 
(1 mg/100 µl; 20 mM Tris (pH 7.8), 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 1% 
Triton X-100, 10% (w/v) glycerol, 1 mM EDTA, 1 mM dithiothreitol) which was 
supplemented with protease (Thermo Scientific) and phosphatase inhibitor cocktail 
(Calbiochem Ref 539630). The sample was homogenised on ice using a dounce 
homogeniser (40-50 passes) and subsequently incubated for 1 hour at 4°C with 
continuous rotation. The sample was then centrifuged at 13000 rpm for 5 minutes and 
the supernatant collected. The protein content of the supernatant was determined using 
a bicinchoninic acid assay (BCA) (Thermo Scientific), diluted to a standard protein 
concentration in 1× Laemmli buffer, before being boiled at 95°C for 5 minutes. For each 
blot, 60 µl of sample was loaded, together with a marker protein standard, onto self-cast 
7% or 10% tris-glycine SDS-polyacrylamide gels and separated by electrophoresis (~1 
hour at 200 V) in Tris-glycine running buffer (0.025 M Tris-HCl, 0.2 M glycine, 0.1% 
SDS, pH 8.3). Gels were electroblotted by semi-dry transfer (0.8 mA/cm2 for 110 min 
(10% gels) or 150 min (7% gels)) onto nitrocellulose membranes in SDS transfer buffer 




(48 mM Tris base pH 8.8, 39 mM glycine, 0.0375% SDS, 20% Methanol). After transfer, 
membranes were washed (6 x 5 minute cycle) in TBS-T (Tris-buffered saline buffer 
containing Tween 20; 0.09% NaCl, 1M Tris-HCl pH 7.4, 0.1% Tween,) and then 
incubated for 1 hour in a blocking solution consisting of 5% skimmed milk  (Marvel, 
Premier International Foods Ltd, UK) made up with TBS-T. Having been thoroughly 
rewashed (6 x 5 min cycles) again in TBS-T, membranes were then incubated overnight 
at 4°C with primary antibodies against p-AMPKT172, total AMPK, p-ACCS79 (acetyl-
CoA carboxylase), p-p38 MAPKT180, and total p38 MAPK (All from Cell Signalling 
Technologies except p-ACCS79 which is from Millipore). After incubation, membranes 
were washed thoroughly in TBS-T (6 x 5 minute cycles) before being incubated with an 
appropriate dilution of anti-species IgG horseradish peroxidase-conjugated secondary 
antibodies made up with blocking solution (5% skimmed milk made up with TBS-T). 
Having been rewashed, membranes were then exposed to an enhanced 
chemiluminescence reagent for 2 mins and visualised using a chemiluminescent imager 
(EpiChemi II Darkroom, UVP, Upland, Canada). Band densities were quantified using 
Labworks Image Acquisition and Analysis Software Version 4.0.0.8 for Windows 
(UVP, Upland, Canada). All samples taken from each subject were run on the same gel. 
Representative blots for each protein are shown in figure 1. Blots for p-AMPK and p-
p38 have been normalised to the total amount of each respective protein, and p-ACC has 
been normalised to total AMPK content. Post-exercise time-points are expressed as a 
fold-change relative to pre-exercise values.  
Quantitative real-time PCR 
Gene expression analysis was only performed on muscle samples collected at 
baseline and 180 min post-exercise. Total RNA was extracted from ~10 mg of frozen 
muscle using Trizol reagent according to the manufacturer’s instructions (Life 
Technologies Ltd, Paisley, UK). Briefly, samples were suspended in 1 ml of Trizol, 
homogenized using a mechanical glass-Teflon (or Potter-Elvenheim) homogeniser, and 
then mixed with chloroform to produce an aqueous RNA phase which was subsequently 
mixed with isopropanol to precipitate RNA. The resulting RNA pellet was then washed 
with 75% ethanol, dried and resuspended in nuclease free water. RNA quantity and 
quality was subsequently assessed using a NanoVue Spectophotometer (Thermo Fisher 
Scientfic, Leicester, UK). RNA samples with a 260:280 ratio (i.e., the absorbance at 260 




nm and 280 nm) <1.6 were considered of poor quality and were not processed further. 
RNA was stored at -80°C before being reverse transcribed to cDNA using the High-
Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Life Technologies, 
Paisley, UK). Quantitative real-time PCR for GLUT4 (Hs00168966_m1) and PGC1α 
(HS01016719_m1) relative to GAPDH (Hs.pt.39a.22214836; Integrated DNA 
technologies) was carried out using TaqMan Fast Universal, No AmpErase UNG 
chemistry in combination with a StepOne Fast 7500 real-time PCR system (All Applied 
Biosystems, Warrington, UK). cDNA (45 ng) was amplified under the following 
conditions: 95°C for 20 seconds, followed by 40 cycles of 95°C for 3 seconds and 60°C 
for 30 seconds. All PCR reactions were carried out in duplicate and a non-template 
control (i.e., nuclease free water) was included for each housekeeping gene/gene of 
interest on all plates. The resulting amplification plots were used to generate CT values 
for genes of interest/housekeeping gene and the ∆CT was calculated. The comparative 
CT method was used to calculated gene expression at 180 min post-exercise relative to 
baseline.  
5.2.6. Data Handling and Statistical Analysis 
Due to difficulties with sample extraction and the subsequent size and quality of 
sample, in some participants we were unable to obtain the full time course for all 
measured variables. The number of samples missing for each analysis, the reason and 
the approach to data handling is summarised in table 1. For analysis of glycogen, two 
participants had missing data immediately post-exercise (i.e., time 0). However, as 
values for 30 minutes post-exercise were available for these participants, and because 
the mean difference between 0 and 30 min post-exercise time points in the other 9 
participants was negligible (~15 mmol/kg dry wt; P>0.05), it was deemed appropriate to 
substitute in the 30 min value at 0 min for these particular cases. For the western blotting 
there was more variation between participants and between time points so this approach 
was not appropriate; in this case missing data points have been replaced with the mean 
response for the group at that time point. Since comparisons for gene expression were 
only made between two time points, and thus any missing data point prevented that 
comparison being made, any participant with a missing data point was excluded from 
the statistical analysis.  
 




Table 5.2. Summary of missing data and approach to data handling and statistics 
 Number of Missing Samples   
Analysis Pre 0 30 180 Reason 
Approach for 
Statistics 
Glycogen 0 2 0 0 
Small size of 
sample 
Substitution of value 
from 30 minute time 
point for that subject 
Western Blots 0 2 0 1 
Small size of 
sample 
Substitution of mean 
value for that time point 
qPCR 6 n/a n/a 6 
No 
amplification 
of target genes 
Data excluded (n=6) 
 
  
Statistical analysis was performed using the commercially available Statistics 
Package for Social Sciences (SPSS) software. Gene expression data at pre and 180 min 
were compared using a Wilcoxon Rank Sum Test, since non-parametric tests are more 
appropriate when using very small sample sizes (Siegel & Castellan, 1988). Skeletal 
muscle glycogen and signalling protein data were analysed using a one factor (time) 
repeated-measures analysis of variance (ANOVA) with Ryan Holm Bonferroni correct 
t-tests used to locate any differences between time points. Significance was set at P<0.05 

















 All participants successfully completed the ReHIT exercise bout. Peak power, 
average power and minimum power for the ReHIT session were 9.4 ± 1.5, 8.1 ± 1.1 and 
6.2 ± 1.1 W·kg-1 for the first sprint, and 8.4 ± 1.6, 7.2 ± 1.2 and 5.5 ± 0.8 W·kg-1 for the 
second sprint. 
5.3.1. Glycogen Breakdown 
 Whole muscle glycogen concentrations were reduced on average by ~19% 
immediately post-exercise and remained reduced to a similar extent throughout the 





Figure 5.1. The effect of ReHIT on skeletal muscle glycogen concentrations. Data is presented 
as mean ± SD. *P<0.05 vs. pre 
5.3.2. AMPK, pACC and p38 MAPK signalling 
 Phosphorylation of AMPK did not change significantly at any of the post-
exercise time points (Figure 5.2A). However, ACC phosphorylation was strongly 
increased both immediately and 30 min post-exercise (both P<0.05), returning to 
baseline levels at 180 min (Figure 5.2B). There was no change in phosphorylation of 
p38 MAPK at any of the post-exercise time points (Figure 5.3).  






Figure 5.2. The effect of ReHIT on AMPK (A) and ACC (B) phosphorylation Data is presented 





Figure 5.3. The effect of ReHIT on p38 MAPK phosphorylation. Data is presented as mean ± SD. 








5.3.3 GLUT4 and PGC1α gene expression 
 Due to poor quality of extracted RNA, gene expression analysis for GLUT4 and 
PGC1α is presented for n=5 only. Nevertheless, the expression of PGC-1α was increased 
significantly 180 min following ReHIT (P<0.05) and the change was consistent across 
all 5 subjects (Figure 5.4B). In addition, the expression of GLUT4 showed a tendency 
for an increase (P=0.08), with an increase observed in 4 subjects and no change observed 









Figure 5.4. The effect of ReHIT on PCG1α (B) and GLUT4 (A) gene expression. Data is 
presented as median with individual responses. * denotes P<0.05 vs. pre. 180 denotes the time in minutes 

















 These data show that just 40 seconds of ‘all-out’ exercise is sufficient to reduce 
glycogen by a fifth and increase the mRNA expression of PGC-1α in human skeletal 
muscle. However, it remains unclear whether the reduction in glycogen is associated 
with a signalling response through AMPK or an increase in GLUT4 gene expression. 
Specifically, whilst we were unable to detect a significant change in AMPK 
phosphorylation, there was a robust activation of ACC-β suggesting there may have been 
a level of AMPK activation in our subjects. In addition we noted a trend for an increase 
in GLUT4 gene expression, but this will require confirmation with a larger sample size.   
5.4.1. Glycogen Depletion  
In line with our hypothesis, glycogen levels in the vastus lateralis were reduced 
by ~20% on average immediately following ReHIT. This response fits with the data of 
Parolin et al who examined the response of glycogen phosphorylase during maximal 
cycling exercise and demonstrated that, during a repeated 30-s sprint bout, glycogen 
phosphorylase (and hence glycogenolysis) was predominantly activated during the first 
15-s of the first sprint (Parolin et al., 1999). More importantly, these data confirm our 
hypothesis that glycogen degradation with ReHIT is similar to that observed following 
HIT protocols incorporating a greater number of more prolonged (e.g., 4 x 30-s) sprint 
efforts (Parolin et al., 1999; Gibala et al., 2009) and provide further indirect support for 
our hypothesis that regular turnover of muscle glycogen stores may be associated with 
improved insulin sensitivity (Chapter 3).  
5.4.2. AMPK and p38 MAPK signalling responses  
AMPK is an αβγ heterotrimer with a well-established role in regulating acute 
energy flux (Jensen et al., 2009). In addition, AMPK is thought to play a role in 
regulating the metabolic adaptation to exercise by signalling through several 
transcription factors (Holmes et al., 1999; Jørgensen et al., 2006; Winder et al., 2006; 
Pogozelski et al., 2009). Classically, AMPK activity was thought to be regulated 
primarily by the cytoplasmic AMP:ATP ratio (Moore et al., 1991; Corton et al., 1994), 
but recent evidence has suggested an important role of glycogen availability as well 
(McBride et al., 2009; McBride & Hardie, 2009). Specifically, AMPK is known to 




contain a glycogen binding domain and it is thought that, in a glycogen replete state, a 
certain amount of AMPK is bound within glycogen granules (Philp et al., 2012). In turn, 
it would be expected that degrading a certain level of glycogen during exercise would 
release a respective amount of the bound AMPK which may then become activated if 
the cytosolic concentration of AMP also increased (Philp et al., 2012). The current study 
shows a ~20% reduction in skeletal muscle glycogen levels, whilst previous studies 
suggest that cytoplasmic AMP concentrations (not measured here) would also have been 
increased with ReHIT (Karatzaferi et al., 2001a; Karatzaferi et al., 2001b). Therefore, it 
was hypothesised that there would be a corresponding increase in AMPK activity 
following ReHIT. We measured phosphorylation of AMPK at the threonine 172 site, 
which is the main site regulated by muscle contraction and has previously been shown 
to be phosphorylated with single and repeated Wingate sprint protocols (Gibala et al., 
2009; Fuentes et al., 2012; Fuentes et al., 2013). However, we could not detect a 
statistically significant increase in AMPK phosphorylation at any measured time point 
following ReHIT. On the other hand, we did detect a robust activation of ACC-β, a 
known downstream target of AMPK (Davies et al., 1990; Ha et al., 1994), and this 
suggests there may have been a level of AMPK activation which we were unable to 
detect. Indeed, some authors rely solely on ACC-β phosphorylation as a marker of 
AMPK activity following exercise (Little et al., 2011b; Cochran et al., 2014). The fact 
that the numerical increase in AMPK phosphorylation 30 min post-exercise was similar 
to that observed in previous studies following a single Wingate sprint (Gibala et al., 
2009; Fuentes et al., 2012; Fuentes et al., 2013) provides some additional support for 
this contention. However, ACC-β may also be regulated via AMPK independent 
mechanisms and dissociation between AMPK and ACC-β activity exists during 
prolonged low intensity exercise, for example (Vavvas et al., 1997; Wojtaszewski et al., 
2002; Jørgensen et al., 2004). Therefore, whether ACC-β provides a representative index 
of AMPK activity is not certain, meaning it is not possible to determine with any 
certainty whether AMPK activity was altered in the present study. 
The rapid breakdown in muscle glycogen may be associated with an increase in 
intramyocellular osmotic tension (Low et al., 1996; Philp et al., 2012). Indeed, in 
Chapter 4 we demonstrated a substantial drop in plasma volume which was speculated 
to be related to the rapid glycogen breakdown and subsequent fluid uptake. Interestingly, 
increased osmotic tension has previously been shown to activate p38 MAPK in isolated 




cell preparations (Sheikh-Hamad & Gustin, 2004). As such, we hypothesised that the 
rapid reduction in muscle glycogen (and simultaneous increase in intramyocellular 
osmotic tension) with ReHIT would be associated with an increase in p38 MAPK 
phosphorylation. In disparity to this hypothesis there was no increase in phosphorylation 
of p38 following ReHIT in the current study. Previous studies have shown no effect of 
a single Wingate sprint on p38 MAPK phosphorylation (Gibala et al., 2009c; Fuentes et 
al., 2012; Fuentes et al., 2013); however p38 has been shown to be activated following 
4 repeated 30-second Wingates (Gibala et al., 2009; Little et al., 2011b). As glycogen 
depletion, and the associated increase in osmotic pressure, would likely have been 
similar amongst these three sprint protocols, it seems likely that p38 MAPK 
phosphorylation is regulated by factors unrelated to glycogen depletion with sprint 
exercise. For example, p38 MAPK has been shown to be regulated by increases in 
cytosolic calcium and activation of CAMK II and there is evidence that p38 MAPK 
regulates PGC-1α activity in a calcium dependent manner (Wright et al., 2007). 
However, current evidence for an increase in CAMK activity following HIT in humans 
is lacking (Gibala et al., 2009). It may be that the time points used to assess CAMK II 
activity in previous HIT studies, and p38 MAPK activity in the present study, were not 
appropriate as these effects will be transient.  
 Whilst in the current study we have measured AMPK and p38 MAPK 
phosphorylation in a whole-muscle biopsy sample, it must be recognised that changes 
in the cellular localisation of these signalling proteins with exercise will likely also be 
of key importance for the adaptive response. Certainly, the regulation of gene 
transcription will either require direct translocation of the protein to the nucleus or a 
signalling cascade which transcends the nuclear membrane. Previous studies have 
observed translocation of AMPK, p38 MAPK and PGC-1α subunits to the nucleus 
during or in the recovery from an acute exercise bout (McGee et al., 2003; Chan et al., 
2004; Steinberg et al., 2006; Little et al., 2011b). Whether a similar response occurs 








5.4.3. GLUT4 and PGC-1α mRNA expression  
 Although it was only possible to obtain mRNA data for n=5 in the current study, 
we were still able to detect a significant increase in PGC-1α gene expression following 
ReHIT. This suggests that ReHIT may be associated with an adaptive increase in 
mitochondrial biogenesis in skeletal muscle with training. In agreement with this 
proposal, it has recently been shown that several markers of oxidative capacity in 
skeletal muscle, such as citrate synthase and COX IV, are increased following a ReHIT 
like exercise training programme (Gillen et al., 2014). Furthermore, increases in PGC1α 
gene expression is a common acute response (Gibala et al., 2009; Little et al., 2011b), 
and an enhanced muscle oxidative capacity is a well characterised training response 
(Burgomaster et al., 2005; Gibala et al., 2006; Little et al., 2010b; Hood et al., 2011), 
with a variety of submaximal and supramaximal HIT protocols. The current study 
provides promising data to suggest that this response may be achieved with a much 
smaller volume of exercise than previously thought, but this will require confirmation 
with a larger sample size.  
 We also observed a tendency for an increase in GLUT4 mRNA content following 
ReHIT, despite the limited statistical power. More specifically, there was an increase in 
GLUT4 gene expression in four subjects, whilst the expression remained unchanged in 
one subjects. Whilst only tentative at present, this suggests that ReHIT may also be 
associated with a gene expression response linked to improved carbohydrate transport 
and insulin sensitivity, and this represents the smallest volume of exercise to be 
associated with an increase in GLUT4 gene expression to date. Moreover, this would 
provide a potential mechanism for the improvements in insulin sensitivity observed 
following 6 weeks of ReHIT (Chapter 3). These data fit with recent work from Gillen et 
al. (2014) who showed an increase in muscle GLUT4 protein content following a 6-
week ReHIT like intervention in sedentary men and women. Numerous other studies 
have also shown increase in GLUT4 following both submaximal and supramaximal HIT 
protocols (Burgomaster et al., 2007; Little et al., 2010; Hood et al., 2011). The tendency 
for GLUT4 gene expression to increase with such a small volume of intense exercise, 
which nevertheless results in a relatively large reduction in muscle glycogen stores, 
would suggest that glycogen levels may play an important role in regulating GLUT4 
gene expression. Indeed, it makes physiological sense that the regulation of GLUT4 gene 
expression (and indeed protein expression) would be coupled to muscle glycogen levels, 




as this represents the main signal of carbohydrate availability in skeletal muscle. From 
an evolutionary perspective, such coupling would have provided a rapid adaptive 
increase in muscle glucose transport following a period of intense exercise, resulting in 
a more efficient replenishment of muscle glycogen stores when dietary carbohydrate 
became available (Chakravarthy & Booth, 2004).  
5.4.4. Conclusions 
To summarise, these data confirm the hypothesis that ReHIT is associated with 
similar levels of glycogen degradation (~20%) compared with more strenuous HIT 
protocols. There also appeared to be increases in the expression of GLUT4 and PGC-1α 
following ReHIT, but these responses will require confirmation with a larger sample 
size. Likewise, there was some evidence of AMPK activation following ReHIT but 
further studies will be required to clarify this response.  
 
 















The impact of six weeks of ReHIT on aerobic 























The impact of six weeks of ReHIT on aerobic capacity and insulin 
sensitivity in previously sedentary men and women 
6.1. Introduction 
Aerobic capacity and insulin sensitivity represent key physiological variables in 
the development of human metabolic disease and are therefore logical targets for 
preventative intervention (Blair et al., 1989; Blair et al., 1995; Blair et al., 1996; Myers 
et al., 2002; Balkau & Eschwege, 1999; Petersen et al., 2007; Lorenzo et al., 2010). 
Previously in this thesis we presented data which suggested that both of these variables 
could be modified with as little as two minutes of sprint exercise per week in a group of 
young sedentary males (Chapter 2). We noted potential sex differences in the response 
to this type of exercise, with female subjects showing an improvement in aerobic 
capacity but no change in insulin sensitivity.  
Both of these findings have recently been confirmed by an independent research 
group and supported via the measurement of skeletal muscle GLUT4 protein content 
which showed a similar sex-dependent increase (Gillen et al., 2014). It is our view that 
the very low time commitment and relatively low ratings of perceived exertion and 
tiredness reported by participants makes our ReHIT protocol the most viable HIT 
protocol for recommendation to the general population. However, both of the studies 
examining the effects of ReHIT to date have been limited by small sample sizes and, 
considering the known variation in the human metabolic and cardiorespiratory responses 
to exercise training (Bouchard et al., 1999; Boulé et al., 2005; Sisson et al., 2009), a 
detailed reappraisal of the insulin sensitivity and aerobic capacity adaptations to ReHIT 
is required in a larger cohort. As such, the primary aim of this study was to re-examine 
the impact of 6 weeks of ReHIT on insulin sensitivity and aerobic capacity in sedentary 
men and women. Given that we didn’t observe any improvement in insulin sensitivity 
in females in Chapter 3, it is necessary to investigate whether the current ReHIT protocol 
can be modified to promote an adaptive response for insulin sensitivity in women. In 
our previous study we observed that some female subjects struggled with the transition 




from 60 W to ‘all-out’ sprinting and were not always able to substantially increase their 
pedal cadence (and hence their power output) during the sprints. We hypothesised that 
this may have increased the aerobic contribution to the sprints, reduced glycogen 
degradation, and hence attenuated our hypothesised adaptive response related to 
glycogen turnover (Chapter 3). In an attempt to ameliorate this, in the current study we 
substituted the 60-W warm-up for unloaded pedalling and reduced the braking force 
applied to the bike during the sprints from 7.5% to 5% body mass. Therefore, we 
hypothesised that 6 weeks of ReHIT would be effective at improving insulin sensitivity 





















Fifty young or middle aged men (n=27) and women (n=23) gave their written 
informed consent to take part in this study, which received ethical approval from the 
NHS South West Research Ethics Committee (Central Bristol REC Reference: 
12/SW/0018)). Seven participants dropped out prior to completing baseline testing, nine 
discontinued the intervention, and we were unable obtain post-training blood samples 
from one male subject who was excluded from the analysis (figure 6.1); thus, thirty-four 
men (n=16) and women (n=18) completed the full experimental procedures and are 
included in this completion-only analysis (table 6.1).  
 Participants were recruited based on the following inclusion criteria: aged 18-
50; classified as sedentary according to the IPAQ self-report questionnaire (Craig et al., 
2003); no contraindications to strenuous exercise according to the standard PAR-Q 
(Thomas et al., 1992); weight stable and no conscious change in diet or physical activity 
patterns over the preceding 6 months; no evidence of clinically significant hypertension 
(>140/90 mm Hg and/or resting heart rate ≥ 100 bpm); and no personal history of 
metabolic or cardiovascular disease. The potentially confounding impact of changes in 
diet and exercise patterns was fully explained to all participants and (outwith the study 
intervention) they were asked to maintain their normal lifestyle over the 8 week study 
period.  
 Habitual physical activity status was estimated over a representative 7 day period 
at baseline using synchronised accelerometry and heart rate monitoring with branched 
model equations (Actiheart, Cambridge Neurotechnology Ltd., Cambridge, UK). The 
Actiheart is a non-invasive physical activity monitor that is both reliable and valid, can 
accurately estimate energy expenditure across low, moderate and high intensity physical 
activities, and provides useful quantitative data on patterns of physical activity, allowing 
a comprehensive characterisation of physical activity status (Thompson et al., 2006). 
Participants wore the monitor continuously (day and night) and were instructed to only 
remove it when showering or bathing.  
 
 




Table 6.1. Participant Characteristics 
*Sedentary = <1.5 METs; Light = <3 METs; Moderate = ≥3 METs; Vigorous = ≥6 METs 
6.2.2. Experimental Design 
All participants underwent pre- and post-intervention testing for fasting lipid 
profile, insulin sensitivity and maximal aerobic capacity. Insulin sensitivity was assessed 
during an oral glucose tolerance test (OGTT) and aerobic capacity was assessed during 
an incremental cycling testing to limit of tolerance. The baseline OGTTs were performed 
two weeks before training commenced and post-training OGTTs were conducted 3 days 
after the final training bout, at the same time of day as the pre-intervention OGTTs. This 
meant that there were exactly 8 weeks between the pre- and post-training OGTTs which 
ensured that female subjects were in the same stage of their menstrual cycle. The 
V̇O2peak tests took place 1-2 days after the OGTTs. Given that we included a ‘lifestyle 
maintenance’ control condition in our previous training study and observed no 
improvements in our primary endpoints (i.e., insulin sensitivity and maximal aerobic 
capacity), we did not deem it necessary (or ethical) to include a control condition in the 
present analysis. 
 
 Males (n=16) Females (n=18) 
Variable Mean ± SD Range Mean ± SD Range 
Age (y) 33±9  21-43 36±9  18-50 
Height (m) 1.75±0.08 1.59-1.87 1.67±0.07 1.54-1.84 
Weight (Kg) 76.9±7.2 66.6-88.9 66.2±9.6 54.3-85.9 
BMI (kg/m2) 25.1±2.1 21.0-28.9 24.0±3.5 18.4-29.1 
V̇O2max (L/min) 3.0±0.6 1.7-4.0 2.1±0.3 1.6-2.7 
V̇O2max (ml/kg/min) 39.2±8.6 24.5-57.3 31.7±4.6 25.7-39.0 
Maximal Workload (W) 221±33 132-270 167±22 134-214 
PA Score (IPAQ) 258±190 0-692 328±355 0-1386 
PAL 1.61±0.22 1.27-1.85 1.64±0.22 1.33-2.00 
Sedentary (min/day)* 985±178 743-1261 973±178 606-1235 
Light (min/day)* 341±122 153-521 335±122 159-609 
Moderate (min/day)* 114±63 26-175 132±63 45-224 
Vigorous (min/day)* 7±7 1-19 7±7 1-23 





















Figure 6.1. Flow of participants through the study 
6.2.3. V̇O2peak test  
Maximal oxygen uptake capacity (V̇O2max) was determined during an 
incremental cycling test to the limit of tolerance. However, as more sophisticated 
equipment (an electronically braked ergometer and an online gas analysis system) 
became available to us during the course of this study, two different protocols and sets 
of equipment were used to determine V̇O2max, with protocols kept identical for each 
subject. We were unable to perform a post-training V̇O2max test in one female 
participant due to technical difficulties, so V̇O2max data is presented for 16 men and 17 
women.  
13 participants (6 men and 7 women) completed the test on a mechanically 
braked cycle ergometer (Ergomedic 874e, Monark, Vansbro, Sweden) with expired air 
analysed using the Douglas bag method. The test started at 60 W and then increased in 
increments of 30 W every 2 min until volitional exhaustion. Participants respired 




through a rubber mouthpiece connected to a two-way Hans Rudolph valve and were 
asked to indicate when they felt they were nearing exhaustion, after which expired air 
was continuously collected into pre-evacuated Douglas bags until the point of actual 
fatigue (i.e. cadence dropped below 60 rpm for > 5 secs). Expired concentrations of O2 
and CO2 were measured using paramagnetic and infrared analysers respectively 
(Servomex miniMP 5200). Douglas bags were then completely evacuated using a dry 
gas meter (Harvard Apparatus, Kent, UK) and the total volume and temperature (Model 
C, Edale Intruments, Cambridge, UK) were recorded for calculation of V̇O2max, 
V̇CO2max, VEmax and RERmax by indirect calorimetry (Frayn, 1983). All values were 
corrected to reflect standard temperature and pressures, and during each gas collection, 
samples of ambient (i.e. inspired) CO2 and O2 concentrations were measured within 
close proximity to the participant (Servomex miniMP 5200) rather than just assuming 
standard atmospheric concentrations, as has recently been recommended (Betts & 
Thompson, 2012). 
The other 20 participants (10 men and 10 women) completed the test on an 
electronically braked cycle ergometer (Lode Excalibur Sport, Groningen, the 
Netherlands) with expired air analysed using an online metabolic cart (ParvoMedics 
TrueOne 2400, Utah, USA). Participants cycled at 50 W for 5 minutes for determination 
of submaximal heart rate and substrate oxidation responses, and then a 15 W∙min-1 
continuous ramp protocol was initiated with participants cycling at a self-selected 
cadence until volitional exhaustion (i.e., when cadence dropped below 50 rpm for longer 
than 5 seconds). Participants respired through a rubber mouthpiece connected to a two-
way Hans Rudolph valve and continuous breath-by-breath analysis of respiratory 
volume, flow, and expired levels of O2 and CO2 (ParvoMedics TrueOne 2400, Utah, 
USA) allowed determination of pulmonary gas exchange via indirect calorimetry 
(Frayn, 1983). V̇O2, V̇CO2, VE and RER responses were first inspected manually in 
Microsoft Excel using scatterplots and any clear outlying (i.e., not physiological) values 
removed; a 15-breath rolling average was calculated and the respective maximum for 
each variable was taken as the highest 15-breath value achieved during the test. In all 
tests two or more of the following criteria were met: a plateau in V̇O2 despite increasing 
intensity, RER > 1.15, heart rate within 10 beats of age-predicted maximum, and/or 
volitional exhaustion (Howley et al., 1995).  
 




6.2.4. Oral Glucose Tolerance Test 
Prior to OGTTs subjects were asked to perform no moderate or vigorous 
intensity physical activities for three days, refrain from drinking alcohol and caffeine for 
one day, and drink 1 pint of water on the morning of the test to ensure adequate 
hydration. On the day of the OGTT participants reported to the laboratory between 7:30 
and 9:30 am following an overnight fast from 10 pm the previous evening. Having rested 
quietly for 15 minutes, a cannula (BD Venflon Pro, BD, Helsingborg, Sweden) was 
inserted into an antecubital vein and a fasting venous blood sample was drawn. Subjects 
then consumed a drink containing 75 g of glucose dissolved in 300 ml of water (Polycal, 
Nutricia, UK), and further blood samples were drawn at 30 min intervals for 2 hours. 
All blood samples were collected into pre-cooled plastic tubes containing EDTA, stored 
on ice for 30 min, and then centrifuged at 5000 rpm and 4°C for 10 min. The plasma 
was subsequently dispensed into 0.5 ml aliquots and stored at -80°C until analysis. 
Plasma glucose concentrations were determined in duplicate on an automated analyser 
with a CV for repeated measures of <1% (Randox RX Daytona, Co. Antrim, UK). 
Plasma insulin concentrations were determined in duplicate using a commercially 
available ELISA kit, with a CV for repeated measures of 3.2% (Mercodia, Uppsala, 
Sweden).  
6.2.5. Training Protocol 
All training sessions were carried out on a Monark cycle ergometer (Ergomedic 
894e, Vansbro, Sweden). Participants completed three supervised exercise sessions per 
week for 6 weeks with 1-2 days recovery in between each session, completing 18 
sessions overall. All exercise sessions lasted 10 min in total, including a warm up and 
cool down, which meant a total training time of 30 min per week. Each training session 
consisted of unloading pedalling and one (1st session) or two (all other sessions) all-out 
cycling sprints. Just before each sprint, subjects increased their pedal cadence to their 
maximal speed, a braking force equivalent to 5% of body weight was then applied to the 
ergometer, and participants sprinted against the applied braking force for a designated 
time period. The duration of the sprints increased from 10 seconds in week 1, to 15 
seconds in weeks 2 and 3, and 20 seconds in the final 3 weeks. Strong verbal 
encouragement was given during each sprint. An RPE score was also collected at the 




end of the10 min training session to reflect the session as a whole (i.e., participants were 
asked to consider the whole training session when giving their ratings). 
6.2.6. Calculations and Statistics 
  All variables were analysed using the commercially available Statistics Package 
for Social Sciences (SPSS) software. In order to simplify the statistical analysis and aid 
interpretation of a complex data set, the insulin and glucose responses to the OGTT pre- 
and post-training were converted into simple summary statistics (within subject fasting 
and peak concentrations, total AUCs and estimates of insulin sensitivity (Cederholm 
Index (Cederholm & Wibell, 1990)). The impact of ReHIT on body mass, maximal 
incremental cycling variables, and OGTT summary statistics was analysed by two-way 
mixed model ANOVA (sex [male, female] × time [pre, post]). ANOVA were performed 
regardless of any minor deviances from a normal distribution (Maxwell & Delaney, 
2004), and with Greenhouse-Geisser corrections applied for contrasts where ɛ<0.75 and 
the Huynh-Feldt corrections applied for less severe asphercity (Atkinson, 2002). 
Correlations between variables were determined using a Pearsons product-moment 
correlation coefficient. Statistical significance was accepted at p<0.05 and, unless 





Figure 6.2. Schematic of the ReHIT training protocol. Grey boxes represent ‘all-out’ sprints against 









29 out of the 34 participants completed all 18 training sessions, i.e., 100% 
adherence. 2 participants missed a total of 3 non-consecutive sessions over the course of 
the 6 weeks (83% adherence), whilst 3 missed 1 session (94% adherence), meaning the 
overall adherence to the training programme was 98%. All subjects have been retained 
in the final analysis.  
Whole-session rating of perceived exertion scores taken at the end of each 
training week are shown in Figure 7.2. The training sessions were well tolerated by all 
participants and rated consistently at ~14 on the Borg 6-20 scale (i.e., between 
‘somewhat hard’ and ‘hard’). There were no differences in the ratings given by male and 
female participants.  
 
 
          
Figure 6.3. Whole session RPE scores during ReHIT in men and women RPE scores were taken 
at the end of each training week. Data is presented as mean ± SD 
6.3.1. Changes in Body Mass  
There was a small but significant increase in body mass (main effect for time, 
P<0.05) and a tendency for increased BMI (main effect for time, p=0.06) following 
ReHIT with no significant impact of sex upon this effect (Table 6.2).   





 An independent t-test performed on absolute change in V̇O2max (l∙min-1) 
revealed no significant difference between the two protocols used, so the data was 
pooled. V̇O2max increased in both men (+9%) and women (+10%) following ReHIT 
(Figure 6.3, main effect for time, p<0.05), and this was associated with an increased 
time-to-exhaustion (main effect for time, p<0.05), an increase in maximal CO2 
production (main effect for time, p<0.05), but no significant change in maximal minute 
ventilation, maximal RER or maximal heart rate (Table 6.2). There was no mediating 
effect of sex on any of the maximal exercise responses that were measured. Although 
the mean V̇O2max improved in both men and women with ReHIT, there was 
considerable individual variability associated with this response (+240±220 ml O2; 
Figure 6.7). 15 subjects demonstrated a response that was within 5% of the mean change, 
7 subjects showed a much greater than average response (17 to 34% increase) and 11 
subjects showed either no change or a poor response (7% decrease to 4% increase). The 
likelihood of showing a low/average/high response for VO2max did not appear to be 
influenced by sex (Figure 6.7), and there was no correlation between baseline VO2max 
and the subsequent training response (r2=0.08). 
 
 
Figure 6.4. Changes in maximal oxygen uptake following ReHIT. N=16 for men and n=17 for 
women. * denotes p<0.05 for main effect of time (i.e., pre- vs. post-training). Data is presented as mean 
± SD.  
 




6.3.3. Plasma Glucose and Insulin Responses to the OGTT 
 Mean fasting and peak plasma glucose concentrations were unaltered in both 
men and women in response to ReHIT (Table 6.2), as was the total glucose AUC during 
the OGTT (Figure 6.4A and 6.4B). Similarly, there were no changes in mean fasting and 
peak insulin concentrations (Table 6.2); however, there was a trend for reduced insulin 
AUC following ReHIT (P=0.076 for time main effect) with no sex × time interaction 
(Figure 6.4C and 6.4D). Insulin sensitivity as estimated using the Cederholm Index 














Figure 6.5. Plasma glucose and insulin responses to the OGTTs. Plasma glucose (A) and insulin 
(C) responses to the OGTT are presented as mean ± SEM for clarity. Total plasma glucose (B) and insulin 
(D) AUC in response to the OGTTs are presented as mean ± SD. N=16 for men and n=18 for women. For 
men, the 0, 30 and 90 minutes OGTT points are n=15; for women 30, 60 and 90 minute OGTT points are 
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Figure 6.6. Changes in insulin sensitivity following ReHIT. N=16 for men and n=18 for women. 
Data is presented as mean ± SD 
 
Similar to the VO2max responses, there was considerable variability associated 
with the training induced change in glucose AUC (mean ± SD: -2.4±17%; range; -24 to 
+62%), insulin AUC (mean ± SD: -0.7 ± 28.1%; range: -53.7 to +69.6%) and insulin 
sensitivity (mean ± SD: +5.8±21.2%; range -48.2 to 55%), which can be seen in figure 
6.7. There was a significant but weak correlation between the pre training value and the 
change score (%) for fasting glucose (r2= 0.14, p<0.05), fasting insulin (r2=0.13, 
p<0.05), glucose AUC (r2=0.18, p<0.05), insulin AUC (r2=0.14, p<0.05) and Cederholm 













































Table 6.2. The impact of ReHIT on BMI, maximal gas exchange, and fasting and peak plasma glucose and insulin concentrations 
 Males (n=16)  Females (n=18)  Combined (n=34) 
 Pre  Post   Pre Post   Pre Post 
Body Mass (kg) 76.9±7.2 77.6±7.6*  66.2±9.6 66.4±9.6*  71.5±9.9 72.0±10.1* 
BMI (kg/m2) 25.1±2.1 25.3±2.2†  23.8±3.5 23.9±3.4†  24.6±2.9 24.7±2.9† 
         
Time to Exhaustion (secs) 887±163 986±133*  651±166 720±153*  761±204 844±199* 
VO2max (L/min) 2.95±0.56 3.22±0.54*  2.08±0.30 2.28±0.36*  2.50±0.63 2.74±0.66* 
VO2max (ml/kg/min) 38.6±8.3 41.9±8.5*  32.0±4.5 34.9±4.9*  35.0±7.4 38.1±7.7* 
VCO2max (L/min)  3.62±0.72 3.90±0.76*  2.51±0.31 2.73±0.42*  3.04±0.79 3.29±0.85* 
VEmax (L/min) 110.6±35.9 110.8±29.3  77.0±13.0 82.4±11.7  93.3±31.3 96.3±26.0 
RERmax  1.23±0.09 1.23±0.08  1.23±0.09 1.22±0.06  1.23±0.09 1.22±0.09 
HRmax (beats/min)  192±10 190±12  187±9 187±10  189±10 188±11 
         
Fasting Glucose (mmol/l) 5.29±0.47 5.25±0.51  4.96±0.46 4.91±0.40  5.09±0.49 5.05±0.49 
Fasting Insulin (mU/ml) 5.7±3.3 6.6±3.4  5.6±4.0 5.7±4.2  5.6±3.6 6.0±3.8 
HOMA-IR 1.30±0.93 1.47±0.95  1.29±1.02 1.26±0.93  1.29±1.02 1.34±0.93 
Peak Glucose (mmol/l) 9.26±1.68 8.91±2.17  7.41±1.69 7.26±1.23  8.22±1.94 7.98±1.92 
Peak Insulin (mU/ml) 111.3±82.0 97.9±51.5  61.3±43.2 61.0±39.5  85.8±67.9 78.6±48.5 
All data are shown as mean ± SD. * denotes p<0.05 pre- vs post-training. † denotes p=0.06 pre vs. post training. Maximal cycling and gas exchange data for females 
are shown for n=17 (combined n=33) due to technical difficulties during the post-training assessment. 
 























Figure 6.7. Variability in training responses following ReHIT. Dots represent the training 
adaptation for individual subjects (V̇O2max n=33, OGTT variables n=34) as a percentage of their 
individual baseline (i.e., 90% represents a 10% decrease, 110% represents a 10% increase). Green dots 
are female and red dots are male subjects. Note that for V̇O2max and insulin sensitivity (Cederholm) an 
‘improvement’ is represented by a % increase, whilst for glucose AUC and insulin AUC an ‘improvement’ 
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 The current data confirm that ReHIT improves VO2max to a similar extent in 
sedentary men and women; however, in contrast to our previous observations, mean 
improvements in insulin sensitivity were not evident in either sex, although it is worth 
highlighting that there was a statistical trend for a reduction in insulin AUC post training. 
The current study raises some concerns over the efficacy of ReHIT as a strategy for 
improving insulin sensitivity, and highlights the potential problems with studies utilising 
small sample sizes in the studies of metabolic responses to exercise training.  
6.4.1. Insulin Sensitivity Reponses with ReHIT 
 The current study is the largest to date to examine the impact of HIT on insulin 
sensitivity. We could not detect any mean improvements in OGTT estimated insulin 
sensitivity in men or women following 6-wks of ReHIT. This is in contrast both with 
previous work in this thesis (Chapter 3) and recent data from Gillen et al. (2014) who 
showed improvements in glycaemic control in men (but not women) after a ReHIT like 
protocol using 24-hr CGM measurements under standardised dietary conditions. They 
also provided direct biochemical support for this finding by showing a similar sex-
dependent increase in muscle GLUT4 protein content post-training (Gillen et al., 2014). 
There are a number of potential explanations for the differences between current findings 
and previous work which require discussion. Firstly, it is possinble that altering the 
sprint load (7.5% to 5% body mass) diminishes the adaptive response for insulin 
sensitivity in men and not alter the response in females. Secondly, it cannot be 
discounted that ReHIT does not, in either of its current forms, results in improved insulin 
sensitivity in either men or women. Thirdly, as there is naturally a high level of 
variability associated with exercise training induced improvements in insulin sensitivity 
the variation observed in the current study may have masked the impact of ReHIT on 
insulin sensitivity. Each of these possibilities will be discussed next.  
Firstly, in the current study we substituted the 60-W warm-up for unloaded 
pedalling and reduced the mass applied during the sprints from 7.5% to 5% of body 
mass. Therefore, we were examining the impact of an altered training intervention in the 
current study, and it is logical to question whether this has impacted on the alterations 
in observed training response. Indeed, whilst Gillen et al. (2014) also used an applied 




resistance of 5% body mass, they included an extra 20-s sprint during their 10-min 
training sessions and this may have compensated for any reduction in applied resistance. 
Although we noted similar improvements in VO2max in the current study, there was no 
correlation between the change in VO2max and the change in insulin sensitivity, 
implying that the determinants of these two adaptations are distinct. However, it is 
important to point out that an ‘all-out’ sprint against 5% body weight still produces an 
average exercise intensity in the region of ~200% of peak aerobic power (Wmax) and, 
physiologically, it is likely that this would be associated with a very similar muscular 
and whole-body metabolic disturbance (Chapter 4 and Chapter 5). Therefore, although 
it cannot be proven at this point, it seems likely that the training stimulus provided in the 
current study would have been of similar (and sufficient) magnitude to that which was 
used previously.  
Alternatively, it is possible that our positive finding in Chapter 2 was the result 
of a type 1 statistical error, and it could simply be the case that ReHIT just does not 
provide any benefit to insulin sensitivity. In agreement with this possibility are a number 
of studies which, using a variety of HIT models, have been unable to detect any 
statistically significant mean change in OGTT derived measures of insulin sensitivity at 
similar post-training time points (Whyte et al., 2010; Gillen et al., 2013). This possibility 
is more difficult to refute; however, there are several pieces of information which require 
further discussion. Firstly, it is particularly noteworthy that the reduction in insulin AUC 
following training approached statistical significance. In addition, analysis of the 
individual responses (figure 6.7) reveals that for each OGTT-derived variable, the 
majority of subjects showed evidence of some ‘improvement’ post-training (62%, 58% 
and 62% of subjects for glucose AUC, insulin AUC and insulin sensitivity, respectively). 
For each variable we also observed particularly poor responses in several subjects, a 
phenomenon that is not limited only to the current study (Boulé et al., 2005; Bouchard 
et al., 2012; Kuehnbaum et al., 2014). In the context of relatively low statistical power 
(n=34) and large interindividual variability, such extreme low and high responders can 
have a large effect on the statistical outcome. Indeed, the observation that ~40% of our 
subjects demonstrated no measurable change (or a worsening) in insulin sensitivity with 
ReHIT is strikingly similar to reports with high volume aerobic exercise training (Boulé 
et al., 2005), the major difference being that Boulé et al trained over 600 subjects and 
were therefore able to detect a ~10% average increase in insulin sensitivity in their 




cohort. Of course, it is possible that these observations simply represent physiological 
‘noise’ associated with performing repeated OGTTs eight weeks apart. The observed 
weak correlations between baseline and subsequent training response for each OGTT-
derived variable would indeed suggest a certain amount of ‘regression to the mean value’ 
in our current data set. However, without a ‘lifestyle maintenance’ control group it is 
difficult to estimate the error associated with our measurement, and this represents a 
limitation to the current analysis. At this point, we cannot draw any firm explanations or 
conclusions on these data. Further studies with much larger sample sizes will be required 
to determine the true impact of ReHIT on insulin sensitivity.  
6.4.2. Aerobic Capacity Responses with ReHIT 
Maximal aerobic capacity improved on average by ~10% in both men and 
women following ReHIT in the current analysis, confirming our previous observations 
from Chapter 3. Whilst improved aerobic capacity is now a well-established finding with 
HIT (Weston et al., 2014b), this finding remains important as ReHIT still represents the 
smallest volume of sprint exercise which has been shown to improve this parameter. The 
fact that VO2max appears to improve so consistently following such a small volume of 
maximal exercise would suggest that intensity is the key variable underpinning 
adaptations in the oxygen transport system following exercise training in humans. This 
has implications for exercise prescription given that aerobic capacity is a powerful 
predictor of cardiovascular and metabolic disease (Blair et al., 1989; Blair et al., 1995; 
Blair et al., 1996; Myers et al., 2002).  
Aerobic capacity is thought to be limited by central and peripheral oxygen 
delivery rather than peripheral oxygen utilisation (Bassett & Howley, 2000). As such, 
changes in aerobic capacity are thought to be explained by structural, functional and 
compositional changes in the central and peripheral cardiovascular system resulting in 
enhanced maximal cardiac output and hence oxygen delivery to the periphery (Bassett 
& Howley, 2000). Recent work suggests that expansion of blood volume may be of key 
importance, since removing the individually calculated training-induced change in blood 
volume via phlebotomy simultaneously abolishes any improvement in both maximal 
cardiac output and aerobic capacity (Bonne et al., 2014). In addition, in a selectively 
bred murine model, Lessard et al. (2013) demonstrated that low responders for exercise 




capacity with aerobic training also exhibit an impaired angiogenic response in skeletal 
muscle, suggesting that increased muscle capillarisation with training might be of crucial 
importance. There are currently no studies which have examined the change in blood 
volume with HIT, however, Cocks et al. (2014) have shown that HIT and endurance 
exercise are equally as effective at increasing muscle microvascular density. 
Mechanisms underlying the increase in blood volume and capillary density are 
incompletely understood, but are likely related to a number of factors, including 
contractile activity; exercise-induced increases in blood flow, blood pressure and shear 
stress; localised reductions in O2 tension; and signalling mechanisms related 
intramyocellular metabolic processes (Gustafsson et al., 1999; Egginton, 2009; Wagner, 
2011). From this perspective, it is noteworthy that HIT/ReHIT is associated with an 
exaggerated acute cardiorespiratory response, resulting in rapid increases in heart rate 
(and presumably blood pressure and shear stress), prolonged elevations in oxygen 
uptake, and a substantial drop in plasma volume (Chapters 3 and 4). Linking these acute 
responses with training induced adaptations will be a fruitful area for future research.  
Although aerobic capacity improved on average following ReHIT it should be 
noted that this improvement was still associated with substantial variation. Indeed ~10% 
of our subjects demonstrated no measurable response for VO2max and several others 
responded poorly. Equally, our sample also included several individuals who showed a 
particularly exaggerated improvement (~30% increase from baseline), i.e., high 
responders. The existence of such variation in trainability for VO2max with aerobic 
training has been known for many years (Bouchard et al., 1999; Sisson et al., 2009), and 
this issue has lately been highlighted in response to HIT as well (Astorino & Schubert, 
2014). At least part of this variability is explainable by genetic factors (Bouchard et al., 
1999); in fact, Timmons et al. (2010) have now validated a set of predictor genes which 
can establish the magnitude of change in aerobic capacity prior to the initiation of 
aerobic training. An important question that will need to be answered is whether the 
same predictor can be used to establish the variability in aerobic capacity responses to 
different modes of training, for example, HIT/ReHIT. This would appear likely since 
the predictor genes are not responsive to exercise, but rather their expression appears 
pre-set and related to processes such tissue development (e.g., angiogenesis), which 
appears a key mechanism underpinning improvement in aerobic capacity with aerobic 
exercise and HIT (Timmons et al., 2010; Cocks et al., 2013; Lessard et al., 2013).  





In summary, this study represents the largest study to date of the effects of HIT 
upon cardiometabolic health. We confirm that 2 min of all out intermittent exercise per 
week for 6 weeks improves maximal aerobic capacity in sedentary men and women; 
however, the previously observed beneficial impact upon insulin sensitivity was not 
apparent. The variability for changes in OGTT derived variables was extremely high 
and warrants further investigation.  
 










































7.1. Overview  
From the perspective of public health, it is well known that regular exercise, in 
general, is a beneficial behaviour. Indeed, whilst many questions remain unanswered, 
there is a wealth of descriptive literature demonstrating that various exercise 
interventions, on average, acutely and chronically modulate key cardiometabolic risk 
factors in a direction that would be expected to reduce the risk of developing chronic 
disease (Garber et al., 2011). In fact, regular exercise alone, or in combination with other 
lifestyle interventions (e.g., ‘healthier diet’) has been shown to reduce the risk of 
developing T2D by at least 50% (Pan et al., 1997; Knowler et al., 2002). When one then 
considers the detrimental impact of enforced periods of physical inactivity on a range of 
cardiometabolic risk factors (Krogh-Madsen et al., 2010; Knudsen et al., 2012), and 
epidemiological evidence detailing the independent relationship between sedentary 
behaviours and chronic disease risk (Helmrich et al., 1991; Hu et al., 1999; Laaksonen 
et al., 2002; Grøntved & Hu, 2011), the need to become and remain physically active 
becomes even more apparent. Nevertheless, the level of exercise participation in general 
population remains poor (Allender et al., 2008a). 
 As a result, the challenge now being undertaken by many exercise physiologists 
is not solely to establish the impact of exercise upon human health, but also to search 
for exercise modalities which may help to promote motivation to exercise, and exercise 
adherence in the general population. In particular, many researchers have focused on 
overcoming the so-called ‘exercise time barrier’, as this is commonly reported as the 
major barrier to exercise participation in the general population (Reichert et al., 2007; 
Korkiakangas et al., 2009). High-intensity interval training (HIT) has shown promising 
results from this perspective; indeed, when performed repeatedly over a period of a few 
weeks, HIT yields substantial gains in aerobic capacity, oxidative capacity, insulin 
sensitivity, and vascular function, for example (Gibala et al., 2006; Burgomaster et al., 
2008; Rakobowchuk et al., 2008; Babraj et al., 2009; Richards et al., 2010; Cocks et al., 
2013; Shepherd et al., 2013; Weston et al., 2014b). What’s more, there is some evidence 
that participants find HIT a more enjoyable mode of exercise training (Bartlett et al., 




2011; Guiraud et al., 2011). However, the extrapolation that HIT would stimulate greater 
exercise adherence based on these findings currently lacks empirical evidence. Indeed, 
at this point in time, this is largely irrelevant as major questions remain concerning the 
optimal structure of a HIT intervention (in terms of mode, frequency, duration, intensity 
of sprints and recovery), both from the perspective of promoting healthy adaptations and 
in terms of suitability for the general population. Specifically, the HIT models that have 
been studied to date, whilst generally effective at improving physiological functioning, 
require very high levels of participant motivation, are very fatiguing, can be associated 
with feelings of nausea, and/or are still associated with a total time commitment of >20 
minutes per session (Trapp et al., 2008; Little et al., 2010; Richards et al., 2010; Gillen 
et al., 2013). As such, it seems unlikely that these protocols would be suitable for 
recommendation to the general population. 
 The research presented in this thesis has attempted to overcome some of the 
concerns with HIT protocols to date. The initial aim was to design a HIT protocol that 
was genuinely associated with reduced total time-commitment and also lower levels of 
exertion, and characterise its effect on biomarkers of human health in the context of a 
training intervention. Having designed an intervention requiring a total of 2 × 20 sec 
sprints in a 10 min training session (reduced-exertion HIT; ReHIT), and shown 
promising improvements in aerobic capacity (men and women) and insulin sensitivity 
(men only) in Chapter 2, subsequent studies were undertaken to examine acute effects 
upon insulin sensitivity (Chapter 3), skeletal muscle and whole-body metabolic 
responses (Chapters 4 and 5) and potential effects upon appetite (Chapter 5) with ReHIT. 
Chapter 6 aimed to further establish the training effects of a modified ReHIT protocol 
upon insulin sensitivity and aerobic capacity in a larger cohort of sedentary men and 
women.  
7.2. Discussion of Major Findings 
7.2.1. Effects of ReHIT on Insulin Sensitivity  
 Insulin sensitivity represented a primary outcome measure in the current thesis 
based on its relevance for the development of metabolic and cardiovascular disease 
(Balkau & Eschwege, 1999; Petersen et al., 2007; Lorenzo et al., 2010). Indeed, the 




ReHIT intervention was designed specifically to improve insulin sensitivity based on 
the hypothesis that glycogen degradation during exercise may underpin the adaptations 
in whole-body insulin sensitivity with exercise training (Chapter 2 and 6). However, the 
two training studies carried out in this thesis have revealed contrasting results. Neither 
study has revealed mean improvements in insulin sensitivity in women; on the other 
hand mean improvements were apparent in men in Chapter 2, but not in Chapter 6. In 
combination, a total of 49 sedentary individuals have been ReHIT trained for the studies 
in this thesis, including 23 men and 26 women. The combined average responses for 






Figure 7.1. The effect of ReHIT on glucose and insulin AUC (n=49). Data shown is training 
responses combined from Chapters 3 and 7 (mean ± SD). The statistics shown represent two way ANOVA 




Overall, the combined results from this thesis tentatively suggest that ReHIT, 
consisting of a maximum of 40 seconds of intense exercise per session, may improve 
insulin action on average in men, but not in women. This contention is supported by 
recently published data from Martin J Gibala’s laboratory which showed a similar sex-
dependent improvement in glycaemic control (measured via CGM) 72 h following a 
ReHIT like intervention (Gillen et al., 2014). However, it is recognised that the 
coefficient of variation for repeated measures of insulin sensitivity over 6 weeks under 
control conditions using the OGTT are high (13% in study 1), and this makes it difficult 
to pick up the true signal of HIT in the present thesis. Thus, these results will require 
confirmation in a further much larger study, ideally using a randomised controlled 
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research design. In agreement with the majority of previous (Brestoff et al., 2009; 
Richards et al., 2010; Whyte et al., 2013) but not all (Ortega et al., 2014) previous 
literature, there was no impact of a single ReHIT session on insulin sensitivity 14 h post-
exercise (Chapter 4), so the utility of ReHIT for improving insulin sensitivity may be 
limited to training adaptations. Nevertheless it is important to consider temporal issues 
with regards to the assessment of insulin sensitivity in the training studies in this thesis. 
Specifically, we used a 3 day post-training time point for our assessment and it is 
possible that insulin sensitivity may have been improved (either more consistently or to 
a greater extent) in the days prior to the assessment. Further studies will be required to 
appraise this caveat.  
7.2.2. Effects of ReHIT on Aerobic Capacity 
Aerobic capacity was consistently increased in both men and women following 
ReHIT, with an average improvement of ~10% (Chapters 2 and 6). Whilst changes in 
insulin sensitivity were the primary target with ReHIT, the consistent improvement in 
aerobic capacity arguably has greater clinical/preventative utility given that aerobic 
fitness consistently manifests as the strongest predictor of future morbidity and mortality 
(Blair et al., 1989; Barlow et al., 1995; Blair et al., 1995; Blair et al., 1996; Lee et al., 
1998; Lee et al., 1999; Myers et al., 2002). Based upon the results of Lee et al. (2011) 
the average increase of ~3-4 ml/kg/min in VO2max (i.e., ~1 metabolic equivalent) would 
be expected to reduce the risk of all-cause mortality by 15% and cardiovascular mortality 
by 19%, respectively.  
7.2.3. Sex Differences in the Adaptive Response to HIT/ReHIT 
 Until this programme of research was undertaken, women were, like in many 
physiological fields, a relatively understudied population in response to HIT. This thesis 
has revealed potential gender differences in the response to supervised ReHIT training, 
with females showing no average improvement in insulin sensitivity (Chapter 2 and 6; 
Figure 7.1). This observation is now supported by several studies using varying models 
of HIT (Gillen et al., 2013; Gillen et al., 2014). However, it is important to point out 
that a number of the female participants from all three of these studies did show an 
improvement in insulin sensitivity ((Gillen et al., 2013; Gillen et al., 2014); Figure 7.2). 




Likewise, Richards et al. (2012) showed a consistent improvement in insulin sensitivity 
measured using the gold standard euglycaemic clamp method following 2 weeks of 
classic HIT in females. Therefore, it remains unclear at this point whether the lack of 
average improvement in insulin sensitivity in women is a genuine finding, or a chance 
product of a large number of ‘non-responders’ in the context of relatively small sample 
sizes. Only with much larger studies that employ a greater level of control over, for 
example the menstrual cycle amongst other factors, will this question be able to be 
definitely answered (Gibala et al., 2014).  
 Several studies in females have reported improvements in aerobic capacity, 
skeletal muscle oxidative potential, and changes in vascular function following HIT 
(Astorino et al., 2011; Trilk et al., 2011; Astorino et al., 2013a; Astorino et al., 2013b; 
Gillen et al., 2013; Gillen et al., 2014). Likewise, in this thesis ReHIT was associated 
with a marked improvement in aerobic capacity in women (Chapters 3 and 7). Thus, in 
spite of the question marks over the utility for improving insulin sensitivity in women, 
HIT/ReHIT remains associated with metabolic and vascular changes linked to improved 
health outcomes. The dissociation between average changes in aerobic capacity, muscle 
oxidative potential and insulin sensitivity in women in this thesis suggest that the 
molecular determinants of these adaptations are likely also to be distinct.  
 In light of the suggestion that ReHIT doesn’t improve insulin sensitivity on 
average in women, the potential underlying mechanisms for this finding are worthy of 
further discussion. Firstly, it is important to further highlight that a consistent finding in 
this thesis is that women on average had a higher level of baseline insulin sensitivity 
compared with men (Chapter 2 and 6). This is consistent with previous observations 
(Nuutila et al., 1995; Boulé et al., 2005; Karakelides et al., 2010) and might impact upon 
the capacity for a subsequent training response. The modest correlation between the 
baseline level of insulin sensitivity and the subsequent training response noted in the 
female participants in this thesis may reflect this fact (R2 = 0.21; P<0.05; n=26), or may 
indicate a level of ‘regression to the mean value’ in this data set. In any case, the 
correlation is only modest and therefore the variation in training responses is not 
completely explained by the baseline level.  
In Chapter 2 it was hypothesised that differences in the amount of glycogen 
broken down during a HIT/ReHIT training session may explain sex differences in the 




training response for insulin sensitivity. This hypothesis was based on previous studies 
which had shown that women break down up to 42% less glycogen in type 1 muscle 
fibres during a typical ‘all-out’ 30 sec sprint (Esbjornsson-Liljedahl et al., 1999; 
Esbjornsson-Liljedahl et al., 2002), a finding which is supported both by the smaller 
excursion in blood lactate (Gratas-Delamarche et al., 1994; Esbjornsson-Liljedahl et al., 
2002), and a greater contribution of aerobic metabolism to ATP demand (Hill & Smith, 
1993), in women during sprint exercise. The initial goal of Chapter 6 in this thesis was 
to examine potential sex-differences in glycogen breakdown, glycogen related signalling 
and GLUT4 gene expression with ReHIT. However, as it was not possible to obtain 
usable muscle samples in all of our participants a meaningful gender-comparison was 
not feasible. Nevertheless, preliminary data from 5 men and 6 women suggest similar 
glycogen breakdown between sexes when measured in whole muscle biopsy samples 
(Mean ± SD; Men 71 ± 38 vs Women 105 ± 63 mmol/kg dry weight). However, it would 
be informative to test whether there are sex-differences in glycogen breakdown in 
distinct fibre types, or even potentially in distinct subcellular stores of glycogen as 
different fibre types and subcellular glycogen stores are related to distinct physiological 
functions (Nielsen et al., 2010a; Nielsen et al., 2010b). On the other hand, recent 
evidence has suggested that females have lower levels of total muscle and mitochondrial 
protein accumulation over the course of a 6-week HIT intervention (Scalzo et al., 2014). 
At the same time, a recent study demonstrated a smaller increase in muscle GLUT4 
protein content following 6-weeks of HIT (Gillen et al., 2014). Therefore, the 
diminished adaptive response in women may be unrelated to glycogen breakdown and 
the hypothesised transcriptional response per se; perhaps instead there is down-
regulation of the pathways that link modulations in energy metabolism (and resulting 
gene transcription) and the protein synthetic response, which ultimately defines the 
change in phenotypic function (i.e., insulin sensitivity).  
7.2.4. The importance of human variation in the adaptation to exercise  
 Perhaps the most important discussion point from the current thesis concerns the 
issue of human variation in the adaptive response to exercise training. For example, the 
change in insulin sensitivity with ReHIT ranged from a 100% increase to a 45% 
reduction (Figure 7.3A). Likewise, the change in VO2max with ReHIT ranged from a 
gain of 730 ml of oxygen, to a reduction of 290 ml of oxygen (Figure 7.2C). The 




observed variation in response to ReHIT shows a remarkably similar pattern to that 
observed in the HERITAGE family study, the largest supervised aerobic exercise 
training study to date ((Boulé et al., 2005); figure 7.3). Indeed, such variability in 
cardiovascular and metabolic adaptation to exercise training has been recognised for 
several years, and is in fact a hallmark feature of all major disease risk biomarkers in all 
large exercise training studies (Bouchard et al., 1999; Boulé et al., 2005; Sisson et al., 
2009; Bouchard et al., 2012). Perhaps more importantly, in some individuals, an adverse 
change in some, or several, disease risk biomarkers may be observed (Bouchard et al., 
2012). It should however be noted that the biological basis for an adverse metabolic 
response to physical activity per se is unclear and this finding needs to be confirmed in 
the context of a large randomised controlled trial. Indeed, the deterioration of metabolic 
health parameters under ‘lifestyle maintenance’ control conditions is a common finding 
in human research studies (Patel et al., 2011). Irrespective of this, however, the 
variability in exercise-induced adaptation and the existence of low responders remains 
an important caveat to all exercise related research.  
One of the major issues is that such variation is often ignored in favour of 
presenting a mean ‘effect or improvement’ associated with an intervention, a  method 
which completely overlooks the stark reality that many individuals will not experience 
this proposed improvement (Vollaard et al., 2009; Timmons, 2011). The ramifications 
of such an approach to data analysis become immediately apparent when we consider 
that public health recommendations on levels of exercise are largely based upon these 
average responses. Of course this one-size-fits-all approach is largely driven by the need 
to convey a simple public health promotion message (Timmons, 2011), but crucially has 
limited utility for any given individual starting a new exercise programme. In fact, if the 
adverse response hypothesis (Bouchard et al., 2012) turns out to be physiologically valid 
then this approach arguably contrasts one of the first ethical principles of modern 
medicine: ‘primum non nocere’, ‘first, do no harm’ (Smith, 2005).   
 







Figure 7.2. Variability in insulin sensitivity (A+B) and aerobic capacity (C+D) changes with 
ReHIT (A+C) and aerobic exercise (B+D). A+C: combined data from Chapters 2 and 6 (i.e., 
individual responses to ReHIT). B+D: modified from Boulé et al (2005) and Bouchard and Rankinen 
(2001), respectively; this data comes from the HERITAGE family study (i.e., individual responses to 
standardised aerobic exercise).  
 
The clear importance of the variation in the metabolic adaptation to exercise 
training has led investigators in the logical direction of searching for methods of 
predicting the magnitude of adaptation to exercise prior to the start of an intervention. 
As both ∆VO2max and ∆Insulin Sensitivity cannot, in any large magnitude, be explained 
by basic descriptive traits (e.g., age, weight, body composition etc.), and variance in 
single genes appear also to explain little of the variance (Gill & Malkova, 2006; 
Bouchard et al., 2011), this research has moved towards using more global molecular 
OMIC (e.g., genomics, transcriptomics, metabolomics) techniques (Timmons et al., 
2010; Bouchard et al., 2011).  The majority of research has focused on predicting 
∆VO2max with exercise training and has been discussed previously in this thesis 
(Chapter 6). The robustness of the aerobic capacity predictor likely centres around a 































































explained by genetic variance (i.e., a relatively large portion); 2) apart from physical 
activity, there are few (if any?) free-living factors that impact upon VO2max, in other 
words, the changes in VO2max observed following a supervised exercise intervention 
are likely to be solely explained by the change in physical activity behaviour; and 3) the 
mechanisms contributing to changes in VO2max with chronic exercise training are well 
understood and largely limited to the cardiovascular system. In contrast, insulin 
sensitivity (particularly when measured at the whole-body level) requires the 
coordination of multiple tissues which each can be influenced by a multitude of 
environmental factors modified by the underlying genetic profile. In addition, whilst 
there appears to be a genetic influence over insulin sensitivity and the development of 
T2D (Poulsen et al., 1999), the heritability of changes in response to chronic exercise 
training have not been published. However, it is clear that variance in single genes 
explain little of the training response and are inconsistent across different populations 
(Gill & Malkova, 2006). Thus the development of predictive biomarkers for changes in 
insulin sensitivity with exercise training is likely to be extremely challenging. 
Nevertheless, a large scale clinical trial (NCT01920659; www.metapredict.eu) is 
currently underway with the aim of developing such biomarkers and the data presented 
in Chapter 6 of this thesis will be used to validate this predictor.  
7.2.5. The role of glycogen in adaptation to exercise 
The studies in this thesis have not directly assessed the role of glycogen in insulin 
sensitivity adaptation to exercise training. However, the hypothesis that glycogen has a 
role in exercise induced adaptation has been a central justification of several chapters 
presented (Chapters 2, 5 and 6). In this thesis there was some evidence that targeting 
glycogen degradation with ReHIT resulted in similar acute responses (e.g. AMPK 
activation, PGC-1α and GLUT4 mRNA expression) and chronic adaptation 
(improvements in insulin sensitivity and VO2max) compared with HIT protocols 
utilising a greater number of sprints (Babraj et al., 2009; Gibala et al., 2009; Richards et 
al., 2010). However, we did not directly compare the effects of ReHIT (2 × 20 s) against 
the classic HIT protocol (4-7 × 30 s) so this contention is unsubstantiated at present. It 
may equally be that other metabolic disturbances (unrelated to glycogen degradation) 
that are unique to the early portion of an ‘all-out’ sprint (e.g., rise in AMP, Ca2+, and 
oxidative stress) underpin such acute responses and chronic adaptations. It is clear that 




glycogen can play a regulatory role in muscle adaptation under certain conditions (e.g. 
low glycogen training) (Morton et al., 2009; Hulston et al., 2010), but whether or not 
smaller amounts of glycogen turnover are associated with similar adaptive effects 
remains speculative.  
7.3. General Discussion Points 
7.3.1. Why is HIT so potent?  
 The observation that as little as 40 sec of intense exercise is associated with such 
a robust change in aerobic capacity, and potentially in insulin sensitivity, raises the 
question as to why this type of exercise is such a potent stimulus for adaptation. Of 
course the answer in its entirety is likely to be complex, but at the most rudimentary 
level is probably explained by three basic principles of exercise physiology: overload, 
supercompensation and specificity. Briefly, a single bout of exercise will cause a 
disruption of homeostasis (i.e., overload). So that the system is better able to deal with 
a similar disturbance in the future, an adaptive process occurs whereby homeostasis is 
returned to a higher level than before the bout of exercise (i.e., supercompensation). 
Importantly, the nature of the adaptations is specific to system that has been overloaded.  
It is clear that, whilst brief, the short ‘all-out’ sprints which constitute a ReHIT 
exercise session present an extreme challenge to both muscular metabolism and the 
cardiovascular system (Chapters 4 and 5), for example resulting in rapid reduction in 
muscle glycogen, large excursions in blood lactate, overloading of muscle and blood 
buffering mechanisms, a drop in plasma volume, rapid increases in heart rate (and likely 
blood flow, blood pressure, shear stress and altered oxygen tension) and a prolonged 
increase in oxygen consumption (Chapters 4 and 5). For many sedentary individuals, 
who in some cases will have been sedentary for the majority of their life, this is likely 
the first time they (i.e., their muscle and cardiovascular system) will have experienced 
such a dramatic disturbance in homeostasis. In addition, an often overlooked principle 
of exercise physiology, which is important in understanding the effects of exercise 
intensity on metabolic parameters, relates to the pattern of fibre recruitment (Mcphedran 
et al., 1965; Gordon et al., 2004).  According to this principle, a contracting muscle 
during low-moderate exercise contains both active and inactive muscle fibres; as 




exercise intensity increases further muscle fibres are recruited, and only during maximal 
exercise are the vast majority of muscle fibres ‘active’ (Mcphedran et al., 1965; Gordon 
et al., 2004). As such, compared with moderate intensity exercise, HIT/ReHIT is 
associated with the activation of a much larger muscle mass and, in turn, a greater 
number of fibres will adapt. This may have particular implications in terms of insulin 
action and metabolic control, as a larger portion of ‘metabolically hungry’ tissue will be 
available to take up glucose and to impact upon whole-body metabolic parameters 
(Defronzo & Tripathy, 2009). Likewise, it is likely that the modest disturbances in 
metabolic homeostasis experienced during moderate intensity continuous aerobic 
exercise require more prolonged and more frequent exercise bouts in order to activate 
relevant signalling pathways and initiate metabolic adaptations. In contrast, the 
disturbance in homeostasis with HIT predominantly occurs at the start of the initial sprint 
and is not enhanced much further with longer or repeated sprints (Parolin et al., 1999). 
In addition, certain metabolic changes, for example a drop in cytosolic ATP 
concentration, are unique to ‘all-out’ sprint exercise (Esbjornsson-Liljedahl et al., 1999; 
Esbjornsson-Liljedahl et al., 2002). The fact that the majority of the disturbance of 
physiological homeostasis occurs in the first portion of the first sprint may explain why 
the induced adaptations, for example an increase in VO2max, are similar for HIT 
protocols which utilise few and many, as well as short and long, sprint efforts so long as 
the required intensity is high enough (Hazell et al., 2010; Tjønna et al., 2013).  
7.3.2 Insulin Sensitivity: Improvement or Maintenance in Healthy Individuals?  
The studies in this thesis have largely been concerned with the impact of acute 
and chronic exercise on whole-body insulin action and glucose tolerance; in other words 
the changes in circulating blood glucose and insulin concentrations in response to 
standardised glucose loads. It is important to point out that the studies presented in this 
thesis have examined metabolically healthy individuals who, whilst sedentary, had no 
evidence of impaired glycaemic control. In such individuals, it could logically be argued 
that preventing the deterioration of insulin sensitivity over time could be just as 
important clinically as showing robust improvements in insulin sensitivity. In this 
regards, the assessment of postprandial insulin and glucose concentrations only 
represents one aspect of the potential effects of regular exercise. Perhaps as equally 
important in this population could be changes in the metabolic fate of ingested nutrients 




(Petersen et al., 2007; Rabøl et al., 2011). For example, a single bout of aerobic exercise 
has been shown to divert glucose away from hepatic de novo lipogenesis and towards 
more healthy muscle glycogen storage. Such changes were observed independently of 
changes in systemic insulin and glucose concentrations, and are likely the result of the 
exercise-induced reduction in muscle glycogen creating an increase drive for muscle 
glycogen resynthesis (Petersen et al., 2007; Rabøl et al., 2011). Over a prolonged period 
of time this may help to prevent both the development of dyslipidemia and the 
deterioration of whole-body insulin sensitivity (Petersen et al., 2007; Rabøl et al., 2011). 
It would be interesting to determine if single or repeated bouts of HIT/ReHIT are 
associated with a similar effect across a wide range of populations with normal and 
impaired glycaemic control.  
7.3.3. HIT/ReHIT in the context of overweight and obesity 
 The studies in this thesis have focused on sedentary individuals who in many 
cases were not overweight or obese. This decision was taken as inactivity, independent 
of body fatness, is an independent risk factor for both type 2 diabetes and cardiovascular 
disease (Booth et al., 2002; Chakravarthy & Booth, 2004; Katzmarzyk & Janssen, 2004; 
Thyfault & Krogh-Madsen, 2011). In addition, low cardiorespiratory fitness, not body 
fatness, is the strongest predictor of morbidity and mortality (Barlow et al., 1995; Lee et 
al., 1998; Lee et al., 1999), and an inactive lifestyle predisposes to low levels of aerobic 
fitness (Krogh-Madsen et al., 2010; Knudsen et al., 2012).  
Nevertheless, in the context of a culture where the prevalence of overweight and 
obesity are ever increasing, and exert major strains on public health care systems, the 
question is raised as to whether HIT/ReHIT would be beneficial in overweight men and 
women. In particular, one of the major motivations (both personally and clinically) of 
increasing physical activity in such populations is to aid in the loss of body fat. Whilst 
we have not assessed this directly in this series of studies, there is an accumulating 
number of papers showing that HIT is effective for reducing adiposity (Trapp et al., 
2008; Whyte et al., 2010; Heydari et al., 2012; Gillen et al., 2013). This appears to be 
explained by a prolonged increase in energy expenditure (i.e., for up to 24 hours post-
exercise!) and possibly also a suppression in appetite (Sim et al., 2013; Williams et al., 
2013).  In chapter 4, we showed modulation of key appetite regulating hormones and an 




increased post-exercise energy expenditure with ReHIT. As such, studies examining 
long term changes in body fat content with ReHIT are warranted. In the context of 
cardiometabolic fitness, which is arguably more important from the perspective of 
disease prevention, there is no reason to believe that HIT/ReHIT would not be effective 
in overweight/obese individuals (Whyte et al., 2010; Gillen et al., 2013; Gillen et al., 
2014). Indeed, a recent study reported improvements in aerobic capacity (men and 
women), oxidative capacity (men and women) and glycaemic regulation (men only) in 
a group of overweight individuals following HIT (Gillen et al., 2014).  
7.4. Limitations 
7.4.1. Limitations of training studies  
The findings of the two exercise training studies in this thesis must be considered 
within the context of several limitations which are implicit to all long term intervention 
studies. Firstly, although we performed a supervised intervention in both studies 
meaning incomplete training adaptations can be discounted, it was an otherwise free-
living study meaning that other chronic changes in lifestyle may have contributed to 
individual alterations in insulin sensitivity and aerobic capacity. Whilst we asked each 
participant not to make any conscious changes to their current diet and physical activity 
levels, we have no objective measures to confirm that this was adhered to.  
Perhaps more important to consider is our standardisation procedure for the 3 
days before each OGTT and aerobic capacity assessment. Specifically, we measured 
nutritional intake over the 3 days before each OGTT with food diaries; however, there 
are issues with regards to the validity and sensitivity of this measurement (Cook et al., 
2000). In future studies, in order to better isolate the effects of the training intervention, 
it would be beneficial (but costly) to provide each participant with their meals over these 
three day periods. We also asked each participant not to perform any moderate or 
strenuous exercise over the three days. We confirmed this with each participant verbally, 
but have no objective measure as support, and crucially this may overlook other 
important aspects of physical activity which could acutely influence the response to an 
OGTT. In future studies, it would be beneficial to obtain an objective measure of 
physical activity prior to each OGTT.   




A number of recent studies have shown that signalling and subsequent 
transcriptional response to an acute bout of exercise can be altered in response to changes 
in pre- and post-exercise nutrition. For example, carbohydrate restriction in the post-
exercise period can magnify the increase in GLUT and PGC1α mRNA levels during 
recovery (Holloszy, 2005), whilst carbohydrate feeding prior to exercise suppresses the 
subsequent activation of AMPK (Guerra et al., 2010). In light of these findings, it is 
worth noting that in the current series of training studies we did not control the timing 
or composition of nutrition in the hours before and after each training session. As such, 
it is entirely plausible to speculate that this may be a major cause of the variability in 
changes in insulin sensitivity in response to ReHIT (figure 7.2; figure 6.7) and indeed in 
response to other exercise interventions. This represents a limitation of the current thesis 
but offers multiple opportunities for future research. 
The timing of the post-training OGTT should also be considered as a limitation. 
We chose a 3 day post-exercise time point as we were specifically interested in isolating 
training adaptations, and previous studies have shown that the effects of a single bout of 
exercise on insulin sensitivity can last up to 48 hours (2 days) (Perseghin et al., 1998). 
However, training adaptations can be short-lived and we may have missed clinically 
important (or greater improvements) in insulin sensitivity in response to feedings on day 
1 and day 2 after completion of the training intervention. Indeed, previous HIT studies 
in obese individuals have demonstrated no effect of a single bout of HIT on insulin 
sensitivity (Whyte et al., 2013), yet improvements after a 2 week training intervention 
were evident at 1 day, but not at 3 days, after the final exercise session (Whyte et al., 
2010).  
7.4.2. Characterisation of physical activity at baseline 
Throughout this thesis we have primarily investigated the effects of ReHIT in 
participants who were sedentary at baseline. However, we characterised physical 
activity levels using a self-report questionnaire; participants were classified as sedentary 
if they were not achieving current guidelines for exercise participation according to the 
IPAQ (600 MET minutes consisting of 5 x 30 minutes/day of moderate, 3 x 20 
minutes/day of vigorous, or some combination of the two). However, there are issues 
with using self-reported physical activity measurements. Of particular relevance is the 




fact that IPAQ is not designed to pick up on other important physical activity dimensions 
such as total physical activity energy expenditure. It is possible to be classified as 
sedentary according to public health guidelines for exercise participation but still have 
high daily physical activity energy expenditure (Thompson et al., 2014). Likewise, the 
IPAQ is not designed to pick up very short sporadic bouts of very high intensity physical 
activity, yet this thesis has demonstrated this to have very important acute and chronic 
impacts on metabolism. It is possible that differences in baseline physical activity (not 
picked up by our IPAQ measure) could have impacted upon the response to the 
additional exercise stimulus applied in the training studies (Thompson et al., 2014). 
Indeed, this may be another contributing source to the large variability in adaptive 
response for some variables (e.g. insulin sensitivity) to exercise training (Thompson et 
al., 2014).  
7.4.3. Limitations of the fasting OGTT 
 The main outcome measure in this thesis was insulin sensitivity as measured 
during a fasting OGTT. The test-retest reliability of the OGTT has previously been 
highlighted as a concern; with relatively high coefficients of variation for repeated 
measures of glucose AUC (10%), insulin AUC (21%) and insulin sensitivity (14%) in 6 
week lifestyle maintenance control subjects (Chapter 1). This will clearly impact on our 
ability to pick up the true signal of the ReHIT intervention in the current series of studies. 
In this context, the lack of a control group in the second training study represents a major 
limitation.  
 Over and above the variability of the OGTT, it is also important to note that the 
OGTTs were performed in a fasted state. After an overnight fast, liver glycogen levels 
will be depleted and, as the liver has first refusal of any glucose taken up from the gut, 
the liver will be a major determinant of the glucose and insulin response to an oral 
glucose load on the fasted state. As such, the impact of changes in skeletal muscle insulin 
sensitivity (which are most likely to be altered with exercise (and ReHIT)) will be 
underestimated using a fasting based OGTT. This can be neatly demonstrated with a 
comparison of recent studies examining the acute effects of HIT on insulin sensitivity. 
Several studies, including Chapter 3 of this thesis, utilising a fasting OGTT have 
unequivocally shown that there are no acute alterations in insulin sensitivity with HIT 




(Brestoff et al., 2009; Richards et al., 2010 Whyte et al., 2013). However, a more recent 
study using an intravenous glucose tolerance test (IVGTT), which measures the response 
to a glucose load injected directly into the blood (and therefore misses the liver as a first 
passing), demonstrated large increases in insulin sensitivity which lasted up to 48 hours 
post-exercise (Ortega et al., 2014). Presumably this is because the effect of changes in 
skeletal muscle insulin sensitivity is being measured more directly with the IVGTT. 
Therefore, it would be worthwhile investigating the impact of ReHIT on insulin 
sensitivity (acute and training effects) using the IVGTT or the gold standard insulin 
clamp method.  
7.4.4. Limitations of the acute metabolic and molecular studies (chapter 4 and 5) 
In chapters 4 and 5 we examined the acute metabolic and molecular response to 
a single bout ReHIT. There are several limitations to consider in the interpretation of the 
main findings of these studies. Firstly we found that EPOC was more pronounced with 
ReHIT compared with a bout of aerobic exercise; however we did not take into account 
oxygen consumption during the exercise bout itself and total oxygen uptake would 
perhaps have been a more interesting comparison. Secondly we found alterations in 
acylated ghrelin following ReHIT in a direction which would be expected to suppress 
appetite (subjective appetite was not altered); however we did not include a measure of 
ad libitum energy intake to support these data. As such the relevance of the changes in 
acylated ghrelin with ReHIT on the final outcome remains unclear. The conclusions on 
both of these measures are limited to the 1.5 hour post-exercise measurement period.   
In chapter 5 we measured glycogen concentrations, AMPK and p38 MAPK 
activity and GLUT and PGC1a gene expression in response to a single bout of ReHIT. 
We assessed these changes in whole muscle homogenate. However, for glycogen this 
neglects possible regional subcellular differences in utilisation which may be important 
in determining downstream signalling and transcriptional responses. Likewise, this 
method fails to take into account potential changes in the localisation and regional 
activation of AMPK and p38 MAPK in response to exercise/ReHIT which are likely 
similarly important for initiating transcriptional changes with exercise. Moreover, 
although we measure increases in the transcription of GLUT4 and PGC1a in response 
to ReHIT, we did not include a protein measurement at a later time point, so have no 




way of knowing whether this led to a change in respective protein levels. Lastly, due to 
the invasiveness of the muscle biopsy technique, we could only include 3 post-exercise 
time points. As the activation in AMPK and p38 MAPK can be temporal it is possible 
we may have missed changes in activation at different time points during the recovery.  
7.5. Recommendations for Future Research 
The data presented in this thesis raise several potential areas for future research, 
including further characterisation of the training effects of ReHIT in healthy and clinical 
populations, further examination of the acute impact of ReHIT on insulin sensitivity at 
different post-exercise time points, further examination of the role of glycogen in acute 
exercise signalling responses and training adaptations, as well as wider issues relating 
long term adherence and clinical benefit in a free-living setting. In this section we will 
explore some study designs which could address these issues; where appropriate 
proposed experimental designs will be provided.  
7.6.1. Further characterisation of the training effects of ReHIT 
 As demonstrated in figure 7.1, this thesis has provided some evidence to suggest 
that 6 weeks of ReHIT may improve insulin sensitivity in sedentary men, but overall 
this contention remains unsubstantiated. As such, it is logical to suggest that future 
research should aim to further examine the effects of ReHIT on insulin sensitivity (and 
other biomarkers), not only in sedentary individuals but also in populations with 
impaired glucose tolerance (i.e., at high risk) and type 2 diabetics. The design for any 
future study attempting to answer these questions must take the form of a randomised 
controlled trial with a larger number of subjects, and should measure insulin sensitivity 
using the gold standard hyperinsulinemic euglycaemic clamp. A missing aspect of the 
training studies in the current thesis was the inclusion of tissue specific measures of 
insulin signalling and GLUT4 protein levels to support changes in the whole-body 
outcomes; future research should aim to include these.   
7.6.2. Further characterisation of the acute effects of ReHIT on insulin sensitivity 
 In chapter 3 of this thesis we showed that neither a single bout of ReHIT or 
vigorous aerobic exercise provided any benefit to insulin sensitivity when measure 14-




16 hours post-exercise. Participants were provided with a standardised meal (relatively 
high in carbohydrate content) immediately post-exercise, so in effect we were measuring 
insulin sensitivity in response to the second feeding. As such, a logical follow up 
question to ask is: does ReHIT or aerobic exercise improve insulin sensitivity in response 
to the first post-exercise feeding? The proposed research design to answer this question 
is shown in figure 8.3. Once again it would be optimal to substitute the OGTT 
measurement utilised in Chapter 3 for the gold standard hyperinsulinemic euglycaemic 
clamp. This represents a relatively straight forward research design in its simplest form, 
but again could be combined with tissue specific measures of gene expression or insulin 
signalling to support whole body measures. The application of tracer technologies 
during the OGTT/mixed meal/hyperinsulinemic clamp to track the fate of ingested 




Figure 7.3.  A potential randomised cross-over research design to examine if a single 
bout of ReHIT or aerobic exercise improves insulin sensitivity in response to the first 
feeding.  
 
7.6.3. The Role of Glycogen in Regulating Adaptations with Exercise Training 
The hypothesis that glycogen has a role in exercise induced adaptation has been 
a central theme throughout several chapters in this thesis (Chapters 2, 4, 5 and 6). We 
demonstrated that ReHIT reduced muscle glycogen levels by ~20% and this may largely 
explain several of the downstream signalling/transcriptional responses (Chapter 5) and 
the changes in whole body metabolic homeostasis (Chapter 4). The fact that the 
















sensitivity in response to ReHIT (Chapter 7) supports the hypothesis that glycogen 
turnover regulates adaptations in carbohydrate metabolism. However, this is by no 
means conclusive and further studies are required to examine this relationship.  
It is also plausible to hypothesise that glycogen degradation may indirectly be 
linked to the consistent improvements in aerobic capacity with ReHIT (Chapter 2 and 
6). Briefly, the rapid breakdown of glycogen is likely to create a hypertonic intracellular 
environment and draw water from the cardiovascular system into the intracellular space 
(Philp et al., 2014). This may therefore explain the substantial drop in plasma volume 
measured in the immediate recovery (Chapter 4). Interestingly, increases in blood 
volume appear to play an important role in the improvements in aerobic capacity with 
exercise training (Bonne et al., 2014) and it is plausible that a reduction in plasma 
volume may evoke signalling mechanisms underpinning this change with ReHIT.  
Linking acute disturbances in skeletal muscle and whole-body metabolisms with 
longer term adaptations to training is an important area of research, yet few studies 
examine these two effects in the same group of subjects and within the context of the 
same intervention period. With the aim of examining the role of glycogen depletion in 
exercise induced adaptation, it would be interesting to correlate acute glycogen 
utilisation, plasma volume changes and associated signalling and transcriptional 
responses in muscle, with long term changes in insulin sensitivity and aerobic capacity. 
Similar approaches have been used to examine whether acute changes in muscle protein 
synthesis with resistance exercise can predict the magnitude of hypertrophy with 
resistance training (Mitchell et al., 2014). A schematic of a potential research design to 
examine this question is shown in figure 8.4.  
Briefly, each participant would complete a 6-week exercise training intervention 
with assessments of insulin sensitivity (clamp) and aerobic capacity measured pre- and 
post-training. During the first and last training session the acute responses (substrate 
utilisation, plasma volume changes, signalling response and gene expression) would be 
measured. More complex measures such as changes in specific subcellular glycogen 
deposits (by transmission electron microscopy) and localisation of signalling proteins in 
muscle (by separating the nuclear, mitochondrial and cytosolic subfractions) could be 
built into these acute testing days. The pre exercise biopsy during the acute sessions 
would also allow the muscle specific adaptations to the exercise training intervention to 




be characterised. The acute changes in glycogen and associate signalling/transcription 
responses would then be correlated with chronic changes in insulin sensitivity, whilst 
the acute changes in plasma volume would be correlated with chronic changes in aerobic 
capacity.  
There are of course practical limitations to such a study design; it is relatively 
resource/time heavy, would require significant financial support, and the inclusion of 
multiple testing days and extensive blood and tissue sampling would place significant 
burden on the participants. However, the development of new techniques for obtaining 
muscle biopsies (e.g. the biopsy gun rather than the Bergstrom needle) is making it easier 
to administer and less invasive, whilst still allowing sufficient quantity and quality of 
muscle to be obtained for analysis. Likewise, the number of muscle biopsies could be 
reduced to 6 by removing the 24 hour sample. Overall, the potential quality of the data, 
and indeed the breadth of research questions able to be answered with such a study 
design, means it would be well worth the associated time and resources.  
 
 
Figure 7.4. Schematic of a possible study design to examine the interactions between 
acute responses and chronic adaptations. Insulin sensitivity and aerobic capacity would be 
assessed before and after the 6-week exercise intervention. During the first (1) and last (18) 
training sessions, the acute responses (substrate utilisation, signalling, gene expression, protein 
expression etc.) to the exercise bout would be assessed.  
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 The work in this thesis has attempted to characterise the effect of a reduced-
exertion HIT (ReHIT) protocol on insulin sensitivity and aerobic capacity. Despite the 
exaggerated disturbance of skeletal muscle and whole-body metabolic homeostasis 
(Chapters 4 and 5), data collected on levels of exertion during a ReHIT bout suggest that 
the exercise was well tolerated by participants (Chapters 2, 4 and 6). There was some 
evidence for improvements in key disease biomarkers following ReHIT, with 
improvements in insulin sensitivity observed in men (see section 7.2.1 of general 
discussion) and improvements in VO2max observed in both men and women (Chapter 2 
and 6). These findings provide support for the hypothesis that glycogen plays an 
important regulatory role on the adaptive responses to exercise training (Chapter2). 
However, the improvements in insulin sensitivity in men were not consistent between 
the two training studies conducted (Chapter 2 and 6) and there was a high level of 
variability observed between individuals (see section 7.2.3 of general discussion). As 
such, the impact of ReHIT on insulin sensitivity needs to be further characterised in the 
context of a randomised controlled trial. Likewise, studies examining the mechanisms 
underpinning the variability in the adaptive response to exercise/ReHIT are warranted. 
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